index,title,organ,organismId,sex,lifestage
KE 142,"Hyperplasia, Hyperplasia",liver,Not specified,['Not specified'],['Not specified']
KE 334,"Promotion, Hepatocelluar carcinoma",liver,Not specified,['Not specified'],['Not specified']
KE 57,"Proliferation, Cell proliferation in the absence of cytotoxicity",,Not specified,['Not specified'],['Not specified']
KE 294,"N/A, Unknown",,Not specified,['Not specified'],['Not specified']
KE 887,"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)",,9606,['Not specified'],['Not specified']
KE 887,"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)",,10118,['Not specified'],['Not specified']
KE 887,"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)",,10090,['Not specified'],['Not specified']
KE 888,"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)",,9606,['Not specified'],['Not specified']
KE 888,"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)",,10116,['Not specified'],['Not specified']
KE 888,"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)",,10090,['Not specified'],['Not specified']
KE 177,Mitochondrial dysfunction,,9606,['Unspecific'],['All life stages']
KE 177,Mitochondrial dysfunction,,10090,['Unspecific'],['All life stages']
KE 177,Mitochondrial dysfunction,,10116,['Unspecific'],['All life stages']
KE 889,"Impaired, Proteostasis",,9606,['Not specified'],['Not specified']
KE 889,"Impaired, Proteostasis",,10116,['Not specified'],['Not specified']
KE 889,"Impaired, Proteostasis",,10090,['Not specified'],['Not specified']
KE 188,Neuroinflammation,brain,10116,['Mixed'],"['During brain development, adulthood and aging']"
KE 188,Neuroinflammation,brain,10090,['Mixed'],"['During brain development, adulthood and aging']"
KE 188,Neuroinflammation,brain,9606,['Mixed'],"['During brain development, adulthood and aging']"
KE 188,Neuroinflammation,brain,7955,['Mixed'],"['During brain development, adulthood and aging']"
KE 188,Neuroinflammation,brain,9541,['Mixed'],"['During brain development, adulthood and aging']"
KE 890,Degeneration of dopaminergic neurons of the nigrostriatal pathway,,9606,['Not specified'],['Not specified']
KE 890,Degeneration of dopaminergic neurons of the nigrostriatal pathway,,10116,['Not specified'],['Not specified']
KE 890,Degeneration of dopaminergic neurons of the nigrostriatal pathway,,10090,['Not specified'],['Not specified']
KE 896,Parkinsonian motor deficits,,9606,['Not specified'],['Not specified']
KE 896,Parkinsonian motor deficits,,10116,['Not specified'],['Not specified']
KE 896,Parkinsonian motor deficits,,10090,['Not specified'],['Not specified']
KE 103,"Increase, Ecdysone receptor agonism",,Not specified,['Not specified'],['Not specified']
KE 988,"Decrease, Circulating ecdysis triggering hormone",,Not specified,['Not specified'],['Not specified']
KE 990,"Increase, Incomplete ecdysis",,Not specified,['Not specified'],['Not specified']
KE 993,"Decrease, Abdominal muscle contraction",somatic muscle,Not specified,['Not specified'],['Not specified']
KE 1264,"Increase, Nuclear receptor E75b gene expression",,Not specified,['Not specified'],['Not specified']
KE 1265,"Increase, Fushi tarazu factor-1 gene expression",,Not specified,['Not specified'],['Not specified']
KE 1266,"Decrease, Circulating crustacean cardioactive peptide",haemolymphatic fluid,Not specified,['Not specified'],['Not specified']
KE 1267,"Decrease, Ecdysis motoneuron bursts",nervous system,Not specified,['Not specified'],['Not specified']
KE 1268,"Decrease, Excitatory postsynaptic potential",somatic muscle,Not specified,['Not specified'],['Not specified']
KE 350,"Increase, Mortality",,7375,['Unspecific'],['All life stages']
KE 350,"Increase, Mortality",,35525,['Unspecific'],['All life stages']
KE 858,"Decreased, PPARalpha transactivation of gene expression",,9606,"['Male', 'Female']",['Not Otherwise Specified']
KE 858,"Decreased, PPARalpha transactivation of gene expression",,10090,"['Male', 'Female']",['Not Otherwise Specified']
KE 861,"Decreased, Ketogenesis (production of ketone bodies)",,10090,"['Male', 'Female']","['Not Otherwise Specified', 'Adults']"
KE 861,"Decreased, Ketogenesis (production of ketone bodies)",,9606,"['Male', 'Female']","['Not Otherwise Specified', 'Adults']"
KE 862,"Not Increased, Circulating Ketone Bodies",blood,9606,"['Male', 'Female']","['Not Otherwise Specified', 'Adults']"
KE 862,"Not Increased, Circulating Ketone Bodies",blood,10090,"['Male', 'Female']","['Not Otherwise Specified', 'Adults']"
KE 864,"Decreased, Body Weight",,9606,"['Male', 'Female']",['Adults']
KE 864,"Decreased, Body Weight",,10090,"['Male', 'Female']",['Adults']
KE 864,"Decreased, Body Weight",,9014,"['Male', 'Female']",['Adults']
KE 863,"Increased, Catabolism of Muscle Protein",musculoskeletal system,9606,"['Male', 'Female']",['Adults']
KE 863,"Increased, Catabolism of Muscle Protein",musculoskeletal system,10090,"['Male', 'Female']",['Adults']
KE 863,"Increased, Catabolism of Muscle Protein",musculoskeletal system,10117,"['Male', 'Female']",['Adults']
KE 998,"Binding of antagonist, PPAR alpha",,9606,['Unspecific'],['Not Otherwise Specified']
KE 998,"Binding of antagonist, PPAR alpha",,4932,['Unspecific'],['Not Otherwise Specified']
KE 1000,"stabilization, PPAR alpha co-repressor",,9606,['Not specified'],['Not specified']
KE 1000,"stabilization, PPAR alpha co-repressor",,4932,['Not specified'],['Not specified']
KE 1528,"Fatty Acid Beta Oxidation, Decreased",,9606,"['Male', 'Female']","['Adult, reproductively mature']"
KE 1528,"Fatty Acid Beta Oxidation, Decreased",,10090,"['Male', 'Female']","['Adult, reproductively mature']"
KE 219,"Reduction, Plasma 17beta-estradiol concentrations",blood plasma,10116,['Unspecific'],['Adult']
KE 219,"Reduction, Plasma 17beta-estradiol concentrations",blood plasma,9606,['Unspecific'],['Adult']
KE 219,"Reduction, Plasma 17beta-estradiol concentrations",blood plasma,90988,['Unspecific'],['Adult']
KE 219,"Reduction, Plasma 17beta-estradiol concentrations",blood plasma,8078,['Unspecific'],['Adult']
KE 3,"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells",,90988,['Female'],"['Adult, reproductively mature']"
KE 3,"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells",,8078,['Female'],"['Adult, reproductively mature']"
KE 406,"decreased, Fertility",,10116,"['Male', 'Female']","['Adult, reproductively mature', 'Juvenile', 'Adults']"
KE 406,"decreased, Fertility",,10090,"['Male', 'Female']","['Adult, reproductively mature', 'Juvenile', 'Adults']"
KE 406,"decreased, Fertility",,9606,"['Male', 'Female']","['Adult, reproductively mature', 'Juvenile', 'Adults']"
KE 405,"disrupted, ovarian cycle",,10095,['Female'],"['Adult, reproductively mature']"
KE 405,"disrupted, ovarian cycle",,10116,['Female'],"['Adult, reproductively mature']"
KE 408,"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)",,10116,['Not specified'],['Not specified']
KE 408,"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)",,9606,['Not specified'],['Not specified']
KE 408,"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)",,7955,['Not specified'],['Not specified']
KE 239,"Activation, Pregnane-X receptor, NR1l2",,10116,['Unspecific'],['All life stages']
KE 239,"Activation, Pregnane-X receptor, NR1l2",,10090,['Unspecific'],['All life stages']
KE 239,"Activation, Pregnane-X receptor, NR1l2",,9606,['Unspecific'],['All life stages']
KE 319,"Loss, Cochlear function",ear,10116,['Not specified'],['Not specified']
KE 280,"Thyroxine (T4) in neuronal tissue, Decreased",brain,9606,"['Female', 'Male']",['During brain development']
KE 280,"Thyroxine (T4) in neuronal tissue, Decreased",brain,10116,"['Female', 'Male']",['During brain development']
KE 280,"Thyroxine (T4) in neuronal tissue, Decreased",brain,9031,"['Female', 'Male']",['During brain development']
KE 281,"Thyroxine (T4) in serum, Decreased",serum,9606,"['Female', 'Male']",['All life stages']
KE 281,"Thyroxine (T4) in serum, Decreased",serum,10116,"['Female', 'Male']",['All life stages']
KE 281,"Thyroxine (T4) in serum, Decreased",serum,10090,"['Female', 'Male']",['All life stages']
KE 281,"Thyroxine (T4) in serum, Decreased",serum,9031,"['Female', 'Male']",['All life stages']
KE 281,"Thyroxine (T4) in serum, Decreased",serum,8355,"['Female', 'Male']",['All life stages']
KE 281,"Thyroxine (T4) in serum, Decreased",serum,7955,"['Female', 'Male']",['All life stages']
KE 281,"Thyroxine (T4) in serum, Decreased",serum,90988,"['Female', 'Male']",['All life stages']
KE 281,"Thyroxine (T4) in serum, Decreased",serum,9823,"['Female', 'Male']",['All life stages']
KE 295,"Induction, Upregulation of glucuronyltransferase activity",,8355,['Not specified'],['Not specified']
KE 295,"Induction, Upregulation of glucuronyltransferase activity",,10116,['Not specified'],['Not specified']
KE 757,"Hippocampal anatomy, Altered",brain,10090,"['Male', 'Female']",['During brain development']
KE 757,"Hippocampal anatomy, Altered",brain,10116,"['Male', 'Female']",['During brain development']
KE 757,"Hippocampal anatomy, Altered",brain,9606,"['Male', 'Female']",['During brain development']
KE 758,"Hippocampal Physiology, Altered",brain,9606,"['Female', 'Male']",['During brain development']
KE 758,"Hippocampal Physiology, Altered",brain,10116,"['Female', 'Male']",['During brain development']
KE 758,"Hippocampal Physiology, Altered",brain,10090,"['Female', 'Male']",['During brain development']
KE 756,"Hippocampal gene expression, Altered",brain,10090,"['Female', 'Male']",['During brain development']
KE 756,"Hippocampal gene expression, Altered",brain,10116,"['Female', 'Male']",['During brain development']
KE 756,"Hippocampal gene expression, Altered",brain,9606,"['Female', 'Male']",['During brain development']
KE 961,"Increased, Clearance of thyroxine from serum",liver,8355,['Not specified'],['Not specified']
KE 961,"Increased, Clearance of thyroxine from serum",liver,10118,['Not specified'],['Not specified']
KE 961,"Increased, Clearance of thyroxine from serum",liver,10090,['Not specified'],['Not specified']
KE 64,"Reduction, Ionotropic GABA receptor chloride channel conductance",brain,9606,['Not specified'],['Not specified']
KE 64,"Reduction, Ionotropic GABA receptor chloride channel conductance",brain,10116,['Not specified'],['Not specified']
KE 64,"Reduction, Ionotropic GABA receptor chloride channel conductance",brain,10090,['Not specified'],['Not specified']
KE 64,"Reduction, Ionotropic GABA receptor chloride channel conductance",brain,7227,['Not specified'],['Not specified']
KE 616,"Occurrence, A paroxysmal depolarizing shift",brain,9606,['Unspecific'],['Adult']
KE 616,"Occurrence, A paroxysmal depolarizing shift",brain,10116,['Unspecific'],['Adult']
KE 613,"Occurrence, Epileptic seizure",,9606,['Unspecific'],['Adult']
KE 613,"Occurrence, Epileptic seizure",,10116,['Unspecific'],['Adult']
KE 613,"Occurrence, Epileptic seizure",,10090,['Unspecific'],['Adult']
KE 613,"Occurrence, Epileptic seizure",,7460,['Unspecific'],['Adult']
KE 613,"Occurrence, Epileptic seizure",,6396,['Unspecific'],['Adult']
KE 667,"Binding at picrotoxin site, iGABAR chloride channel",brain,9606,['Unspecific'],['Adult']
KE 667,"Binding at picrotoxin site, iGABAR chloride channel",brain,10116,['Unspecific'],['Adult']
KE 667,"Binding at picrotoxin site, iGABAR chloride channel",brain,7227,['Unspecific'],['Adult']
KE 667,"Binding at picrotoxin site, iGABAR chloride channel",brain,10090,['Unspecific'],['Adult']
KE 667,"Binding at picrotoxin site, iGABAR chloride channel",brain,9615,['Unspecific'],['Adult']
KE 669,"Reduction, Neuronal synaptic inhibition",,10116,['Unspecific'],['Adult']
KE 669,"Reduction, Neuronal synaptic inhibition",,10141,['Unspecific'],['Adult']
KE 669,"Reduction, Neuronal synaptic inhibition",,9606,['Unspecific'],['Adult']
KE 669,"Reduction, Neuronal synaptic inhibition",,93934,['Unspecific'],['Adult']
KE 682,"Generation, Amplified excitatory postsynaptic potential (EPSP)",brain,10090,['Unspecific'],['Adult']
KE 682,"Generation, Amplified excitatory postsynaptic potential (EPSP)",brain,10116,['Unspecific'],['Adult']
KE 682,"Generation, Amplified excitatory postsynaptic potential (EPSP)",brain,10141,['Unspecific'],['Adult']
KE 245,"Activation, PXR/SXR",,Not specified,['Not specified'],['Not specified']
KE 195,"Inhibition, NMDARs",,9606,['Not specified'],['Not specified']
KE 195,"Inhibition, NMDARs",,10116,['Not specified'],['Not specified']
KE 195,"Inhibition, NMDARs",,10090,['Not specified'],['Not specified']
KE 352,"N/A, Neurodegeneration",brain,9606,['Mixed'],"['During brain development, adulthood and aging']"
KE 352,"N/A, Neurodegeneration",brain,10090,['Mixed'],"['During brain development, adulthood and aging']"
KE 352,"N/A, Neurodegeneration",brain,7955,['Mixed'],"['During brain development, adulthood and aging']"
KE 52,"Decreased, Calcium influx",,9606,['Not specified'],['Not specified']
KE 52,"Decreased, Calcium influx",,10116,['Not specified'],['Not specified']
KE 52,"Decreased, Calcium influx",,10095,['Not specified'],['Not specified']
KE 52,"Decreased, Calcium influx",,7955,['Not specified'],['Not specified']
KE 201,"Binding of antagonist, NMDA receptors",,9606,['Not specified'],['Not specified']
KE 201,"Binding of antagonist, NMDA receptors",,10116,['Not specified'],['Not specified']
KE 201,"Binding of antagonist, NMDA receptors",,10090,['Not specified'],['Not specified']
KE 381,Reduced levels of BDNF,,9606,['Mixed'],['During brain development']
KE 381,Reduced levels of BDNF,,10116,['Mixed'],['During brain development']
KE 381,Reduced levels of BDNF,,10090,['Mixed'],['During brain development']
KE 55,"Increase, Cell injury/death",,9606,['Unspecific'],['All life stages']
KE 55,"Increase, Cell injury/death",,9606,['Unspecific'],['All life stages']
KE 55,"Increase, Cell injury/death",,10116,['Unspecific'],['All life stages']
KE 55,"Increase, Cell injury/death",,10090,['Unspecific'],['All life stages']
KE 341,"Impairment, Learning and memory",,9606,['Mixed'],"['During brain development', 'Adult, reproductively mature']"
KE 341,"Impairment, Learning and memory",,10116,['Mixed'],"['During brain development', 'Adult, reproductively mature']"
KE 341,"Impairment, Learning and memory",,7227,['Mixed'],"['During brain development', 'Adult, reproductively mature']"
KE 341,"Impairment, Learning and memory",,7955,['Mixed'],"['During brain development', 'Adult, reproductively mature']"
KE 341,"Impairment, Learning and memory",,160004,['Mixed'],"['During brain development', 'Adult, reproductively mature']"
KE 341,"Impairment, Learning and memory",,10090,['Mixed'],"['During brain development', 'Adult, reproductively mature']"
KE 382,"Aberrant, Dendritic morphology",,9606,['Not specified'],['Not specified']
KE 382,"Aberrant, Dendritic morphology",,10116,['Not specified'],['Not specified']
KE 382,"Aberrant, Dendritic morphology",,10090,['Not specified'],['Not specified']
KE 382,"Aberrant, Dendritic morphology",,9031,['Not specified'],['Not specified']
KE 382,"Aberrant, Dendritic morphology",,7227,['Not specified'],['Not specified']
KE 385,Decrease of synaptogenesis,,9606,['Mixed'],['During brain development']
KE 385,Decrease of synaptogenesis,,10116,['Mixed'],['During brain development']
KE 385,Decrease of synaptogenesis,,10090,['Mixed'],['During brain development']
KE 386,Decrease of neuronal network function,brain,9606,['Mixed'],['During brain development']
KE 386,Decrease of neuronal network function,brain,10116,['Mixed'],['During brain development']
KE 386,Decrease of neuronal network function,brain,10095,['Mixed'],['During brain development']
KE 386,Decrease of neuronal network function,brain,9685,['Mixed'],['During brain development']
KE 383,"Reduced, Presynaptic release of glutamate",,9606,['Not specified'],['Not specified']
KE 383,"Reduced, Presynaptic release of glutamate",,10116,['Not specified'],['Not specified']
KE 383,"Reduced, Presynaptic release of glutamate",,10095,['Not specified'],['Not specified']
KE 122,"Activation, Glucocorticoid Receptor",,Not specified,['Mixed'],['All life stages']
KE 202,"Inhibition, Nuclear factor kappa B (NF-kB)",immune system,9606,['Unspecific'],['All life stages']
KE 202,"Inhibition, Nuclear factor kappa B (NF-kB)",immune system,10090,['Unspecific'],['All life stages']
KE 202,"Inhibition, Nuclear factor kappa B (NF-kB)",immune system,10116,['Unspecific'],['All life stages']
KE 152,"Suppression, Inflammatory cytokines",,Not specified,['Not specified'],['Not specified']
KE 168,"Decreased, Lymphocytes",,Not specified,['Not specified'],['Not specified']
KE 145,"Induction, IKB inhibitory protein",,Not specified,['Not specified'],['Not specified']
KE 323,"Increased, Disease susceptibility",,Not specified,['Not specified'],['Not specified']
KE 403,"Suppression, Immune system",,Not specified,['Not specified'],['Not specified']
KE 336,"Increase, Heritable mutations in offspring",,10090,['Not specified'],['Not specified']
KE 336,"Increase, Heritable mutations in offspring",,8090,['Not specified'],['Not specified']
KE 336,"Increase, Heritable mutations in offspring",,7227,['Not specified'],['Not specified']
KE 97,"Alkylation, DNA",,10090,['Mixed'],['Not specified']
KE 97,"Alkylation, DNA",,10036,['Mixed'],['Not specified']
KE 97,"Alkylation, DNA",,10116,['Mixed'],['Not specified']
KE 97,"Alkylation, DNA",,9606,['Mixed'],['Not specified']
KE 185,"Increase, Mutations",,10090,['Unspecific'],['All life stages']
KE 185,"Increase, Mutations",,8090,['Unspecific'],['All life stages']
KE 185,"Increase, Mutations",,10116,['Unspecific'],['All life stages']
KE 185,"Increase, Mutations",,9606,['Unspecific'],['All life stages']
KE 155,Inadequate DNA repair,,10090,['Unspecific'],['All life stages']
KE 155,Inadequate DNA repair,,10116,['Unspecific'],['All life stages']
KE 155,Inadequate DNA repair,,10036,['Unspecific'],['All life stages']
KE 155,Inadequate DNA repair,,9606,['Unspecific'],['All life stages']
KE 155,Inadequate DNA repair,,9913,['Unspecific'],['All life stages']
KE 351,Increased Mortality,,131567,['Unspecific'],['All life stages']
KE 12,Acetylcholinesterase (AchE) Inhibition,nervous system,Not specified,['Unspecific'],['All life stages']
KE 10,Acetylcholine accumulation in synapses,,7955,['Unspecific'],['All life stages']
KE 445,Respiratory distress/arrest,respiration organ,Not specified,['Not specified'],['Not specified']
KE 39,Increased Cholinergic Signaling,nervous system,Not specified,['Not specified'],['Not specified']
KE 1703,Dysregulation of heart rate and vascular tone,,Not specified,['Not specified'],['Not specified']
KE 360,"Decrease, Population growth rate",,131567,['Unspecific'],['All life stages']
KE 1487,"Binding, Thiol/seleno-proteins involved in protection against oxidative stress",brain,10116,"['Female', 'Male']",['During brain development']
KE 1487,"Binding, Thiol/seleno-proteins involved in protection against oxidative stress",brain,10090,"['Female', 'Male']",['During brain development']
KE 1487,"Binding, Thiol/seleno-proteins involved in protection against oxidative stress",brain,7955,"['Female', 'Male']",['During brain development']
KE 1487,"Binding, Thiol/seleno-proteins involved in protection against oxidative stress",brain,9606,"['Female', 'Male']",['During brain development']
KE 1487,"Binding, Thiol/seleno-proteins involved in protection against oxidative stress",brain,9031,"['Female', 'Male']",['During brain development']
KE 1392,Oxidative Stress,,10116,['Mixed'],['All life stages']
KE 1392,Oxidative Stress,,9606,['Mixed'],['All life stages']
KE 1488,Glutamate dyshomeostasis,brain,Not specified,['Not specified'],['Not specified']
KE 1492,Tissue resident cell activation,,9606,['Not specified'],['All life stages']
KE 1492,Tissue resident cell activation,,9541,['Not specified'],['All life stages']
KE 1492,Tissue resident cell activation,,10116,['Not specified'],['All life stages']
KE 1492,Tissue resident cell activation,,10090,['Not specified'],['All life stages']
KE 1492,Tissue resident cell activation,,7955,['Not specified'],['All life stages']
KE 1493,Increased Pro-inflammatory mediators,,9606,['Unspecific'],['All life stages']
KE 1493,Increased Pro-inflammatory mediators,,7742,['Unspecific'],['All life stages']
KE 1538,Decreased protection against oxidative stress,brain,10116,"['Male', 'Female']",['All life stages']
KE 1538,Decreased protection against oxidative stress,brain,10090,"['Male', 'Female']",['All life stages']
KE 1538,Decreased protection against oxidative stress,brain,9606,"['Male', 'Female']",['All life stages']
KE 227,"Activation, PPARα",liver,10116,['Not specified'],['Not specified']
KE 227,"Activation, PPARα",liver,10090,['Not specified'],['Not specified']
KE 227,"Activation, PPARα",liver,9606,['Not specified'],['Not specified']
KE 266,"Decrease, Steroidogenic acute regulatory protein (STAR)",,10090,['Not specified'],['Not specified']
KE 266,"Decrease, Steroidogenic acute regulatory protein (STAR)",,9606,['Not specified'],['Not specified']
KE 266,"Decrease, Steroidogenic acute regulatory protein (STAR)",,10116,['Not specified'],['Not specified']
KE 447,"Reduction, Cholesterol transport in mitochondria",,10090,['Not specified'],['Not specified']
KE 447,"Reduction, Cholesterol transport in mitochondria",,9606,['Not specified'],['Not specified']
KE 447,"Reduction, Cholesterol transport in mitochondria",,10116,['Not specified'],['Not specified']
KE 413,"Reduction, Testosterone synthesis in Leydig cells",,10116,['Not specified'],['Not specified']
KE 413,"Reduction, Testosterone synthesis in Leydig cells",,9606,['Not specified'],['Not specified']
KE 413,"Reduction, Testosterone synthesis in Leydig cells",,10095,['Not specified'],['Not specified']
KE 289,"Decrease, Translocator protein (TSPO)",,9606,['Not specified'],['Not specified']
KE 289,"Decrease, Translocator protein (TSPO)",,10116,['Not specified'],['Not specified']
KE 289,"Decrease, Translocator protein (TSPO)",,10090,['Not specified'],['Not specified']
KE 348,"Malformation, Male reproductive tract",male reproductive system,9606,['Not specified'],['Not specified']
KE 348,"Malformation, Male reproductive tract",male reproductive system,10116,['Not specified'],['Not specified']
KE 1690,"Decrease, circulating testosterone levels",blood,40674,"['Male', 'Female']",['During development and at adulthood']
KE 310,"Alteration, Wnt pathway",,Not specified,['Not specified'],['Not specified']
KE 240,"Feminisation or incomplete development, Primary and accessory male sex organs",male reproductive system,Not specified,['Not specified'],['Not specified']
KE 286,"Altered, Transcription of genes by the androgen receptor",,40674,['Mixed'],['During development and at adulthood']
KE 337,"N/A, Impairment of reproductive capacity",,Not specified,['Not specified'],['Not specified']
KE 26,"Antagonism, Androgen receptor",,40674,['Mixed'],['During development and at adulthood']
KE 18,"Activation, AhR",,7955,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,9031,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,143350,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,7904,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,41871,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,8022,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,8030,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,8355,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,8296,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,9054,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,93934,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,10090,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,10116,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,9606,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,34823,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 18,"Activation, AhR",,9606,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,9031,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,7955,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,10090,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,93934,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,9054,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,8022,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,143350,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,41871,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,7904,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,8030,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,8355,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,9606,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,8296,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 944,"dimerization, AHR/ARNT",,34823,['Unspecific'],"['Embryo', 'Development', 'All life stages']"
KE 317,"Altered, Cardiovascular development/function",heart,7742,['Unspecific'],['Embryo']
KE 317,"Altered, Cardiovascular development/function",heart,50557,['Unspecific'],['Embryo']
KE 1269,"Increase, COX-2 expression",,7955,['Unspecific'],['Embryo']
KE 1269,"Increase, COX-2 expression",,8090,['Unspecific'],['Embryo']
KE 1269,"Increase, COX-2 expression",,9031,['Unspecific'],['Embryo']
KE 1269,"Increase, COX-2 expression",,10090,['Unspecific'],['Embryo']
KE 1269,"Increase, COX-2 expression",,9606,['Unspecific'],['Embryo']
KE 947,"Increase, Early Life Stage Mortality",,7742,['Unspecific'],"['Embryo', 'Foetal', 'Development']"
KE 25,"Agonism, Androgen receptor",,90988,"['Female', 'Male']","['Adult, reproductively mature', 'During development and at adulthood']"
KE 25,"Agonism, Androgen receptor",,8090,"['Female', 'Male']","['Adult, reproductively mature', 'During development and at adulthood']"
KE 25,"Agonism, Androgen receptor",,40674,"['Female', 'Male']","['Adult, reproductively mature', 'During development and at adulthood']"
KE 274,"Reduction, Testosterone synthesis by ovarian theca cells",,90988,['Female'],"['Adult, reproductively mature']"
KE 274,"Reduction, Testosterone synthesis by ovarian theca cells",,8078,['Female'],"['Adult, reproductively mature']"
KE 285,"Reduction, Vitellogenin synthesis in liver",liver,90988,"['Unspecific', 'Female']","['Adult, reproductively mature']"
KE 285,"Reduction, Vitellogenin synthesis in liver",liver,8078,"['Unspecific', 'Female']","['Adult, reproductively mature']"
KE 285,"Reduction, Vitellogenin synthesis in liver",liver,8090,"['Unspecific', 'Female']","['Adult, reproductively mature']"
KE 285,"Reduction, Vitellogenin synthesis in liver",liver,7955,"['Unspecific', 'Female']","['Adult, reproductively mature']"
KE 78,"Reduction, Cumulative fecundity and spawning",,90988,['Female'],"['Adult, reproductively mature']"
KE 78,"Reduction, Cumulative fecundity and spawning",,8078,['Female'],"['Adult, reproductively mature']"
KE 78,"Reduction, Cumulative fecundity and spawning",,8090,['Female'],"['Adult, reproductively mature']"
KE 221,"Reduction, Plasma vitellogenin concentrations",blood plasma,90988,['Not specified'],"['Adult, reproductively mature']"
KE 221,"Reduction, Plasma vitellogenin concentrations",blood plasma,8090,['Not specified'],"['Adult, reproductively mature']"
KE 221,"Reduction, Plasma vitellogenin concentrations",blood plasma,7955,['Not specified'],"['Adult, reproductively mature']"
KE 309,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",,90988,['Female'],"['Adult, reproductively mature']"
KE 309,"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development",,8090,['Female'],"['Adult, reproductively mature']"
KE 129,"Reduction, Gonadotropins, circulating concentrations",blood plasma,Not specified,['Unspecific'],['Not Otherwise Specified']
KE 36,"Inhibition, Aromatase",ovary growing follicle,7742,['Unspecific'],['All life stages']
KE 51,"Inhibition, Ca++ ATPase",,Not specified,['Not specified'],['Not specified']
KE 50,"Increase, Ca++ (intracellular)",,Not specified,['Not specified'],['Not specified']
KE 178,"Disruption, Mitochondrial electron transport chain",,Not specified,['Not specified'],['Not specified']
KE 40,"Decrease, Mitochondrial ATP production",,Not specified,['Not specified'],['Not specified']
KE 193,"Decreased, Nitric Oxide",,Not specified,['Not specified'],['Not specified']
KE 166,"Decreased, Long-term potentiation (LTP)",nervous system,Not specified,['Not specified'],['Not specified']
KE 1115,"Increase, Reactive oxygen species",organ,7742,['Unspecific'],['All life stages']
KE 1115,"Increase, Reactive oxygen species",organ,9606,['Unspecific'],['All life stages']
KE 1115,"Increase, Reactive oxygen species",organ,9606,['Unspecific'],['All life stages']
KE 1115,"Increase, Reactive oxygen species",organ,10090,['Unspecific'],['All life stages']
KE 1115,"Increase, Reactive oxygen species",organ,35525,['Unspecific'],['All life stages']
KE 1115,"Increase, Reactive oxygen species",organ,4472,['Unspecific'],['All life stages']
KE 1115,"Increase, Reactive oxygen species",organ,7955,['Unspecific'],['All life stages']
KE 41,"Inhibition, Bile Salt Export Pump (ABCB11)",,9606,['Not specified'],['Not specified']
KE 288,"Activation of specific nuclear receptors, Transcriptional change",,Not specified,['Not specified'],['Not specified']
KE 214,"Bile accumulation, Pathological condition",,Not specified,['Not specified'],['Not specified']
KE 87,"Release, Cytokine",,9606,['Not specified'],['Not specified']
KE 87,"Release, Cytokine",,10090,['Not specified'],['Not specified']
KE 149,"Increase, Inflammation",,9606,['Unspecific'],['All life stages']
KE 149,"Increase, Inflammation",,10090,['Unspecific'],['All life stages']
KE 149,"Increase, Inflammation",,10116,['Unspecific'],['All life stages']
KE 249,"Production, Reactive oxygen species",,Not specified,['Not specified'],['Not specified']
KE 209,Peptide Oxidation,,9606,['Unspecific'],['All life stages']
KE 209,Peptide Oxidation,,10116,['Unspecific'],['All life stages']
KE 209,Peptide Oxidation,,9606,['Unspecific'],['All life stages']
KE 357,"Cholestasis, Pathology",,Not specified,['Not specified'],['Not specified']
KE 79,"Inhibition, Cyclooxygenase activity",,Not specified,['Not specified'],['Not specified']
KE 243,"Reduction, Prostaglandin E2 concentration",blood,Not specified,['Not specified'],['Not specified']
KE 49,"Reduction, Ca and HCO3 transport to shell gland",oviduct shell gland,Not specified,['Not specified'],['Not specified']
KE 106,"Reduction, Eggshell thickness",eggshell,Not specified,['Not specified'],['Not specified']
KE 119,"N/A, Gap",eggshell,Not specified,['Not specified'],['Not specified']
KE 253,"N/A, Reproductive failure",,Not specified,['Not specified'],['Not specified']
KE 111,"Agonism, Estrogen receptor",,Not specified,['Not specified'],['Not specified']
KE 220,"Increase, Plasma vitellogenin concentrations",blood plasma,Not specified,['Not specified'],['Not specified']
KE 307,"Increase, Vitellogenin synthesis in liver",liver,Not specified,['Not specified'],['Not specified']
KE 252,"Increase, Renal pathology due to VTG deposition",kidney,Not specified,['Not specified'],['Not specified']
KE 363,"Altered, Reproductive behaviour",,Not specified,['Not specified'],['Not specified']
KE 339,"Altered, Larval development",,Not specified,['Not specified'],['Not specified']
KE 364,"Impaired development of, Reproductive organs",,Not specified,['Not specified'],['Not specified']
KE 112,"Antagonism, Estrogen receptor",,Not specified,['Not specified'],['Not specified']
KE 213,"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)",,Not specified,['Not specified'],['Not specified']
KE 21,"Altered regulation, Alpha hemoglobin",,Not specified,['Not specified'],['Not specified']
KE 250,"Damaging, Red blood cells; hemolysis",,Not specified,['Not specified'],['Not specified']
KE 118,"Formation, Formation of hemoglobin adducts",,Not specified,['Not specified'],['Not specified']
KE 131,"Down Regulation, Gulcose-6-phosphate dehydrogenase",,Not specified,['Not specified'],['Not specified']
KE 246,"Increase, RBC congestion in liver",liver,Not specified,['Not specified'],['Not specified']
KE 161,"Increase, Liver and splenic hemosiderosis",liver,Not specified,['Not specified'],['Not specified']
KE 173,"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number",blood,Not specified,['Not specified'],['Not specified']
KE 321,"N/A, Cyanosis occurs",,Not specified,['Not specified'],['Not specified']
KE 77,"Production, Critical Metabolites (CGA 330050 and CGA 265307)",,Not specified,['Not specified'],['Not specified']
KE 164,"Induction, Liver “Dysfunctional” Changes by CGA 330050",liver,Not specified,['Not specified'],['Not specified']
KE 147,"Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307",,Not specified,['Not specified'],['Not specified']
KE 270,"Induction, Sustained Hepatotoxicity",,Not specified,['Not specified'],['Not specified']
KE 269,"Induction, Sustained Cell Proliferation",,Not specified,['Not specified'],['Not specified']
KE 347,"Formation, Liver tumor",,Not specified,['Not specified'],['Not specified']
KE 9,"Activation, 5HT2c",,Not specified,['Not specified'],['Not specified']
KE 759,"Increased, Kidney Failure",,Not specified,['Not specified'],['Not specified']
KE 167,"Activation, LXR",,7742,['Unspecific'],"['Adult', 'Juvenile']"
KE 54,"Up Regulation, CD36",,7742,['Unspecific'],"['Adult', 'Juvenile']"
KE 115,"Increase, FA Influx",,7742,['Unspecific'],"['Adult', 'Juvenile']"
KE 66,"Activation, ChREBP",,Not specified,['Not specified'],['Not specified']
KE 264,"Activation, SREBP-1c",,Not specified,['Not specified'],['Not specified']
KE 116,"Activation, FAS",,Not specified,['Not specified'],['Not specified']
KE 258,"Activation, SCD-1",,Not specified,['Not specified'],['Not specified']
KE 89,"Synthesis, De Novo Fatty Acid (FA)",,7742,['Unspecific'],"['Adult', 'Juvenile']"
KE 291,"Accumulation, Triglyceride",,7742,['Unspecific'],"['Adult', 'Juvenile']"
KE 345,"N/A, Liver Steatosis",liver,Not specified,['Not specified'],['Not specified']
KE 228,peroxisome proliferator activated receptor promoter demethylation,,10095,['Not specified'],['Not specified']
KE 228,peroxisome proliferator activated receptor promoter demethylation,,9606,['Not specified'],['Not specified']
KE 228,peroxisome proliferator activated receptor promoter demethylation,,10116,['Not specified'],['Not specified']
KE 46,"Accumulation, Biological membranes",,Not specified,['Not specified'],['Not specified']
KE 169,"Disruption, Membrane integrity",,Not specified,['Not specified'],['Not specified']
KE 231,"Decreased, PPAR-alpha activation",,Not specified,['Not specified'],['Not specified']
KE 232,"Decreased, PPAR-beta activation",,Not specified,['Not specified'],['Not specified']
KE 233,"Decreased, PPAR-gamma activation",,9606,['Unspecific'],['All life stages']
KE 233,"Decreased, PPAR-gamma activation",,10090,['Unspecific'],['All life stages']
KE 233,"Decreased, PPAR-gamma activation",,10116,['Unspecific'],['All life stages']
KE 327,"Accumulation, Fatty acid",liver,Not specified,['Not specified'],['Not specified']
KE 140,"Decreased, HSD17B10 expression",,Not specified,['Not specified'],['Not specified']
KE 179,"Decreased, Mitochondrial fatty acid beta-oxidation",,9606,['Not specified'],['Not specified']
KE 8,"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity",,Not specified,['Not specified'],['Not specified']
KE 459,"Increased, Liver Steatosis",liver,7742,['Unspecific'],['All life stages']
KE 1170,"Increase, Phenotypic enzyme activity",liver,435440,['Mixed'],['All life stages']
KE 1170,"Increase, Phenotypic enzyme activity",liver,1090580,['Mixed'],['All life stages']
KE 716,"Increase, cell proliferation (hepatocytes)",liver,10116,['Unspecific'],['All life stages']
KE 716,"Increase, cell proliferation (hepatocytes)",liver,10090,['Unspecific'],['All life stages']
KE 716,"Increase, cell proliferation (hepatocytes)",liver,9606,['Unspecific'],['All life stages']
KE 716,"Increase, cell proliferation (hepatocytes)",liver,10037,['Unspecific'],['All life stages']
KE 716,"Increase, cell proliferation (hepatocytes)",liver,9615,['Unspecific'],['All life stages']
KE 1171,"Increase, Clonal Expansion of Altered Hepatic Foci",liver,Not specified,['Not specified'],['Not specified']
KE 719,"Increase, hepatocellular adenomas and carcinomas",liver,Not specified,['Not specified'],['Not specified']
KE 344,"N/A, Liver fibrosis",liver,9606,['Unspecific'],['All life stages']
KE 344,"N/A, Liver fibrosis",liver,10116,['Unspecific'],['All life stages']
KE 344,"N/A, Liver fibrosis",liver,10090,['Unspecific'],['All life stages']
KE 244,"Alkylation, Protein",,9606,['Not specified'],['Not specified']
KE 244,"Alkylation, Protein",,10116,['Not specified'],['Not specified']
KE 244,"Alkylation, Protein",,10090,['Not specified'],['Not specified']
KE 265,"Activation, Stellate cells",,9606,['Unspecific'],['All life stages']
KE 265,"Activation, Stellate cells",,9606,['Unspecific'],['All life stages']
KE 265,"Activation, Stellate cells",,10116,['Unspecific'],['All life stages']
KE 265,"Activation, Stellate cells",,10090,['Unspecific'],['All life stages']
KE 265,"Activation, Stellate cells",,9823,['Unspecific'],['All life stages']
KE 68,"Accumulation, Collagen",connective tissue,9606,['Unspecific'],['All life stages']
KE 68,"Accumulation, Collagen",connective tissue,10116,['Unspecific'],['All life stages']
KE 68,"Accumulation, Collagen",connective tissue,10090,['Unspecific'],['All life stages']
KE 313,"Increase, Allergic Respiratory Hypersensitivity Response",lung,9606,['Unspecific'],['During development and at adulthood']
KE 313,"Increase, Allergic Respiratory Hypersensitivity Response",lung,10141,['Unspecific'],['During development and at adulthood']
KE 313,"Increase, Allergic Respiratory Hypersensitivity Response",lung,10116,['Unspecific'],['During development and at adulthood']
KE 398,"Activation, Dendritic Cells",,10090,['Not specified'],['Not specified']
KE 398,"Activation, Dendritic Cells",,9606,['Not specified'],['Not specified']
KE 272,"Activation/Proliferation, T-cells",lymph node,9606,['Not specified'],['Not specified']
KE 272,"Activation/Proliferation, T-cells",lymph node,10090,['Not specified'],['Not specified']
KE 396,"Covalent Binding, Protein",,9606,['Unspecific'],['All life stages']
KE 396,"Covalent Binding, Protein",,10141,['Unspecific'],['All life stages']
KE 396,"Covalent Binding, Protein",,10090,['Unspecific'],['All life stages']
KE 1496,"Increased, secretion of proinflammatory mediators",,10090,"['Male', 'Female']",['Adults']
KE 1496,"Increased, secretion of proinflammatory mediators",,10116,"['Male', 'Female']",['Adults']
KE 1496,"Increased, secretion of proinflammatory mediators",,9606,"['Male', 'Female']",['Adults']
KE 827,"sensitisation, skin",,9606,['Not specified'],['Not specified']
KE 827,"sensitisation, skin",,10090,['Not specified'],['Not specified']
KE 827,"sensitisation, skin",,10141,['Not specified'],['Not specified']
KE 826,"Activation, Keratinocytes",,9606,['Not specified'],['Not specified']
KE 826,"Activation, Keratinocytes",,10090,['Not specified'],['Not specified']
KE 139,"N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects",,1002698,['Not specified'],['Not specified']
KE 165,"Activation, Long term AHR receptor driven direct and indirect gene expression changes",,435435,['Not specified'],['Not specified']
KE 165,"Activation, Long term AHR receptor driven direct and indirect gene expression changes",,10090,['Not specified'],['Not specified']
KE 853,"Changes/Inhibition, Cellular Homeostasis and Apoptosis",,10116,['Not specified'],['Not specified']
KE 853,"Changes/Inhibition, Cellular Homeostasis and Apoptosis",,10090,['Not specified'],['Not specified']
KE 854,"Alterations, Cellular proliferation / hyperplasia",liver,10116,['Not specified'],['Not specified']
KE 856,"Formation, Hepatocellular and Bile duct tumors",hepatobiliary system,10116,['Not specified'],['Not specified']
KE 279,"Thyroperoxidase, Inhibition",thyroid follicle,10116,"['Female', 'Male']",['All life stages']
KE 279,"Thyroperoxidase, Inhibition",thyroid follicle,9606,"['Female', 'Male']",['All life stages']
KE 279,"Thyroperoxidase, Inhibition",thyroid follicle,9823,"['Female', 'Male']",['All life stages']
KE 279,"Thyroperoxidase, Inhibition",thyroid follicle,8355,"['Female', 'Male']",['All life stages']
KE 279,"Thyroperoxidase, Inhibition",thyroid follicle,9031,"['Female', 'Male']",['All life stages']
KE 279,"Thyroperoxidase, Inhibition",thyroid follicle,7955,"['Female', 'Male']",['All life stages']
KE 279,"Thyroperoxidase, Inhibition",thyroid follicle,90988,"['Female', 'Male']",['All life stages']
KE 279,"Thyroperoxidase, Inhibition",thyroid follicle,10090,"['Female', 'Male']",['All life stages']
KE 277,"Thyroid hormone synthesis, Decreased",thyroid gland,10116,"['Male', 'Female']",['All life stages']
KE 277,"Thyroid hormone synthesis, Decreased",thyroid gland,9606,"['Male', 'Female']",['All life stages']
KE 277,"Thyroid hormone synthesis, Decreased",thyroid gland,8355,"['Male', 'Female']",['All life stages']
KE 277,"Thyroid hormone synthesis, Decreased",thyroid gland,7955,"['Male', 'Female']",['All life stages']
KE 277,"Thyroid hormone synthesis, Decreased",thyroid gland,90988,"['Male', 'Female']",['All life stages']
KE 277,"Thyroid hormone synthesis, Decreased",thyroid gland,9823,"['Male', 'Female']",['All life stages']
KE 402,"Cognitive function, decreased",,9606,"['Male', 'Female']",['All life stages']
KE 402,"Cognitive function, decreased",,10116,"['Male', 'Female']",['All life stages']
KE 402,"Cognitive function, decreased",,10090,"['Male', 'Female']",['All life stages']
KE 305,"Inhibition, VegfR2",,7955,['Not specified'],['Not specified']
KE 305,"Inhibition, VegfR2",,10090,['Not specified'],['Not specified']
KE 305,"Inhibition, VegfR2",,10116,['Not specified'],['Not specified']
KE 305,"Inhibition, VegfR2",,9606,['Not specified'],['Not specified']
KE 28,"Reduction, Angiogenesis",,Not specified,['Not specified'],['Not specified']
KE 110,"Impairment, Endothelial network",embryo,7742,['Unspecific'],"['Embryo', 'Development']"
KE 298,"Insufficiency, Vascular",embryo,Not specified,['Not specified'],['Not specified']
KE 1001,"Increased, Developmental Defects",,Not specified,['Not specified'],['Not specified']
KE 373,"Formation, Pro-mutagenic DNA Adducts",,8022,['Not specified'],['Not specified']
KE 373,"Formation, Pro-mutagenic DNA Adducts",,10116,['Not specified'],['Not specified']
KE 373,"Formation, Pro-mutagenic DNA Adducts",,10090,['Not specified'],['Not specified']
KE 373,"Formation, Pro-mutagenic DNA Adducts",,9606,['Not specified'],['Not specified']
KE 373,"Formation, Pro-mutagenic DNA Adducts",,9031,['Not specified'],['Not specified']
KE 373,"Formation, Pro-mutagenic DNA Adducts",,8839,['Not specified'],['Not specified']
KE 373,"Formation, Pro-mutagenic DNA Adducts",,9103,['Not specified'],['Not specified']
KE 378,"Tumorigenesis, Hepatocellular carcinoma",,Not specified,['Not specified'],['Not specified']
KE 376,"Increased, Induced Mutations in Critical Genes",,Not specified,['Not specified'],['Not specified']
KE 409,"Metabolism of AFB1, Production of Reactive Electrophiles",,Not specified,['Not specified'],['Not specified']
KE 491,"Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF)",liver,Not specified,['Not specified'],['Not specified']
KE 493,"Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts",,Not specified,['Not specified'],['Not specified']
KE 388,"Overactivation, NMDARs",brain,9606,['Male'],"['During brain development, adulthood and aging']"
KE 388,"Overactivation, NMDARs",brain,10090,['Male'],"['During brain development, adulthood and aging']"
KE 388,"Overactivation, NMDARs",brain,10116,['Male'],"['During brain development, adulthood and aging']"
KE 388,"Overactivation, NMDARs",brain,7955,['Male'],"['During brain development, adulthood and aging']"
KE 389,"Increased, Intracellular Calcium overload",,7955,['Mixed'],"['During brain development, adulthood and aging']"
KE 389,"Increased, Intracellular Calcium overload",,10116,['Mixed'],"['During brain development, adulthood and aging']"
KE 389,"Increased, Intracellular Calcium overload",,10090,['Mixed'],"['During brain development, adulthood and aging']"
KE 389,"Increased, Intracellular Calcium overload",,9606,['Mixed'],"['During brain development, adulthood and aging']"
KE 618,"Decreased, Neuronal network function in adult brain",brain,Not specified,['Not specified'],['Not specified']
KE 875,"Binding of agonist, Ionotropic glutamate receptors",,7227,['Not specified'],['Not specified']
KE 875,"Binding of agonist, Ionotropic glutamate receptors",,10116,['Not specified'],['Not specified']
KE 875,"Binding of agonist, Ionotropic glutamate receptors",,976298,['Not specified'],['Not specified']
KE 875,"Binding of agonist, Ionotropic glutamate receptors",,9606,['Not specified'],['Not specified']
KE 875,"Binding of agonist, Ionotropic glutamate receptors",,10095,['Not specified'],['Not specified']
KE 414,"Increase, Luteinizing hormone (LH)",,Not specified,['Not specified'],['Not specified']
KE 415,"Hyperplasia, Leydig cell",,Not specified,['Not specified'],['Not specified']
KE 416,"Increase proliferation, Leydig cell",,Not specified,['Not specified'],['Not specified']
KE 417,"skewed, sex ratio",,Not specified,['Not specified'],['Not specified']
KE 418,"Increased, Vitellogenin synthesis",,Not specified,['Not specified'],['Not specified']
KE 419,"Increased, renal vitellogenin deposition",kidney,Not specified,['Not specified'],['Not specified']
KE 421,"Increased, glomerular rupture and renal hemorrhaging",kidney,Not specified,['Not specified'],['Not specified']
KE 422,"Increased, nephropathy",,Not specified,['Not specified'],['Not specified']
KE 425,Decrease of Thyroidal iodide,thyroid gland,10116,['Mixed'],"['Birth to < 1 month', 'Pregnancy', 'During brain development']"
KE 425,Decrease of Thyroidal iodide,thyroid gland,10090,['Mixed'],"['Birth to < 1 month', 'Pregnancy', 'During brain development']"
KE 425,Decrease of Thyroidal iodide,thyroid gland,9823,['Mixed'],"['Birth to < 1 month', 'Pregnancy', 'During brain development']"
KE 425,Decrease of Thyroidal iodide,thyroid gland,9606,['Mixed'],"['Birth to < 1 month', 'Pregnancy', 'During brain development']"
KE 425,Decrease of Thyroidal iodide,thyroid gland,7955,['Mixed'],"['Birth to < 1 month', 'Pregnancy', 'During brain development']"
KE 425,Decrease of Thyroidal iodide,thyroid gland,451443,['Mixed'],"['Birth to < 1 month', 'Pregnancy', 'During brain development']"
KE 425,Decrease of Thyroidal iodide,thyroid gland,8355,['Mixed'],"['Birth to < 1 month', 'Pregnancy', 'During brain development']"
KE 851,Decrease of GABAergic interneurons,,9606,['Mixed'],['During brain development']
KE 851,Decrease of GABAergic interneurons,,10116,['Mixed'],['During brain development']
KE 851,Decrease of GABAergic interneurons,,6239,['Mixed'],['During brain development']
KE 424,"Inhibition, Na+/I- symporter (NIS)",,9606,['Mixed'],"['Pregnancy', 'Birth to < 1 month', 'During brain development']"
KE 424,"Inhibition, Na+/I- symporter (NIS)",,10116,['Mixed'],"['Pregnancy', 'Birth to < 1 month', 'During brain development']"
KE 424,"Inhibition, Na+/I- symporter (NIS)",,10090,['Mixed'],"['Pregnancy', 'Birth to < 1 month', 'During brain development']"
KE 424,"Inhibition, Na+/I- symporter (NIS)",,9823,['Mixed'],"['Pregnancy', 'Birth to < 1 month', 'During brain development']"
KE 424,"Inhibition, Na+/I- symporter (NIS)",,7955,['Mixed'],"['Pregnancy', 'Birth to < 1 month', 'During brain development']"
KE 424,"Inhibition, Na+/I- symporter (NIS)",,224340,['Mixed'],"['Pregnancy', 'Birth to < 1 month', 'During brain development']"
KE 424,"Inhibition, Na+/I- symporter (NIS)",,8355,['Mixed'],"['Pregnancy', 'Birth to < 1 month', 'During brain development']"
KE 450,"Suppression, VLDL secretion",,Not specified,['Not specified'],['Not specified']
KE 451,"Inhibition, Mitochondrial fatty acid beta-oxidation",,Not specified,['Not specified'],['Not specified']
KE 216,"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)",,Not specified,['Not specified'],['Not specified']
KE 465,"Increased, FA Influx",,Not specified,['Not specified'],['Not specified']
KE 466,"Up Regulation, LDLR (low density lipoprotein receptor)",,Not specified,['Not specified'],['Not specified']
KE 467,"Increased, LDL uptake",,Not specified,['Not specified'],['Not specified']
KE 80,"Up Regulation, CYP1A1",,7904,['Not specified'],['Not specified']
KE 80,"Up Regulation, CYP1A1",,8022,['Not specified'],['Not specified']
KE 462,"Up Regulation, SCD-1",,Not specified,['Not specified'],['Not specified']
KE 456,"Suppression, Constitutive androstane receptor, NR1l3",,Not specified,['Not specified'],['Not specified']
KE 457,"Activation, SREBF1",,Not specified,['Not specified'],['Not specified']
KE 458,"Increased, De Novo FA synthesis",,Not specified,['Not specified'],['Not specified']
KE 454,"Increased, Triglyceride formation",,Not specified,['Not specified'],['Not specified']
KE 463,"Up Regulation, FAS",,Not specified,['Not specified'],['Not specified']
KE 468,"Inhibition, PPAR alpha",,Not specified,['Not specified'],['Not specified']
KE 470,"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)",,Not specified,['Not specified'],['Not specified']
KE 461,"Suppression, HNF4alpha",,Not specified,['Not specified'],['Not specified']
KE 471,"Inhibition, FoxA2",,Not specified,['Not specified'],['Not specified']
KE 472,"Down Regulation, CPT1A",,Not specified,['Not specified'],['Not specified']
KE 474,"Down Regulation, HMGCS2",,Not specified,['Not specified'],['Not specified']
KE 477,"Decreased, Ketogenesis",,Not specified,['Not specified'],['Not specified']
KE 478,"Activation, NRF2",,Not specified,['Not specified'],['Not specified']
KE 479,"Activation, NR1H4",,Not specified,['Not specified'],['Not specified']
KE 480,"Activation, SHP",,Not specified,['Not specified'],['Not specified']
KE 482,"Decreased, DHB4/HSD17B4",,Not specified,['Not specified'],['Not specified']
KE 483,"Activation, LXR alpha",,Not specified,['Not specified'],['Not specified']
KE 878,"Inhibition, SREBP1c",,Not specified,['Not specified'],['Not specified']
KE 879,"Activation, MTTP",,Not specified,['Not specified'],['Not specified']
KE 880,"Increased, ApoB100",blood,Not specified,['Not specified'],['Not specified']
KE 881,"Increased, Triglyceride",,Not specified,['Not specified'],['Not specified']
KE 484,"Activation, AKT2",,Not specified,['Not specified'],['Not specified']
KE 486,systemic inflammation leading to hepatic steatosis,,Not specified,['Not specified'],['Not specified']
KE 675,"Reduced, Reproductive Success",,Not specified,['Not specified'],['Not specified']
KE 488,"Decrease, Ovulation",female gonad,Not specified,['Not specified'],['Not specified']
KE 685,"Reduced, Prostaglandins, ovary",female gonad,Not specified,['Not specified'],['Not specified']
KE 494,"Glucocorticoid Receptor Agonist, Activation",,Not specified,['Not specified'],['Not specified']
KE 495,Repressed expression of steroidogenic enzymes,,Not specified,['Not specified'],['Not specified']
KE 496,"Increased apoptosis, decreased fetal/adult Leydig Cells",,Not specified,['Not specified'],['Not specified']
KE 520,"Decreased sperm quantity or quality in the adult, Decreased fertility",,Not specified,['Not specified'],['Not specified']
KE 186,"Altered, Neuroanatomy",brain,9606,['Not specified'],['Not specified']
KE 186,"Altered, Neuroanatomy",brain,10116,['Not specified'],['Not specified']
KE 192,"Altered, Neurophysiology",brain,10116,['Not specified'],['Not specified']
KE 505,"Decreased sperm quantity / quality in the adult, Decreased fertility",,Not specified,['Not specified'],['Not specified']
KE 653,"Decreased testosterone by the fetal Leydig cells, Increased corticosterone",,Not specified,['Not specified'],['Not specified']
KE 654,"Decreased testosterone by the fetal Leydig cells, Activation by other glucocorticoid receptor agonists",,Not specified,['Not specified'],['Not specified']
KE 655,"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells",,Not specified,['Not specified'],['Not specified']
KE 656,"Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII)",,40674,['Unspecific'],['Development']
KE 657,"Decreased testosterone by the fetal Leydig cells, Dysgenesis of fetal Leydig cells",,Not specified,['Not specified'],['Not specified']
KE 658,"Decreased testosterone by the fetal Leydig cells, Increased estradiol",,Not specified,['Not specified'],['Not specified']
KE 659,"Decreased testosterone by the fetal Leydig cells, Activation by other estradiol agonists",,Not specified,['Not specified'],['Not specified']
KE 660,"decreased testosterone by fetal Leydig cells, Dysgenesis of fetal Leydig cells",testis,Not specified,['Not specified'],['Not specified']
KE 661,"Decreased testosterone by the fetal Leydig cells, Alterations in the fetal testis proteome",,Not specified,['Not specified'],['Not specified']
KE 642,"Decreased Cholesterol, Decreased De Novo Biosynthesis of Choleseterol",,Not specified,['Not specified'],['Not specified']
KE 643,"Decreased Cholesterol, Decreased Uptake of Lipoproteins",,Not specified,['Not specified'],['Not specified']
KE 644,"Decreased Cholesterol, Decreased Transport of Cholesterol to the Inner Mitochondrial Membrane",,Not specified,['Not specified'],['Not specified']
KE 645,"Decreased Cholesterol, Decreased Testosterone Production by Adult Leydig Cells",,Not specified,['Not specified'],['Not specified']
KE 646,"Decreased Cholesterol, Decreased sperm quantity and/or quality in the adult testis",,Not specified,['Not specified'],['Not specified']
KE 640,"Decreased steroidogenesis, Proteomic alterations in the adult Leydig cell",,Not specified,['Not specified'],['Not specified']
KE 647,"Decreased, steroidogenic protein expression",,40674,['Unspecific'],['Development']
KE 648,"Decreased steroidogenesis, Increased Apoptosis of Adult Leydig Cells",testis,Not specified,['Not specified'],['Not specified']
KE 649,"Decreased steroidogenesis, Alterations in the Leydig Cell Cytoskeleton",testis,Not specified,['Not specified'],['Not specified']
KE 525,"Apoptosis of adult Leydig cells, Decreased testosterone by adult Leydig cells",,Not specified,['Not specified'],['Not specified']
KE 650,"Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid",,Not specified,['Not specified'],['Not specified']
KE 651,"Glucocorticoid Receptor mediated alterations in steriodogenic enzymes, Decreased testosterone by adult Leydig cells",,Not specified,['Not specified'],['Not specified']
KE 652,"Direct effects of Corticosterone on steroidogenesis, Decreased testosterone by adult Leydig cells",,Not specified,['Not specified'],['Not specified']
KE 1028,"Activation of specific nuclear receptors, PPAR-gamma activation",,Not specified,['Not specified'],['Not specified']
KE 1447,obesity,,Not specified,['Not specified'],['Not specified']
KE 1448,activation of CCAAT/enhancer-binding protein alpha,,Not specified,['Not specified'],['Not specified']
KE 1449,increased adipogenesis,,Not specified,['Not specified'],['Not specified']
KE 1450,decreased dopamine,,Not specified,['Not specified'],['Not specified']
KE 1451,decreased reward,,Not specified,['Not specified'],['Not specified']
KE 1452,decreased DNA methylation of tyrosine hydroxylase,,Not specified,['Not specified'],['Not specified']
KE 1453,decreased methylation of dopamine transporter promoter,,Not specified,['Not specified'],['Not specified']
KE 1454,chronic high fat diet,,Not specified,['Not specified'],['Not specified']
KE 526,"Inhibition, Inhibition of Dopamine-beta-hydroxylase",,Not specified,['Not specified'],['Not specified']
KE 527,"Decreased, Decreased fecundity",,Not specified,['Not specified'],['Not specified']
KE 528,"Decreased, Synthesis of NE",,Not specified,['Not specified'],['Not specified']
KE 529,"Decreased, GnRH cfos activity",,Not specified,['Not specified'],['Not specified']
KE 530,"Decreased, GnRH pulsatility/release",,40674,['Unspecific'],['All life stages']
KE 530,"Decreased, GnRH pulsatility/release",,50557,['Unspecific'],['All life stages']
KE 530,"Decreased, GnRH pulsatility/release",,7955,['Unspecific'],['All life stages']
KE 530,"Decreased, GnRH pulsatility/release",,8782,['Unspecific'],['All life stages']
KE 531,"Decreased, LH Surge",pituitary gland,40674,['Unspecific'],['All life stages']
KE 531,"Decreased, LH Surge",pituitary gland,50557,['Unspecific'],['All life stages']
KE 531,"Decreased, LH Surge",pituitary gland,7955,['Unspecific'],['All life stages']
KE 531,"Decreased, LH Surge",pituitary gland,8782,['Unspecific'],['All life stages']
KE 532,"Delayed, Ovulation",,Not specified,['Not specified'],['Not specified']
KE 533,"Decreased, Cortical granule release/distribution upon fertilization",,Not specified,['Not specified'],['Not specified']
KE 534,"Altered, Formation of cortical envelope",,Not specified,['Not specified'],['Not specified']
KE 535,"Abnormal, Sperm penetration (polyspermy)",,Not specified,['Not specified'],['Not specified']
KE 536,"Altered, Chromosome number (polyploid) zygote",,Not specified,['Not specified'],['Not specified']
KE 543,"Decreased fertility in the adult, Decreased sperm quantity and/or quality in the adult testis",,Not specified,['Not specified'],['Not specified']
KE 662,"Decreased testosterone by the fetal Leydig cells, Hypermethylation in the fetal testis",,Not specified,['Not specified'],['Not specified']
KE 540,"Decreased testosterone by the fetal Leydig cells, Dysgensis of fetal Leydig cells",,Not specified,['Not specified'],['Not specified']
KE 541,"Decreased testosterone by the fetal Leydig cells, Decreased COUP-TFII stem Leydig cells",,Not specified,['Not specified'],['Not specified']
KE 559,"Activation, Nicotinic acetylcholine receptor",,Not specified,['Not specified'],['Not specified']
KE 560,"Abnormal, Foraging activity and behavior",,Not specified,['Not specified'],['Not specified']
KE 563,"Death/Failure, Colony",,Not specified,['Not specified'],['Not specified']
KE 1107,"Weakened, Colony",,Not specified,['Not specified'],['Not specified']
KE 1243,"Altered, Ca2+-calmodulin activated signal transduction",,Not specified,['Not specified'],['Not specified']
KE 564,"Abnormal, Roll change within caste",,Not specified,['Not specified'],['Not specified']
KE 565,"Reduced, Brood care",,Not specified,['Not specified'],['Not specified']
KE 566,"impaired, Larval development",,Not specified,['Not specified'],['Not specified']
KE 568,"impaired, Hive thermoregulation",,Not specified,['Not specified'],['Not specified']
KE 570,"Accumulation, Damaged mitochondrial DNA",,Not specified,['Not specified'],['Not specified']
KE 571,"Accelerated, Aging",,Not specified,['Not specified'],['Not specified']
KE 572,"Decrease, Number of worker bees",,Not specified,['Not specified'],['Not specified']
KE 664,"Overwhelmed, Mitochondrial DNA repair mechanisms",,Not specified,['Not specified'],['Not specified']
KE 573,"Increase, Energetic demands and therefore metabolic stress",,Not specified,['Not specified'],['Not specified']
KE 574,"Increased, Appetite and hunger",,Not specified,['Not specified'],['Not specified']
KE 576,"Increased, Viral susceptibility",,Not specified,['Not specified'],['Not specified']
KE 577,"impaired, Development",,Not specified,['Not specified'],['Not specified']
KE 578,"Decreased, Glucose oxidase enzyme activity",,Not specified,['Not specified'],['Not specified']
KE 579,"Decreased, Hydrogen peroxide production",,Not specified,['Not specified'],['Not specified']
KE 580,"Reduced, Antiseptic incorporated in food",,Not specified,['Not specified'],['Not specified']
KE 561,"Reduced, Food storage",,Not specified,['Not specified'],['Not specified']
KE 1108,"Abnormal, Role change within caste",,Not specified,['Not specified'],['Not specified']
KE 663,"Desensitization, Nicotinic acetylcholine receptor",,Not specified,['Not specified'],['Not specified']
KE 584,"Inhibition, sodium channel",,Not specified,['Not specified'],['Not specified']
KE 585,"Decreased, Sodium conductance 1",,Not specified,['Not specified'],['Not specified']
KE 586,"Reduced, swimming speed",,8090,['Not specified'],['Not specified']
KE 586,"Reduced, swimming speed",,52641,['Not specified'],['Not specified']
KE 586,"Reduced, swimming speed",,6087,['Not specified'],['Not specified']
KE 587,"Reduced, feeding 1",,Not specified,['Not specified'],['Not specified']
KE 588,"Increased, predation",,Not specified,['Not specified'],['Not specified']
KE 592,"Reduced, survival",,Not specified,['Not specified'],['Not specified']
KE 444,"Increased, Atrioventricular block and bradycardia",heart,Not specified,['Not specified'],['Not specified']
KE 590,"N/A, hypoxia",,Not specified,['Not specified'],['Not specified']
KE 591,"Increased, amputations",,10116,['Not specified'],['Not specified']
KE 591,"Increased, amputations",,10090,['Not specified'],['Not specified']
KE 591,"Increased, amputations",,9606,['Not specified'],['Not specified']
KE 593,"Inhibition, Ether-a-go-go (ERG) voltage-gated potassium channel",,Not specified,['Not specified'],['Not specified']
KE 598,"modulation, sodium channel",,Not specified,['Not specified'],['Not specified']
KE 599,"prolonged, Depolarization of neuronal membrane",,Not specified,['Not specified'],['Not specified']
KE 600,"Overactivation, Neuronotransmitter release",,Not specified,['Not specified'],['Not specified']
KE 601,"Overactivation, muscle contraction",muscle tissue,Not specified,['Not specified'],['Not specified']
KE 602,"Increased, Ataxia, paralysis, or hyperactivity",skeletal muscle tissue,Not specified,['Not specified'],['Not specified']
KE 619,"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)",,10116,['Unspecific'],['All life stages']
KE 619,"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)",,7955,['Unspecific'],['All life stages']
KE 623,"Increase, predation",,Not specified,['Not specified'],['Not specified']
KE 625,"Increased, muscular waves in foot",muscle of pes,31229,['Not specified'],['Not specified']
KE 625,"Increased, muscular waves in foot",muscle of pes,76178,['Not specified'],['Not specified']
KE 1139,"Increased, water retention in foot",,Not specified,['Not specified'],['Not specified']
KE 1142,"Increased, valve movement",,396373,['Not specified'],['Not specified']
KE 1143,"Depletion, energy reserves",,Not specified,['Not specified'],['Not specified']
KE 624,"Increased, foot detachment",,Not specified,['Not specified'],['Not specified']
KE 622,"Increased, locomotion",,Not specified,['Not specified'],['Not specified']
KE 626,"Increased, serotonin (5-HT)",,Not specified,['Not specified'],['Not specified']
KE 627,"Decreased, anxiety",,Not specified,['Not specified'],['Not specified']
KE 629,"Decreased, sheltering",,Not specified,['Not specified'],['Not specified']
KE 633,"Decrease, histaminergic neuron excitation",,Not specified,['Not specified'],['Not specified']
KE 634,"N/A, sedation",,Not specified,['Not specified'],['Not specified']
KE 635,"Decreased, locomotion",,Not specified,['Not specified'],['Not specified']
KE 636,"Decreased, survival",,Not specified,['Not specified'],['Not specified']
KE 638,"Antagonism, Histamine Receptor (H2)",,Not specified,['Not specified'],['Not specified']
KE 671,"Reduced, Prostaglandin F2alpha concentration, plasma",,Not specified,['Not specified'],['Not specified']
KE 672,"Reduced, Prostaglandin F2alpha synthesis, ovary",female gonad,Not specified,['Not specified'],['Not specified']
KE 673,"Reduced, Spawning behavior",,Not specified,['Not specified'],['Not specified']
KE 674,"Reduced, Ability to attract spawning mates",,Not specified,['Not specified'],['Not specified']
KE 678,"Reduced, Pheromone release",,Not specified,['Not specified'],['Not specified']
KE 681,"Decreased, Prostaglandin F2alpha synthesis, ovary",female gonad,Not specified,['Not specified'],['Not specified']
KE 687,"Reduced, Prostaglandin E2 concentration, hypothalamus",hypothalamus,Not specified,['Not specified'],['Not specified']
KE 689,"Reduced, Gonadotropin releasing hormone, hypothalamus",hypothalamus,Not specified,['Not specified'],['Not specified']
KE 690,"Reduced, Luteinizing hormone (LH), plasma",blood plasma,Not specified,['Not specified'],['Not specified']
KE 691,"Reduced, Maturation inducing steroid, plasma",blood plasma,Not specified,['Not specified'],['Not specified']
KE 692,"Reduced, Maturation inducing steroid receptor signalling, oocyte",,Not specified,['Not specified'],['Not specified']
KE 694,"Reduced, Meiotic prophase I/metaphase I transition, oocyte",,Not specified,['Not specified'],['Not specified']
KE 693,"Increased, cyclic adenosine monophosphate",,Not specified,['Not specified'],['Not specified']
KE 695,"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte",,Not specified,['Not specified'],['Not specified']
KE 696,"Increased, Chromosome misseggregation",,Not specified,['Not specified'],['Not specified']
KE 697,"impaired, ion channels",,Not specified,['Not specified'],['Not specified']
KE 698,"Altered, Action Potential",,Not specified,['Not specified'],['Not specified']
KE 699,"Increased, cardiac arrthymia",heart,Not specified,['Not specified'],['Not specified']
KE 708,"Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium)",proximal tubular epithelium,Not specified,['Not specified'],['Not specified']
KE 709,"Increase, Cytotoxicity (renal tubular cell)",,Not specified,['Not specified'],['Not specified']
KE 710,"Increase, Regenerative cell proliferation (tubular epithelial cells)",,Not specified,['Not specified'],['Not specified']
KE 713,"Increase, Adenomas/carcinomas (renal tubular)",renal tubule,Not specified,['Not specified'],['Not specified']
KE 767,"Increase, Hyperplasia (renal tubular cells)",,Not specified,['Not specified'],['Not specified']
KE 714,"Increased, Binding of chemicals to 2u (serum)",serum,Not specified,['Not specified'],['Not specified']
KE 718,"Binding, Tubulin",,10090,['Mixed'],['All life stages']
KE 718,"Binding, Tubulin",,9606,['Mixed'],['All life stages']
KE 718,"Binding, Tubulin",,10116,['Mixed'],['All life stages']
KE 718,"Binding, Tubulin",,8355,['Mixed'],['All life stages']
KE 720,"Disruption, Microtubule dynamics",,10090,['Mixed'],['All life stages']
KE 720,"Disruption, Microtubule dynamics",,9606,['Mixed'],['All life stages']
KE 720,"Disruption, Microtubule dynamics",,8355,['Mixed'],['All life stages']
KE 721,"Disorganization, Meiotic Spindle",,10090,['Mixed'],['All life stages']
KE 721,"Disorganization, Meiotic Spindle",,9606,['Mixed'],['All life stages']
KE 728,"Increase, Aneuploid offspring",,10090,['Female'],"['Adult, reproductively mature']"
KE 728,"Increase, Aneuploid offspring",,9606,['Female'],"['Adult, reproductively mature']"
KE 752,"Altered, Meiotic chromosome dynamics",,10090,['Mixed'],['All life stages']
KE 723,"Altered, Chromosome number",,10090,['Mixed'],['All life stages']
KE 723,"Altered, Chromosome number",,10037,['Mixed'],['All life stages']
KE 723,"Altered, Chromosome number",,9606,['Mixed'],['All life stages']
KE 715,"Activation, Constitutive androstane receptor",,10116,['Unspecific'],['All life stages']
KE 715,"Activation, Constitutive androstane receptor",,10090,['Unspecific'],['All life stages']
KE 715,"Activation, Constitutive androstane receptor",,10037,['Unspecific'],['All life stages']
KE 715,"Activation, Constitutive androstane receptor",,9606,['Unspecific'],['All life stages']
KE 715,"Activation, Constitutive androstane receptor",,9615,['Unspecific'],['All life stages']
KE 715,"Activation, Constitutive androstane receptor",,9544,['Unspecific'],['All life stages']
KE 774,"Increase, Preneoplastic foci (hepatocytes)",,Not specified,['Not specified'],['Not specified']
KE 1214,"Altered gene expression specific to CAR activation, Hepatocytes",liver,10116,['Unspecific'],['All life stages']
KE 1214,"Altered gene expression specific to CAR activation, Hepatocytes",liver,10090,['Unspecific'],['All life stages']
KE 1214,"Altered gene expression specific to CAR activation, Hepatocytes",liver,10037,['Unspecific'],['All life stages']
KE 1214,"Altered gene expression specific to CAR activation, Hepatocytes",liver,9606,['Unspecific'],['All life stages']
KE 1214,"Altered gene expression specific to CAR activation, Hepatocytes",liver,9615,['Unspecific'],['All life stages']
KE 1214,"Altered gene expression specific to CAR activation, Hepatocytes",liver,9544,['Unspecific'],['All life stages']
KE 768,"Increase, Cytotoxicity",,435435,['Not specified'],['Not specified']
KE 768,"Increase, Cytotoxicity",,10090,['Not specified'],['Not specified']
KE 768,"Increase, Cytotoxicity",,9606,['Not specified'],['Not specified']
KE 726,"Increased, Induction of pyruvate dehydrogenase (PDH)",,Not specified,['Not specified'],['Not specified']
KE 724,"Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme",,Not specified,['Not specified'],['Not specified']
KE 769,"Increase, Oxidative metabolism",,Not specified,['Not specified'],['Not specified']
KE 733,"Increase, Necrosis (terminal bronchiolar cells)",,Not specified,['Not specified'],['Not specified']
KE 734,"Increase, Regenerative cell proliferation (terminal bronchiolar epithelial cells)",,Not specified,['Not specified'],['Not specified']
KE 735,"Increase, Hyperplasia (terminal bronchiolar cells)",terminal bronchiole epithelium,Not specified,['Not specified'],['Not specified']
KE 736,"Increase, Adenomas/carcinomas (bronchioloalveolar)",lung,Not specified,['Not specified'],['Not specified']
KE 770,"Increase, Cytotoxicity (club cells)",,Not specified,['Not specified'],['Not specified']
KE 739,"Increase, Hypertrophy and proliferation (follicular cell)",,10116,['Not specified'],['Not specified']
KE 739,"Increase, Hypertrophy and proliferation (follicular cell)",,10090,['Not specified'],['Not specified']
KE 740,"Increase, Hyperplasia (follicular cells)",,10116,['Not specified'],['Not specified']
KE 740,"Increase, Hyperplasia (follicular cells)",,10090,['Not specified'],['Not specified']
KE 741,"Increase, Adenomas/carcinomas (follicular cell)",thyroid gland,10116,['Not specified'],['Not specified']
KE 741,"Increase, Adenomas/carcinomas (follicular cell)",thyroid gland,10090,['Not specified'],['Not specified']
KE 1023,"Increased, Thyroid-stimulating hormone (TSH)",serum,8355,['Not specified'],['Not specified']
KE 1023,"Increased, Thyroid-stimulating hormone (TSH)",serum,10118,['Not specified'],['Not specified']
KE 1023,"Increased, Thyroid-stimulating hormone (TSH)",serum,10090,['Not specified'],['Not specified']
KE 743,"Decreased, Testosterone binding to androgen receptor (hypothalamus)",,Not specified,['Not specified'],['Not specified']
KE 744,"Increase, Hyperplasia (Leydig cells)",,Not specified,['Not specified'],['Not specified']
KE 745,"Increase, Leydig cell tumors",,Not specified,['Not specified'],['Not specified']
KE 754,"Increased, Luteinizing hormone (LH)",blood,Not specified,['Not specified'],['Not specified']
KE 1614,"Decrease, androgen receptor activation",,40674,['Mixed'],['During development and at adulthood']
KE 746,"Increase, Dopaminergic activity",,Not specified,['Not specified'],['Not specified']
KE 747,"Decreased, Prolactin",blood,Not specified,['Not specified'],['Not specified']
KE 748,"Increased, Estrogen receptor (ER) activity",,Not specified,['Not specified'],['Not specified']
KE 749,"Decreased, Progesterone from corpus luteum",corpus luteum,Not specified,['Not specified'],['Not specified']
KE 772,"Increase, Hyperplasia (glandular epithelial cells of endometrium)",,Not specified,['Not specified'],['Not specified']
KE 773,"Increase, Endometrial adenocarcinomas",endometrium,Not specified,['Not specified'],['Not specified']
KE 760,"Activation, Glutamate-gated chloride channel",,Not specified,['Not specified'],['Not specified']
KE 761,"Increased, Chloride conductance",,Not specified,['Not specified'],['Not specified']
KE 763,"hyperpolarisation, neuron",,Not specified,['Not specified'],['Not specified']
KE 764,"N/A, Ataxia, paralysis, or hyperactivity",skeletal muscle tissue,Not specified,['Not specified'],['Not specified']
KE 765,"Decreased, population 1",,Not specified,['Not specified'],['Not specified']
KE 766,"Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme",,Not specified,['Not specified'],['Not specified']
KE 775,"Increased, Plasma tyrosine",blood plasma,Not specified,['Not specified'],['Not specified']
KE 776,"Increase, Cytotoxicity (corneal cells)",,Not specified,['Not specified'],['Not specified']
KE 777,"Increase, Inflammation (corneal cells)",,Not specified,['Not specified'],['Not specified']
KE 778,"Increase, Regenerative cell proliferation (corneal cells)",,Not specified,['Not specified'],['Not specified']
KE 779,"Increase, Papillomas/carcinomas (squamous cells)",,Not specified,['Not specified'],['Not specified']
KE 780,"Increase, Cytotoxicity (epithelial cells)",,Not specified,['Not specified'],['Not specified']
KE 781,"Increase, Regenerative cell proliferation (forestomach epithelial cells)",murine forestomach,Not specified,['Not specified'],['Not specified']
KE 782,"Increase, Hyperplasia (forestomach epithelial cells)",murine forestomach,Not specified,['Not specified'],['Not specified']
KE 783,"Increase, Cytotoxicity (tubular epithelial cells)",,Not specified,['Not specified'],['Not specified']
KE 784,"Increase, Hyperplasia (tubular epithelial cells)",,Not specified,['Not specified'],['Not specified']
KE 786,"Increase, Cytotoxicity (hepatocytes)",,Not specified,['Not specified'],['Not specified']
KE 787,"Increase, Regenerative cell proliferation (hepatocytes)",,Not specified,['Not specified'],['Not specified']
KE 791,"Increased, Leutinizing hormone (LH)",serum,Not specified,['Not specified'],['Not specified']
KE 1617,"Inhibition, 5α-reductase",,40674,['Mixed'],['During development and at adulthood']
KE 793,"Increase, Urinary bladder calculi",,Not specified,['Not specified'],['Not specified']
KE 794,"Increase, Cytotoxicity (urothelial cells)",,Not specified,['Not specified'],['Not specified']
KE 795,"Increase, Regenerative cell proliferation (urothelial cells)",,Not specified,['Not specified'],['Not specified']
KE 796,"Increase, Hyperplasia (urothelial)",,Not specified,['Not specified'],['Not specified']
KE 797,"Increase, Adenomas/carcinomas (urothelial)",urothelium,Not specified,['Not specified'],['Not specified']
KE 798,"Inhibition, Prolyl hydroxylases",,Not specified,['Not specified'],['Not specified']
KE 799,"Increased, HIF-1 heterodimer",,Not specified,['Not specified'],['Not specified']
KE 800,"Decreased, Aromatase (Cyp19a1) mRNA",,7955,['Not specified'],['Not specified']
KE 801,"modulation, Unknown",,Not specified,['Not specified'],['Not specified']
KE 802,"Increased, HIF-1 alpha transcription",,Not specified,['Not specified'],['Not specified']
KE 804,"Inhibition, HMG-CoA reductase",,Not specified,['Not specified'],['Not specified']
KE 805,"Decreased, mevalonate",,Not specified,['Not specified'],['Not specified']
KE 807,"Decreased, cholesterol",blood plasma,7742,"['Male', 'Female']","['Adult', 'All life stages']"
KE 809,"malformed, Male reproductive tract",male reproductive system,Not specified,['Not specified'],['Not specified']
KE 330,"Decrease, Fertility",,10095,['Not specified'],['Not specified']
KE 330,"Decrease, Fertility",,9606,['Not specified'],['Not specified']
KE 848,"Decreased, Binding of NE to NE receptors on GnRH neurons",,Not specified,['Not specified'],['Not specified']
KE 849,"Inhibition, Antgonism of NE receptor",,Not specified,['Not specified'],['Not specified']
KE 814,"Occurrence, Kidney toxicity",kidney,10116,['Not specified'],['Not specified']
KE 814,"Occurrence, Kidney toxicity",kidney,9606,['Not specified'],['Not specified']
KE 819,"Decreased, Glomerular filtration",kidney,10116,['Not specified'],['Not specified']
KE 819,"Decreased, Glomerular filtration",kidney,9606,['Not specified'],['Not specified']
KE 820,"Decreased, Renal plasma flow",kidney,10116,['Not specified'],['Not specified']
KE 820,"Decreased, Renal plasma flow",kidney,9606,['Not specified'],['Not specified']
KE 821,"Decreased, Sodium reabsorption",kidney,10116,['Not specified'],['Not specified']
KE 821,"Decreased, Sodium reabsorption",kidney,9606,['Not specified'],['Not specified']
KE 813,"Increased, Serum creatinine",serum,10116,['Not specified'],['Not specified']
KE 813,"Increased, Serum creatinine",serum,9606,['Not specified'],['Not specified']
KE 823,"Occurrence, Cystic dilatation (renal tubule)",kidney,10116,['Not specified'],['Not specified']
KE 823,"Occurrence, Cystic dilatation (renal tubule)",kidney,9606,['Not specified'],['Not specified']
KE 824,"Occurrence, Cytoplasmic vacuolization (podocyte)",kidney,10116,['Not specified'],['Not specified']
KE 824,"Occurrence, Cytoplasmic vacuolization (podocyte)",kidney,9606,['Not specified'],['Not specified']
KE 818,"Occurrence, Cytoplasmic vacuolization (Renal tubule)",kidney,10116,['Not specified'],['Not specified']
KE 818,"Occurrence, Cytoplasmic vacuolization (Renal tubule)",kidney,9606,['Not specified'],['Not specified']
KE 825,"Decreased, Renal ability to dilute urine",,10116,['Not specified'],['Not specified']
KE 825,"Decreased, Renal ability to dilute urine",,9606,['Not specified'],['Not specified']
KE 828,"Inhibition, Phospholipase A",,Not specified,['Not specified'],['Not specified']
KE 829,"Damage, Lipid bilayer",,Not specified,['Not specified'],['Not specified']
KE 831,"Disturbance, Lysosomal function",,Not specified,['Not specified'],['Not specified']
KE 833,"Occurrence, Cytoplasmic vacuolization (hepatocyte)",,Not specified,['Not specified'],['Not specified']
KE 835,"Occurrence, Ballooning degeneration (hepatocyte)",,Not specified,['Not specified'],['Not specified']
KE 837,"Occurrence, Cytoplasmic vacuolization (kupffer cell)",,Not specified,['Not specified'],['Not specified']
KE 838,"Induction, Microvesicular fat",,Not specified,['Not specified'],['Not specified']
KE 839,"Formation, Mallory body",,Not specified,['Not specified'],['Not specified']
KE 840,"Formation, Liver fibrosis",liver,Not specified,['Not specified'],['Not specified']
KE 836,"Occurrence, Cytoplasmic vacuolization (Bile duct cell)",,Not specified,['Not specified'],['Not specified']
KE 844,"Oxidation, Uroporphyrinogen",,9606,['Unspecific'],['All life stages']
KE 844,"Oxidation, Uroporphyrinogen",,10090,['Unspecific'],['All life stages']
KE 844,"Oxidation, Uroporphyrinogen",,10116,['Unspecific'],['All life stages']
KE 844,"Oxidation, Uroporphyrinogen",,9031,['Unspecific'],['All life stages']
KE 845,"Inhibition, UROD",,10090,['Unspecific'],"['All life stages', 'Adult']"
KE 845,"Inhibition, UROD",,10116,['Unspecific'],"['All life stages', 'Adult']"
KE 845,"Inhibition, UROD",,9031,['Unspecific'],"['All life stages', 'Adult']"
KE 845,"Inhibition, UROD",,93934,['Unspecific'],"['All life stages', 'Adult']"
KE 846,"Accumulation, Highly carboxylated porphyrins",,10116,['Unspecific'],"['Juvenile', 'Adults']"
KE 846,"Accumulation, Highly carboxylated porphyrins",,10090,['Unspecific'],"['Juvenile', 'Adults']"
KE 846,"Accumulation, Highly carboxylated porphyrins",,9606,['Unspecific'],"['Juvenile', 'Adults']"
KE 846,"Accumulation, Highly carboxylated porphyrins",,9031,['Unspecific'],"['Juvenile', 'Adults']"
KE 846,"Accumulation, Highly carboxylated porphyrins",,93934,['Unspecific'],"['Juvenile', 'Adults']"
KE 846,"Accumulation, Highly carboxylated porphyrins",,35669,['Unspecific'],"['Juvenile', 'Adults']"
KE 369,Uroporphyria,,10116,['Unspecific'],"['Juvenile', 'Adult']"
KE 369,Uroporphyria,,10090,['Unspecific'],"['Juvenile', 'Adult']"
KE 369,Uroporphyria,,9606,['Unspecific'],"['Juvenile', 'Adult']"
KE 369,Uroporphyria,,35669,['Unspecific'],"['Juvenile', 'Adult']"
KE 369,Uroporphyria,,9031,['Unspecific'],"['Juvenile', 'Adult']"
KE 369,Uroporphyria,,93934,['Unspecific'],"['Juvenile', 'Adult']"
KE 850,"Induction, CYP1A2/CYP1A5",,9606,['Unspecific'],['All life stages']
KE 850,"Induction, CYP1A2/CYP1A5",,10090,['Unspecific'],['All life stages']
KE 850,"Induction, CYP1A2/CYP1A5",,10116,['Unspecific'],['All life stages']
KE 850,"Induction, CYP1A2/CYP1A5",,9031,['Unspecific'],['All life stages']
KE 850,"Induction, CYP1A2/CYP1A5",,7955,['Unspecific'],['All life stages']
KE 850,"Induction, CYP1A2/CYP1A5",,52644,['Unspecific'],['All life stages']
KE 850,"Induction, CYP1A2/CYP1A5",,56072,['Unspecific'],['All life stages']
KE 850,"Induction, CYP1A2/CYP1A5",,56069,['Unspecific'],['All life stages']
KE 850,"Induction, CYP1A2/CYP1A5",,8901,['Unspecific'],['All life stages']
KE 850,"Induction, CYP1A2/CYP1A5",,56262,['Unspecific'],['All life stages']
KE 867,"Decrease, Intracellular pH",,435435,['Not specified'],['Not specified']
KE 867,"Decrease, Intracellular pH",,10090,['Not specified'],['Not specified']
KE 867,"Decrease, Intracellular pH",,9606,['Not specified'],['Not specified']
KE 868,"Increase, Tissue Degeneration, Necrosis & Atrophy",olfactory organ,10116,['Not specified'],['Not specified']
KE 868,"Increase, Tissue Degeneration, Necrosis & Atrophy",olfactory organ,10090,['Not specified'],['Not specified']
KE 868,"Increase, Tissue Degeneration, Necrosis & Atrophy",olfactory organ,9606,['Not specified'],['Not specified']
KE 870,"Increase, Cell Proliferation",,10116,['Unspecific'],['All life stages']
KE 870,"Increase, Cell Proliferation",,10090,['Unspecific'],['All life stages']
KE 870,"Increase, Cell Proliferation",,9606,['Unspecific'],['All life stages']
KE 869,"Increase, Respiratory or Squamous Metaplasia",olfactory epithelium,10116,['Not specified'],['Not specified']
KE 869,"Increase, Respiratory or Squamous Metaplasia",olfactory epithelium,10090,['Not specified'],['Not specified']
KE 869,"Increase, Respiratory or Squamous Metaplasia",olfactory epithelium,9606,['Not specified'],['Not specified']
KE 872,"Increase, Site of Contact Nasal Tumors",olfactory organ,10116,['Not specified'],['Not specified']
KE 872,"Increase, Site of Contact Nasal Tumors",olfactory organ,10090,['Not specified'],['Not specified']
KE 872,"Increase, Site of Contact Nasal Tumors",olfactory organ,9606,['Not specified'],['Not specified']
KE 876,"Increase, Mutations in Critical Genes",,10116,['Not specified'],['Not specified']
KE 876,"Increase, Mutations in Critical Genes",,10090,['Not specified'],['Not specified']
KE 876,"Increase, Mutations in Critical Genes",,9606,['Not specified'],['Not specified']
KE 877,"Inhibition, organic anion transporter 1 (OAT1)",proximal tubule,Not specified,['Not specified'],['Not specified']
KE 1096,"Increased, blood uric acid concentration",blood,Not specified,['Not specified'],['Not specified']
KE 1097,"Occurrence, renal proximal tubular necrosis",proximal tubule,Not specified,['Not specified'],['Not specified']
KE 1098,"Increased, blood potassium concentration",blood,Not specified,['Not specified'],['Not specified']
KE 1102,"Occurrence, tophi (urate) deposition",,Not specified,['Not specified'],['Not specified']
KE 1106,"Occurrence, cardiac arrhythmia",heart,Not specified,['Not specified'],['Not specified']
KE 885,"Increase, Cancer",,9606,['Unspecific'],['All life stages']
KE 885,"Increase, Cancer",,10090,['Unspecific'],['All life stages']
KE 885,"Increase, Cancer",,10116,['Unspecific'],['All life stages']
KE 1539,Endocytotic lysosomal uptake,,9606,['Unspecific'],['All life stages']
KE 1539,Endocytotic lysosomal uptake,,10116,['Unspecific'],['All life stages']
KE 1539,Endocytotic lysosomal uptake,,10090,['Unspecific'],['All life stages']
KE 898,"Disruption, Lysosome",,9606,['Unspecific'],['All life stages']
KE 898,"Disruption, Lysosome",,10090,['Unspecific'],['All life stages']
KE 1494,Leukocyte recruitment/activation,,9606,['Unspecific'],['All life stages']
KE 1494,Leukocyte recruitment/activation,,7742,['Unspecific'],['All life stages']
KE 941,"Activation, EGFR",lung,9606,['Mixed'],['Adult']
KE 941,"Activation, EGFR",lung,10090,['Mixed'],['Adult']
KE 941,"Activation, EGFR",lung,10116,['Mixed'],['Adult']
KE 962,"Increase, Mucin production",lung,9606,['Mixed'],['Adult']
KE 962,"Increase, Mucin production",lung,10090,['Mixed'],['Adult']
KE 962,"Increase, Mucin production",lung,10116,['Mixed'],['Adult']
KE 1250,"Decrease, Lung function",,9606,['Mixed'],['Adult']
KE 2117,"Increase, goblet cell number",,10116,['Unspecific'],['Not specified']
KE 2117,"Increase, goblet cell number",,10090,['Unspecific'],['Not specified']
KE 2117,"Increase, goblet cell number",,9986,['Unspecific'],['Not specified']
KE 2117,"Increase, goblet cell number",,10141,['Unspecific'],['Not specified']
KE 2117,"Increase, goblet cell number",,9606,['Unspecific'],['Not specified']
KE 927,"KE1 : S-Glutathionylation, eNOS",,9606,['Unspecific'],['All life stages']
KE 927,"KE1 : S-Glutathionylation, eNOS",,9913,['Unspecific'],['All life stages']
KE 927,"KE1 : S-Glutathionylation, eNOS",,10090,['Unspecific'],['All life stages']
KE 927,"KE1 : S-Glutathionylation, eNOS",,10116,['Unspecific'],['All life stages']
KE 935,"KE2 : Decrease, GTPCH-1",,9606,['Unspecific'],['All life stages']
KE 935,"KE2 : Decrease, GTPCH-1",,9913,['Unspecific'],['All life stages']
KE 935,"KE2 : Decrease, GTPCH-1",,10090,['Unspecific'],['All life stages']
KE 935,"KE2 : Decrease, GTPCH-1",,10116,['Unspecific'],['All life stages']
KE 934,"KE3 : Decrease, Tetrahydrobiopterin",,9606,['Unspecific'],['All life stages']
KE 934,"KE3 : Decrease, Tetrahydrobiopterin",,9913,['Unspecific'],['All life stages']
KE 934,"KE3 : Decrease, Tetrahydrobiopterin",,10090,['Unspecific'],['All life stages']
KE 934,"KE3 : Decrease, Tetrahydrobiopterin",,10116,['Unspecific'],['All life stages']
KE 932,"KE4 : Uncoupling, eNOS",,9606,['Unspecific'],['All life stages']
KE 932,"KE4 : Uncoupling, eNOS",,9913,['Unspecific'],['All life stages']
KE 932,"KE4 : Uncoupling, eNOS",,10090,['Unspecific'],['All life stages']
KE 932,"KE4 : Uncoupling, eNOS",,10116,['Unspecific'],['All life stages']
KE 933,"KE6 : Depletion, Nitric Oxide",blood,9606,['Unspecific'],['All life stages']
KE 933,"KE6 : Depletion, Nitric Oxide",blood,9913,['Unspecific'],['All life stages']
KE 933,"KE6 : Depletion, Nitric Oxide",blood,10090,['Unspecific'],['All life stages']
KE 933,"KE6 : Depletion, Nitric Oxide",blood,10116,['Unspecific'],['All life stages']
KE 937,"KE7 : Impaired, Vasodilation",circulatory system,9606,['Unspecific'],['All life stages']
KE 937,"KE7 : Impaired, Vasodilation",circulatory system,9986,['Unspecific'],['All life stages']
KE 937,"KE7 : Impaired, Vasodilation",circulatory system,10090,['Unspecific'],['All life stages']
KE 937,"KE7 : Impaired, Vasodilation",circulatory system,10116,['Unspecific'],['All life stages']
KE 951,"KE8 : Increase, Vascular Resistance",circulatory system,9606,['Unspecific'],['All life stages']
KE 951,"KE8 : Increase, Vascular Resistance",circulatory system,10116,['Unspecific'],['All life stages']
KE 952,Hypertension,,9606,['Unspecific'],['All life stages']
KE 952,Hypertension,,10090,['Unspecific'],['All life stages']
KE 952,Hypertension,,10116,['Unspecific'],['All life stages']
KE 973,"KE5 : Decrease, AKT/eNOS activity",,9606,['Unspecific'],['All life stages']
KE 973,"KE5 : Decrease, AKT/eNOS activity",,9913,['Unspecific'],['All life stages']
KE 973,"KE5 : Decrease, AKT/eNOS activity",,10116,['Unspecific'],['All life stages']
KE 973,"KE5 : Decrease, AKT/eNOS activity",,10090,['Unspecific'],['All life stages']
KE 945,"reduced dimerization, ARNT/HIF1-alpha",,9031,['Unspecific'],"['Embryo', 'Development']"
KE 945,"reduced dimerization, ARNT/HIF1-alpha",,10090,['Unspecific'],"['Embryo', 'Development']"
KE 945,"reduced dimerization, ARNT/HIF1-alpha",,10116,['Unspecific'],"['Embryo', 'Development']"
KE 945,"reduced dimerization, ARNT/HIF1-alpha",,7955,['Unspecific'],"['Embryo', 'Development']"
KE 945,"reduced dimerization, ARNT/HIF1-alpha",,48416,['Unspecific'],"['Embryo', 'Development']"
KE 945,"reduced dimerization, ARNT/HIF1-alpha",,217509,['Unspecific'],"['Embryo', 'Development']"
KE 945,"reduced dimerization, ARNT/HIF1-alpha",,9606,['Unspecific'],"['Embryo', 'Development']"
KE 948,"reduced production, VEGF",,9031,['Unspecific'],"['Embryo', 'Development', 'Adult']"
KE 948,"reduced production, VEGF",,40674,['Unspecific'],"['Embryo', 'Development', 'Adult']"
KE 948,"reduced production, VEGF",,93934,['Unspecific'],"['Embryo', 'Development', 'Adult']"
KE 948,"reduced production, VEGF",,7955,['Unspecific'],"['Embryo', 'Development', 'Adult']"
KE 948,"reduced production, VEGF",,8355,['Unspecific'],"['Embryo', 'Development', 'Adult']"
KE 1891,"abnormal, placental labyrinth vasculature morphology",,Not specified,['Not specified'],['Not specified']
KE 1892,"increase, placental insufficiency",,Not specified,['Not specified'],['Not specified']
KE 1893,"increase, Preeclampsia",,Not specified,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,9606,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,89462,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,10116,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,10090,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,9031,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,9823,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,9598,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,13616,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,8364,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,9913,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,9544,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,9103,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,9615,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,9940,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,9365,['Not specified'],['Not specified']
KE 957,"Binding, Transthyretin in serum",serum,8355,['Not specified'],['Not specified']
KE 958,"Displacement, Serum thyroxine (T4) from transthyretin",,10116,['Mixed'],['During development and at adulthood']
KE 959,"Increased, Free serum thyroxine (T4)",blood,8355,['Not specified'],['During development and at adulthood']
KE 959,"Increased, Free serum thyroxine (T4)",blood,10116,['Not specified'],['During development and at adulthood']
KE 960,"Increased, Uptake of thyroxine into tissue",,Not specified,['Not specified'],['Not specified']
KE 964,"Inhibition of Aromatase Enzyme, Chemical exposure during critical window of estrous cycle between diestrus 2 and proestrus inhibits aromatase conversion of testosterone to estradiol",,Not specified,['Not specified'],['Not specified']
KE 965,"reduction in ovarian granulosa cells synthesis of estradiol, Reduced steroidogenic production of estradiol in granulosa cells",,Not specified,['Not specified'],['Not specified']
KE 966,"Reduced Estradiol in Circulation, Reduced steroidogenic production of estradiol in granulosa cells leading to decreased estradiol in circulation",,Not specified,['Not specified'],['Not specified']
KE 967,"Decreased positive estrogenic feedback on hypothalamus, Reduced estradiol in circulation decreases estrogen concentration at hypothalamus",,Not specified,['Not specified'],['Not specified']
KE 968,"Decreased Kisspeptin release from neurons in AVPV, Decreased hypothalamic estrogen reduces kisspeptinergic neuron response",,Not specified,['Not specified'],['Not specified']
KE 969,"Decreased GnRH Release, Decreased Kisspeptin stimulation of GnRH neurons",,Not specified,['Not specified'],['Not specified']
KE 970,"Decreased LH release from Anterior Pituitary, Decreased GnRH stimulation of Anterior Pituitary Gonadotrophs",,Not specified,['Not specified'],['Not specified']
KE 971,"Ovulation of oocytes Reduced, Delayed, or Blocked, Decrease or delay in LH surge required for ovulation",,Not specified,['Not specified'],['Not specified']
KE 972,"Decreased fertility, Reduced number of oocytes ovulated",,Not specified,['Not specified'],['Not specified']
KE 979,"Interference, nuclear localization of NFAT",immune system,9606,['Unspecific'],['All life stages']
KE 979,"Interference, nuclear localization of NFAT",immune system,10090,['Unspecific'],['All life stages']
KE 981,"Reduction, NFAT/AP-1 complex formation",immune system,9606,['Unspecific'],['All life stages']
KE 981,"Reduction, NFAT/AP-1 complex formation",immune system,10090,['Unspecific'],['All life stages']
KE 984,"Impairment, T-cell dependent antibody response",,9606,['Unspecific'],['All life stages']
KE 984,"Impairment, T-cell dependent antibody response",,10090,['Unspecific'],['All life stages']
KE 984,"Impairment, T-cell dependent antibody response",,10116,['Unspecific'],['All life stages']
KE 984,"Impairment, T-cell dependent antibody response",,9541,['Unspecific'],['All life stages']
KE 1202,"Suppression, IL-2 and IL-4 production",immune system,9606,['Unspecific'],['All life stages']
KE 1202,"Suppression, IL-2 and IL-4 production",immune system,10090,['Unspecific'],['All life stages']
KE 1202,"Suppression, IL-2 and IL-4 production",immune system,9541,['Unspecific'],['All life stages']
KE 980,"Inhibition, Calcineurin Activity",,9606,['Unspecific'],['All life stages']
KE 980,"Inhibition, Calcineurin Activity",,10090,['Unspecific'],['All life stages']
KE 980,"Inhibition, Calcineurin Activity",,10117,['Unspecific'],['All life stages']
KE 1002,"Inhibition, Deiodinase 2",,10116,['Unspecific'],['All life stages']
KE 1002,"Inhibition, Deiodinase 2",,9606,['Unspecific'],['All life stages']
KE 1002,"Inhibition, Deiodinase 2",,9823,['Unspecific'],['All life stages']
KE 1002,"Inhibition, Deiodinase 2",,8128,['Unspecific'],['All life stages']
KE 1002,"Inhibition, Deiodinase 2",,7955,['Unspecific'],['All life stages']
KE 1002,"Inhibition, Deiodinase 2",,90988,['Unspecific'],['All life stages']
KE 1002,"Inhibition, Deiodinase 2",,8355,['Unspecific'],['All life stages']
KE 1003,"Decreased, Triiodothyronine (T3)",,7955,['Unspecific'],['All life stages']
KE 1003,"Decreased, Triiodothyronine (T3)",,90988,['Unspecific'],['All life stages']
KE 1003,"Decreased, Triiodothyronine (T3)",,8355,['Unspecific'],['All life stages']
KE 1004,"Reduced, Posterior swim bladder inflation",swim bladder,7955,['Unspecific'],['Embryo']
KE 1004,"Reduced, Posterior swim bladder inflation",swim bladder,90988,['Unspecific'],['Embryo']
KE 1004,"Reduced, Posterior swim bladder inflation",swim bladder,8090,['Unspecific'],['Embryo']
KE 1005,"Reduced, Swimming performance",,7955,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1005,"Reduced, Swimming performance",,70862,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1005,"Reduced, Swimming performance",,90988,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1007,"Reduced, Anterior swim bladder inflation",swim bladder,7955,['Unspecific'],['Larvae']
KE 1007,"Reduced, Anterior swim bladder inflation",swim bladder,90988,['Unspecific'],['Larvae']
KE 1009,"Inhibition, Deiodinase 1",,10116,['Unspecific'],['All life stages']
KE 1009,"Inhibition, Deiodinase 1",,10090,['Unspecific'],['All life stages']
KE 1009,"Inhibition, Deiodinase 1",,9823,['Unspecific'],['All life stages']
KE 1009,"Inhibition, Deiodinase 1",,9940,['Unspecific'],['All life stages']
KE 1009,"Inhibition, Deiodinase 1",,90988,['Unspecific'],['All life stages']
KE 1009,"Inhibition, Deiodinase 1",,8078,['Unspecific'],['All life stages']
KE 1009,"Inhibition, Deiodinase 1",,8175,['Unspecific'],['All life stages']
KE 1009,"Inhibition, Deiodinase 1",,8355,['Unspecific'],['All life stages']
KE 1009,"Inhibition, Deiodinase 1",,9606,['Unspecific'],['All life stages']
KE 1009,"Inhibition, Deiodinase 1",,8128,['Unspecific'],['All life stages']
KE 1009,"Inhibition, Deiodinase 1",,7955,['Unspecific'],['All life stages']
KE 762,"Activation, ionotropic GABA Receptor chloride channel",,Not specified,['Not specified'],['Not specified']
KE 1012,"Increased, Inhibitory postsynaptic potential",,Not specified,['Not specified'],['Not specified']
KE 1014,"Induction, Somatic muscle paralysis",somatic muscle,Not specified,['Not specified'],['Not specified']
KE 1015,"Increased, Neuronal synaptic inhibition",,Not specified,['Not specified'],['Not specified']
KE 1016,"Inhibition, Feeding",,33208,['Unspecific'],['All life stages']
KE 1018,"Activation, Glutamate-gated chloride channels",,Not specified,['Not specified'],['Not specified']
KE 1019,"Induction, pharyngeal muscle paralysis",pharyngeal muscle,Not specified,['Not specified'],['Not specified']
KE 1029,"Increased, adipogenesis",,Not specified,['Not specified'],['Not specified']
KE 1032,"Increased, secretion of local growth factors",,Not specified,['Not specified'],['Not specified']
KE 1033,"Increased, proliferation of mesenchymal cells",,Not specified,['Not specified'],['Not specified']
KE 1034,"Increased, IGF-1 (mouse)",,Not specified,['Not specified'],['Not specified']
KE 1035,"Increased, Firbrosarcoma",fibrous connective tissue,Not specified,['Not specified'],['Not specified']
KE 1036,"Increased, liposarcoma",adipose tissue,Not specified,['Not specified'],['Not specified']
KE 1037,"Increased, hemagiosarcoma",blood vessel endothelium,Not specified,['Not specified'],['Not specified']
KE 1038,"Activation, beta-2 adrenergic receptor",,Not specified,['Not specified'],['Not specified']
KE 1039,"Increased activity, beta-2 adrenergic receptor",,Not specified,['Not specified'],['Not specified']
KE 1040,"relaxation, smooth muscle",,Not specified,['Not specified'],['Not specified']
KE 1042,"Proliferation/Clonal Expansion, smooth muscle",,Not specified,['Not specified'],['Not specified']
KE 1043,"Hypertrophy/hyperplasia, smooth muscle",,Not specified,['Not specified'],['Not specified']
KE 1044,"Promotion, mesovarian leiomyomas",uterus,Not specified,['Not specified'],['Not specified']
KE 1045,"Decreased, Ovarian E2",female gonad,Not specified,['Not specified'],['Not specified']
KE 1046,"Suppression, Estrogen receptor (ER) activity",hypothalamus,9606,['Mixed'],['Not Otherwise Specified']
KE 1046,"Suppression, Estrogen receptor (ER) activity",hypothalamus,10116,['Mixed'],['Not Otherwise Specified']
KE 1046,"Suppression, Estrogen receptor (ER) activity",hypothalamus,10095,['Mixed'],['Not Otherwise Specified']
KE 1047,"Increased, secretion of GnRH from hypothalamus",,Not specified,['Not specified'],['Not specified']
KE 1049,"Increased, secrection of FSH from anterior pituitary",,Not specified,['Not specified'],['Not specified']
KE 1050,"Increased, secretion of LH from anterior pituitary",,Not specified,['Not specified'],['Not specified']
KE 1051,"Hyperplasia, ovarian stromal cells",,Not specified,['Not specified'],['Not specified']
KE 1052,"Hyperplasia, ovarian epithelium",epithelium of female gonad,Not specified,['Not specified'],['Not specified']
KE 1053,"Promotion, ovarian adenomas",,Not specified,['Not specified'],['Not specified']
KE 1054,"Promotion, ovarian granular cell tumors",,Not specified,['Not specified'],['Not specified']
KE 1056,"Decrease, E2 blood concentrations at hypothalamus",blood,Not specified,['Not specified'],['Not specified']
KE 1057,"Increased, PPAR-alpha activation",,Not specified,['Not specified'],['Not specified']
KE 1058,"Decreased, bile flow",bile canaliculi,Not specified,['Not specified'],['Not specified']
KE 1059,"Increased, cholestasis",bile duct,Not specified,['Not specified'],['Not specified']
KE 1060,"Alteration, lipid metabolism",,9606,['Unspecific'],['All life stages']
KE 1060,"Alteration, lipid metabolism",,10090,['Unspecific'],['All life stages']
KE 1060,"Alteration, lipid metabolism",,10116,['Unspecific'],['All life stages']
KE 1061,"prolonged, elevation of serun CCK",serum,Not specified,['Not specified'],['Not specified']
KE 1062,"Increased, Cellular proliferation / hyperplasia of acinar cells",,Not specified,['Not specified'],['Not specified']
KE 1063,"Increased, Pancreatic acinar tumors",pancreas,Not specified,['Not specified'],['Not specified']
KE 1064,"prepubertal increase, Estrogen receptor (ER) activity",,Not specified,['Not specified'],['Not specified']
KE 1065,"Activation, estrogen receptor alpha",uterus,40674,['Female'],"['Adult', 'Adult, reproductively mature', 'Old Age']"
KE 1066,"Promotion, SIX-1 postive basal-type progenitor cells",,Not specified,['Not specified'],['Not specified']
KE 1067,"Proliferation/Clonal Expansion, aberrant basal cells",,Not specified,['Not specified'],['Not specified']
KE 1068,"squamous metaplasia, aberrant basal cells",,Not specified,['Not specified'],['Not specified']
KE 1069,"Increased, Hyperplasia (glandular epithelial cells of endometrium)",,Not specified,['Not specified'],['Not specified']
KE 1070,"Increased, adenosquamous carcinomas of endometrium",endometrium,Not specified,['Not specified'],['Not specified']
KE 1071,"Decreased, GnRH pulsatility/release in hypothalamus",,Not specified,['Not specified'],['Not specified']
KE 1072,"Decreased, LH Surge from anterior pituitary",,Not specified,['Not specified'],['Not specified']
KE 1074,"interruption, Ovulation",,Not specified,['Not specified'],['Not specified']
KE 1075,"prolonged, estrus",,Not specified,['Not specified'],['Not specified']
KE 1076,"Increased, circulating estrogen levels",,Not specified,['Not specified'],['Not specified']
KE 1077,"Increased, prolactin exposure",,Not specified,['Not specified'],['Not specified']
KE 1078,"Hyperplasia, Mammary gland",mammary gland,Not specified,['Not specified'],['Not specified']
KE 1079,"Increased, Adenomas/carcinomas (mammary)",mammary gland,Not specified,['Not specified'],['Not specified']
KE 1080,"Increased, latency period",,Not specified,['Not specified'],['Not specified']
KE 1081,"Increased, lactotroph hyperplasia and hypertrophy",,Not specified,['Not specified'],['Not specified']
KE 1082,"Increased, adenomas (pituitary)",pituitary gland,Not specified,['Not specified'],['Not specified']
KE 1083,"Decreased, Dopaminergic activity",,Not specified,['Not specified'],['Not specified']
KE 1084,"Increased, prolactin secretion",,Not specified,['Not specified'],['Not specified']
KE 1085,"Increased, hyperplasia (mammary gland)",mammary gland,Not specified,['Not specified'],['Not specified']
KE 1086,"persistent, cytotoxicity (pleura or peritoneum)",pleura,Not specified,['Not specified'],['Not specified']
KE 1087,"Increased, inflammation",,Not specified,['Not specified'],['Not specified']
KE 1089,"Increased, Cell Proliferation (mesothelium)",mesothelium,Not specified,['Not specified'],['Not specified']
KE 1090,"Increased, mesotheliomas",,Not specified,['Not specified'],['Not specified']
KE 1495,Substance interaction with the lung resident cell membrane components,,10090,['Male'],['Adults']
KE 1495,Substance interaction with the lung resident cell membrane components,,10116,['Male'],['Adults']
KE 1495,Substance interaction with the lung resident cell membrane components,,9606,['Male'],['Adults']
KE 1497,"Increased, recruitment of inflammatory cells",,9606,['Mixed'],['All life stages']
KE 1497,"Increased, recruitment of inflammatory cells",,10090,['Mixed'],['All life stages']
KE 1497,"Increased, recruitment of inflammatory cells",,10116,['Mixed'],['All life stages']
KE 1498,Loss of alveolar capillary membrane integrity,lung,10090,"['Male', 'Female']",['Adult']
KE 1498,Loss of alveolar capillary membrane integrity,lung,9606,"['Male', 'Female']",['Adult']
KE 1499,"Increased, activation of T (T) helper (h) type 2 cells",,Not specified,['Not specified'],['Not specified']
KE 1500,"Increased, fibroblast proliferation and myofibroblast differentiation",,10090,"['Male', 'Female']",['Adult']
KE 1500,"Increased, fibroblast proliferation and myofibroblast differentiation",,9606,"['Male', 'Female']",['Adult']
KE 1458,Pulmonary fibrosis,lung,9606,['Unspecific'],['Adults']
KE 1458,Pulmonary fibrosis,lung,10090,['Unspecific'],['Adults']
KE 1458,Pulmonary fibrosis,lung,10116,['Unspecific'],['Adults']
KE 1101,"Altered, Amphibian metamorphosis",,8355,['Unspecific'],['Development']
KE 1104,"Decreased, Prostaglandin F2alpha concentration, plasma",blood plasma,Not specified,['Not specified'],['Not specified']
KE 1105,"Occurrence, renal ischemia",,Not specified,['Not specified'],['Not specified']
KE 1103,"Inhibition, Cyclooxygenase 1 activity",,Not specified,['Not specified'],['Not specified']
KE 1109,"Increased, Deformed Wing Virus levels",,Not specified,['Not specified'],['Not specified']
KE 1110,"Increased, Energetic demands and therefore metabolic stress",,Not specified,['Not specified'],['Not specified']
KE 1114,"Unknown, MIE",,Not specified,['Not specified'],['Not specified']
KE 1122,"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis",,Not specified,['Not specified'],['Not specified']
KE 1130,"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)",vascular system,Not specified,['Not specified'],['Not specified']
KE 1131,"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin)",,Not specified,['Not specified'],['Not specified']
KE 1132,"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal",,Not specified,['Not specified'],['Not specified']
KE 1133,"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors",,Not specified,['Not specified'],['Not specified']
KE 1134,"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone",,Not specified,['Not specified'],['Not specified']
KE 1135,"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction",,Not specified,['Not specified'],['Not specified']
KE 1136,"Impaired recruitment , Population trajectory",,Not specified,['Not specified'],['Not specified']
KE 1138,"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP",,Not specified,['Not specified'],['Not specified']
KE 1151,"Osteoporosis and vascular calcification, Bone deterioration",,Not specified,['Not specified'],['Not specified']
KE 1169,"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin",,Not specified,['Not specified'],['Not specified']
KE 1152,"Inhibition, Iodotyrosine deiodinase (IYD)",,8355,['Not specified'],['Not specified']
KE 1116,"Decreased, Triiodothyronine (T3) in tissues",,8355,['Unspecific'],['Development']
KE 1828,"Increased, Thyroxine (T4) in serum",,8355,['Not specified'],['Not specified']
KE 1829,"Altered, Thyroid hormone-dependent gene expression",,8355,['Not specified'],['Not specified']
KE 1153,"Inhibition, Deiodinase 3",,8355,['Not specified'],['Not specified']
KE 1154,"Increased, Triiodothyronine (T3) in tissues",,8355,['Not specified'],['Not specified']
KE 1155,"Inhibition, Pendrin",,8355,['Not specified'],['Not specified']
KE 1156,"Inhibition, Dual oxidase",,8355,['Not specified'],['Not specified']
KE 1157,"Activation, Hepatic nuclear receptor(s)",,8355,['Not specified'],['Not specified']
KE 1158,"Increased, Hepatic thyroid hormone uptake/transport",,8355,['Not specified'],['Not specified']
KE 1161,"Increased, oocyte maturation",,Not specified,['Not specified'],['Not specified']
KE 1164,"Increased, Population",,Not specified,['Not specified'],['Not specified']
KE 1255,induced spawning,,Not specified,['Not specified'],['Not specified']
KE 1163,"Increased, Reproductive Success",,Not specified,['Not specified'],['Not specified']
KE 621,"Increase, cilia movement",,Not specified,['Not specified'],['Not specified']
KE 1215,"TRPA1 activation, TRPA1 Receptor",,Not specified,['Not specified'],['Not specified']
KE 1218,"Opening of calcium channel, Calcium influx",,Not specified,['Not specified'],['Not specified']
KE 1220,Trigeminal nerve activation,respiratory tract,Not specified,['Not specified'],['Not specified']
KE 1222,"SP (Substance P) release, Local increase of SP",,Not specified,['Not specified'],['Not specified']
KE 1223,"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea",respiratory tract,Not specified,['Not specified'],['Not specified']
KE 1226,"Increased Respiratory irritability and Chronic Cough,",,Not specified,['Not specified'],['Not specified']
KE 1433,"Increased CGRP, neuronal release of CGRP",respiratory tract,Not specified,['Not specified'],['Not specified']
KE 1434,Irritation of nasal mucosa inducing sneeze reflex,nasal cavity respiratory epithelium,Not specified,['Not specified'],['Not specified']
KE 1435,Increased neurokinin A (NKA) by neuronal cells,respiratory tract,Not specified,['Not specified'],['Not specified']
KE 1176,"Decreased, sodium conductance 2",,Not specified,['Not specified'],['Not specified']
KE 1179,"Decreased, GABA release",,Not specified,['Not specified'],['Not specified']
KE 1181,"Activation, Estrogen receptor",,Not specified,['Not specified'],['Not specified']
KE 1182,"Increase, Cell Proliferation (Epithelial Cells)",,Not specified,['Not specified'],['Not specified']
KE 1183,"Decreased, Apoptosis (Epithelial Cells)",,Not specified,['Not specified'],['Not specified']
KE 1187,"Increased, ER binding to DNA (classical pathway)",,Not specified,['Not specified'],['Not specified']
KE 1188,"Increased, ER binding to T.F. to DNA (non-classical pathway)",,Not specified,['Not specified'],['Not specified']
KE 1189,"Increased, Proliferation (Endothelial cells)",,Not specified,['Not specified'],['Not specified']
KE 1190,"Increased, Migration (Endothelial Cells)",,9606,['Mixed'],['Adult']
KE 1191,"Increased, Non-genomic signaling",,Not specified,['Not specified'],['Not specified']
KE 1192,"Increased, Ductal Hyperplasia",mammary duct,Not specified,['Not specified'],['Not specified']
KE 1193,"N/A, Breast Cancer",,40674,['Mixed'],['Adult']
KE 1193,"N/A, Breast Cancer",,9606,['Mixed'],['Adult']
KE 1194,"Increase, DNA damage",,Not specified,['Not specified'],['Not specified']
KE 1195,"modulation, Extracellular Matrix Composition",,Not specified,['Not specified'],['Not specified']
KE 1196,"Increased, Invasion",,9606,['Mixed'],['Adults']
KE 1197,"Activation, Fibroblasts",,Not specified,['Not specified'],['Not specified']
KE 1198,"Activation, Macrophages",,Not specified,['Not specified'],['Not specified']
KE 1213,"Increased, Angiogenesis",,9606,['Mixed'],['Adults']
KE 1239,"Altered, Gene Expression",,Not specified,['Not specified'],['Not specified']
KE 1240,"Altered, Protein Production",,Not specified,['Not specified'],['Not specified']
KE 1241,"Increased, Motility",,9606,"['Female', 'Male']",['Adult']
KE 1242,"Increased, Second Messenger Production",,Not specified,['Not specified'],['Not specified']
KE 1205,"Activation, Juvenile hormone receptor",,Not specified,['Not specified'],['Not specified']
KE 1206,"Induction, Doublesex1 gene",,Not specified,['Not specified'],['Not specified']
KE 1208,"Increased, Male offspring",,Not specified,['Not specified'],['Not specified']
KE 1209,"Induction, Male reproductive tract",male reproductive system,Not specified,['Not specified'],['Not specified']
KE 361,"Decline, Population",,Not specified,['Not specified'],['Not specified']
KE 1210,"Alteration, Food-web structures",,Not specified,['Not specified'],['Not specified']
KE 1252,Binding to (interferes with) topoisomerase II enzyme,,40674,['Mixed'],['Not specified']
KE 1253,MLL chromosomal translocation,,40674,['Mixed'],['Not specified']
KE 1254,Infant leukaemia,,40674,['Mixed'],['Birth to < 1 month']
KE 1461,"Increase, DNA double-strand breaks",,Not specified,['Not specified'],['Not specified']
KE 1256,increased mantel display,,Not specified,['Not specified'],['Not specified']
KE 1257,Induced parturition,,Not specified,['Not specified'],['Not specified']
KE 1141,"Decreased, Reproductive Success",,Not specified,['Not specified'],['Not specified']
KE 1258,Decompartmentalization,,Not specified,['Not specified'],['Not specified']
KE 1260,Direct mitochondrial inhibition,,Not specified,['Not specified'],['Not specified']
KE 1259,narcosis,,Not specified,['Not specified'],['Not specified']
KE 1262,Apoptosis,organ,9606,['Unspecific'],['Not Otherwise Specified']
KE 1262,Apoptosis,organ,10090,['Unspecific'],['Not Otherwise Specified']
KE 1262,Apoptosis,organ,10116,['Unspecific'],['Not Otherwise Specified']
KE 1262,Apoptosis,organ,6239,['Unspecific'],['Not Otherwise Specified']
KE 1263,Necrosis,,Not specified,['Not specified'],['Not specified']
KE 1270,Inactivation of PPARγ,,Not specified,['Not specified'],['Not specified']
KE 1271,Activation of TGF-β signaling,,Not specified,['Not specified'],['Not specified']
KE 1275,Collagen Deposition,,Not specified,['Not specified'],['Not specified']
KE 1276,Lung fibrosis,,Not specified,['Not specified'],['Not specified']
KE 1457,Epithelial Mesenchymal Transition,organ,9606,['Unspecific'],['Not Otherwise Specified']
KE 1174,"Activation, NADPH Oxidase",,Not specified,['Not specified'],['Not specified']
KE 1277,Reproductive failure,,Not specified,['Not specified'],['Not specified']
KE 1278,ROS formation,,Not specified,['Not specified'],['Not specified']
KE 1279,"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK",,Not specified,['Not specified'],['Not specified']
KE 1280,"Activation, HIF-1",,Not specified,['Not specified'],['Not specified']
KE 1281,"Increased, DNA Damage-Repair",,Not specified,['Not specified'],['Not specified']
KE 1282,"Activation, JAK/STAT pathway",,Not specified,['Not specified'],['Not specified']
KE 1283,"Activation, TGF-beta pathway",,Not specified,['Not specified'],['Not specified']
KE 1284,"Up Regulation, SREBF2",,Not specified,['Not specified'],['Not specified']
KE 1285,"Up Regulation, Unsaturated fatty acid",,Not specified,['Not specified'],['Not specified']
KE 1286,"Down Regulation, GSS and GSTs gene",,Not specified,['Not specified'],['Not specified']
KE 1287,Glutathione synthesis,,Not specified,['Not specified'],['Not specified']
KE 1288,"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene",,Not specified,['Not specified'],['Not specified']
KE 1289,Perturbation of cholesterol,,Not specified,['Not specified'],['Not specified']
KE 1290,Glutathione homeostasis,,Not specified,['Not specified'],['Not specified']
KE 1291,Hepatotoxicity,,Not specified,['Not specified'],['Not specified']
KE 1292,"Activation, JNK",,Not specified,['Not specified'],['Not specified']
KE 1293,"Activation, FOXO",,Not specified,['Not specified'],['Not specified']
KE 1294,"Inhibition, Wnt pathway",,Not specified,['Not specified'],['Not specified']
KE 1295,Defect of Embryogenesis,embryo,Not specified,['Not specified'],['Not specified']
KE 1502,Histone deacetylase inhibition,organ,10116,['Unspecific'],['All life stages']
KE 1502,Histone deacetylase inhibition,organ,9606,['Unspecific'],['All life stages']
KE 1502,Histone deacetylase inhibition,organ,10090,['Unspecific'],['All life stages']
KE 1503,"Histone acetylation, increase",organ,10116,['Unspecific'],['Not Otherwise Specified']
KE 1503,"Histone acetylation, increase",organ,9606,['Unspecific'],['Not Otherwise Specified']
KE 1503,"Histone acetylation, increase",organ,10090,['Unspecific'],['Not Otherwise Specified']
KE 1505,"Cell cycle, disrupted",organ,9606,['Unspecific'],['Not Otherwise Specified']
KE 1505,"Cell cycle, disrupted",organ,10090,['Unspecific'],['Not Otherwise Specified']
KE 1506,Testicular atrophy,testis,10116,['Male'],"['Adult, reproductively mature']"
KE 1506,Testicular atrophy,testis,10090,['Male'],"['Adult, reproductively mature']"
KE 1515,Spermatocyte depletion,testis,10116,['Male'],['Adult']
KE 1515,Spermatocyte depletion,testis,10090,['Male'],['Adult']
KE 1305,"Increase, cytosolic fatty acid",,7742,['Unspecific'],['All life stages']
KE 1489,"N/A, Steatohepatisis",,7742,['Unspecific'],['All life stages']
KE 1490,"Inhibition, Fatty Acid Beta Oxidation",,Not specified,['Not specified'],['Not specified']
KE 1491,"Increased, Oncotic Necrosis",,Not specified,['Unspecific'],['All life stages']
KE 1316,"Inhibit, serotonin transporter activity",,Not specified,['Not specified'],['Not specified']
KE 1317,"Decreased, serotonin transporter activity",,Not specified,['Not specified'],['Not specified']
KE 1318,"Decreased, extracellular sodium (Na+)",,Not specified,['Not specified'],['Not specified']
KE 1319,"Decreased, extracellular chloride (Cl-)",,Not specified,['Not specified'],['Not specified']
KE 1320,"Increased, extracellular serotonin",,10116,['Unspecific'],['All life stages']
KE 1320,"Increased, extracellular serotonin",,7955,['Unspecific'],['All life stages']
KE 1321,"Increased, intracellular sodium (Na+)",,Not specified,['Not specified'],['Not specified']
KE 1322,"Increased, intracellular chloride (Cl-)",,Not specified,['Not specified'],['Not specified']
KE 1323,"Decreased, intracellular serotonin",,Not specified,['Not specified'],['Not specified']
KE 1324,"Decreased, packaged serotonin",,Not specified,['Not specified'],['Not specified']
KE 1325,"Decreased, synaptic release",,Not specified,['Not specified'],['Not specified']
KE 1326,"Increased, 5-HT3 (5-hydroxytryptamine)",,Not specified,['Not specified'],['Not specified']
KE 1328,"Inactivated, 5-HTR (serotonin receptors)",,Not specified,['Not specified'],['Not specified']
KE 1329,"Reduce expression, BDNF (Brain-derived neurotrophic factor)",,Not specified,['Not specified'],['Not specified']
KE 1330,"Decreased, neuroplasticity",,Not specified,['Not specified'],['Not specified']
KE 1334,"Increase, cortisone",,Not specified,['Not specified'],['Not specified']
KE 1335,"Reduced, BDNF (Brain-derived neurotrophic factor)",,Not specified,['Not specified'],['Not specified']
KE 1336,"Activation, 5-HT2A (Serotonin 2A)",,Not specified,['Not specified'],['Not specified']
KE 1337,"Activate, PLC (Phospholipase C)",,Not specified,['Not specified'],['Not specified']
KE 1338,"Increase, inositol triphosphate",,Not specified,['Not specified'],['Not specified']
KE 1339,"Increase, intracellular calcium",brain,10116,['Mixed'],"['Adult, reproductively mature', 'Birth to < 1 month']"
KE 1339,"Increase, intracellular calcium",brain,9606,['Mixed'],"['Adult, reproductively mature', 'Birth to < 1 month']"
KE 1340,"Activate, calmodulin",,Not specified,['Not specified'],['Not specified']
KE 1341,"Increase, myosin light chain phosphorylation",,Not specified,['Not specified'],['Not specified']
KE 1342,"Increase, vascular smooth muscle contraction",,Not specified,['Not specified'],['Not specified']
KE 1344,"Increased, seizure",,Not specified,['Not specified'],['Not specified']
KE 1345,"Increased, agitation",,Not specified,['Not specified'],['Not specified']
KE 1346,"Increased, depression",,Not specified,['Not specified'],['Not specified']
KE 1343,"Increase, hypertension",,Not specified,['Not specified'],['Not specified']
KE 1347,"Decreased, extracellular serotonin",,Not specified,['Not specified'],['Not specified']
KE 1348,"Increase, seizure",,Not specified,['Not specified'],['Not specified']
KE 1349,"Activated, presynaptic neuron 1",,Not specified,['Not specified'],['Not specified']
KE 1350,"Increased, glutamate",,7955,['Unspecific'],['All life stages']
KE 1350,"Increased, glutamate",,10116,['Unspecific'],['All life stages']
KE 1351,"Activated, NMDA receptor",,Not specified,['Not specified'],['Not specified']
KE 1352,"Activated, voltage-gated sodium channel",,Not specified,['Not specified'],['Not specified']
KE 1353,Binding to voltage-gated sodium channel,cell layer,10090,"['Male', 'Female']",['All life stages']
KE 1353,Binding to voltage-gated sodium channel,cell layer,10116,"['Male', 'Female']",['All life stages']
KE 1353,Binding to voltage-gated sodium channel,cell layer,9606,"['Male', 'Female']",['All life stages']
KE 1354,"Treat, carbamazepine",,Not specified,['Not specified'],['Not specified']
KE 1355,"Activated, membrane depolarization",,Not specified,['Not specified'],['Not specified']
KE 1356,"Inactive, membrane depolarization",,Not specified,['Not specified'],['Not specified']
KE 1357,"Increased, RDX dose",,Not specified,['Not specified'],['Not specified']
KE 1358,"Repress, GABA-A receptor",,Not specified,['Not specified'],['Not specified']
KE 1359,"Activate, GABA-A receptor",,Not specified,['Not specified'],['Not specified']
KE 1360,"Activate, presynaptic neuron 2",,Not specified,['Not specified'],['Not specified']
KE 1361,"Increase, GABA",,Not specified,['Not specified'],['Not specified']
KE 1362,"Increased, hippocampal hyperdepolarization",,Not specified,['Not specified'],['Not specified']
KE 1363,"Increased, epilepsy",,Not specified,['Not specified'],['Not specified']
KE 1686,Deposition of Energy,,9606,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,10116,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,10090,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,6239,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,7955,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,3702,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,3349,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,35525,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,3055,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,6396,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,4472,['Unspecific'],['All life stages']
KE 1686,Deposition of Energy,,8030,['Unspecific'],['All life stages']
KE 1635,"Increase, DNA strand breaks",,9606,['Unspecific'],['All life stages']
KE 1444,"Increase, Follicular atresia",,Not specified,['Not specified'],['Not specified']
KE 1366,"Decrease, Oogenesis",,Not specified,['Not specified'],['Not specified']
KE 1367,"Inhibit, gastric ulcer formation",,Not specified,['Not specified'],['Not specified']
KE 1368,"Inhibition, PTGS-1 (Prostaglandin-endoperoxide synthase 1)",,Not specified,['Not specified'],['Not specified']
KE 1369,"Activation, PTGS-1 (Prostaglandin-endoperoxide synthase 1)",,Not specified,['Not specified'],['Not specified']
KE 1370,"Activation, PTGS-2 (Prostaglandin-endoperoxide synthase 2)",,Not specified,['Not specified'],['Not specified']
KE 1371,"Inhibition, PTGS-2 (Prostaglandin-endoperoxide synthase 2)",,Not specified,['Not specified'],['Not specified']
KE 1372,"Increase, bicarbonate",,Not specified,['Not specified'],['Not specified']
KE 1373,"Increase, mucous",,Not specified,['Not specified'],['Not specified']
KE 1374,"Increase, mucosal blood flow",,Not specified,['Not specified'],['Not specified']
KE 1375,"Increase, platelet aggregation",,Not specified,['Not specified'],['Not specified']
KE 1376,"Increase, angiogenesis",,9606,"['Male', 'Female']",['Adults']
KE 1377,"Decrease, leukocyte adherence",,Not specified,['Not specified'],['Not specified']
KE 1378,"Increase, leukocyte adherence",,Not specified,['Not specified'],['Not specified']
KE 1379,"Activate, leukocyte",,Not specified,['Not specified'],['Not specified']
KE 1380,"Activate, mucosal defense",,Not specified,['Not specified'],['Not specified']
KE 1381,"Increase, surfactant",,Not specified,['Not specified'],['Not specified']
KE 1382,"Decrease, surfactant",,Not specified,['Not specified'],['Not specified']
KE 1383,"Activate, phospholipase",,Not specified,['Not specified'],['Not specified']
KE 1384,"Increase, ammonium (NH4+)",,Not specified,['Not specified'],['Not specified']
KE 1385,"Activated, gastric ulcer formation",,Not specified,['Not specified'],['Not specified']
KE 1386,"CYP7B activity, inhibition",,93934,['Mixed'],['All life stages']
KE 1386,"CYP7B activity, inhibition",,8330,['Mixed'],['All life stages']
KE 1386,"CYP7B activity, inhibition",,8018,['Mixed'],['All life stages']
KE 1387,"7α-hydroxypregnenolone synthesis in the brain, decreased",,93934,['Unspecific'],['During development and at adulthood']
KE 1387,"7α-hydroxypregnenolone synthesis in the brain, decreased",,8330,['Unspecific'],['During development and at adulthood']
KE 1387,"7α-hydroxypregnenolone synthesis in the brain, decreased",,10090,['Unspecific'],['During development and at adulthood']
KE 1387,"7α-hydroxypregnenolone synthesis in the brain, decreased",,9606,['Unspecific'],['During development and at adulthood']
KE 1387,"7α-hydroxypregnenolone synthesis in the brain, decreased",,36500,['Unspecific'],['During development and at adulthood']
KE 1388,"Dopamine release in the brain, decreased",,7742,['Mixed'],['All life stages']
KE 1389,"Locomotor activity, decreased",,7742,['Mixed'],['Not specified']
KE 1390,"Sexual behavior, decreased",,93934,['Male'],"['Adult, reproductively mature']"
KE 1390,"Sexual behavior, decreased",,8330,['Male'],"['Adult, reproductively mature']"
KE 1391,Activation of Cyp2E1,,10116,['Mixed'],['All life stages']
KE 1391,Activation of Cyp2E1,,9606,['Mixed'],['All life stages']
KE 1393,Hepatocytotoxicity,liver,10116,['Mixed'],['All life stages']
KE 1393,Hepatocytotoxicity,liver,9606,['Mixed'],['All life stages']
KE 1394,"Induction, persistent proliferation/sustained proliferation",,10116,['Mixed'],['All life stages']
KE 1394,"Induction, persistent proliferation/sustained proliferation",,9606,['Mixed'],['All life stages']
KE 1395,Liver Cancer,liver,10116,['Mixed'],['All life stages']
KE 1396,"Increased, glucocorticoid receptor activity",,Not specified,['Not specified'],['Not specified']
KE 1397,"Increased, serotonin transporter activity",,Not specified,['Not specified'],['Not specified']
KE 1398,"Increased, intracellular serotonin",,Not specified,['Not specified'],['Not specified']
KE 1399,"Increased, packaged serotonin",,Not specified,['Not specified'],['Not specified']
KE 1400,"Increased, synaptic release",,Not specified,['Not specified'],['Not specified']
KE 1401,"Decreased, 5-HT3",,Not specified,['Not specified'],['Not specified']
KE 1402,"Reduced, PTGS1 function",,Not specified,['Not specified'],['Not specified']
KE 1403,"Reduced, platelet aggregation",,Not specified,['Not specified'],['Not specified']
KE 1404,"Decreased, mucosal blood flow",,Not specified,['Not specified'],['Not specified']
KE 1405,"Reduced, mucosal defense",,Not specified,['Not specified'],['Not specified']
KE 1406,"Decreased, mucous",,Not specified,['Not specified'],['Not specified']
KE 1407,"Decreased, bicarbonate",,Not specified,['Not specified'],['Not specified']
KE 1408,"Reduced, PTGS2 function",,Not specified,['Not specified'],['Not specified']
KE 1409,"Decreased, angiogenesis",,Not specified,['Not specified'],['Not specified']
KE 1410,"Increased, leukocyte adherence",,Not specified,['Not specified'],['Not specified']
KE 1411,"Increased, leukocyte activation",,Not specified,['Not specified'],['Not specified']
KE 1412,Helicobacter pylori infection,,Not specified,['Not specified'],['Not specified']
KE 1413,"Reduced, presynaptic neuron 2 activity",,Not specified,['Not specified'],['Not specified']
KE 1414,"Decreased, GABA",,Not specified,['Not specified'],['Not specified']
KE 1415,"Reduced, GABA-A receptor activation",,Not specified,['Not specified'],['Not specified']
KE 1416,"Decreased, intracellular chloride",,Not specified,['Not specified'],['Not specified']
KE 1417,NFE2/Nrf2 repression,,Not specified,['Not specified'],['Not specified']
KE 1419,"Reduced, FXR activity",,Not specified,['Not specified'],['Not specified']
KE 1420,"Reduced, SHP activity",,Not specified,['Not specified'],['Not specified']
KE 1421,"Activated, LXR",,Not specified,['Not specified'],['Not specified']
KE 1422,"Reduced, PPARalpha",,Not specified,['Not specified'],['Not specified']
KE 1423,"Reduced, HSD17B4 activity",,Not specified,['Not specified'],['Not specified']
KE 1424,"Reduced, fatty acid beta oxidation",,Not specified,['Not specified'],['Not specified']
KE 1425,Mu Opioid Receptor Agonism,,Not specified,['Not specified'],['Not specified']
KE 1426,Release of G Proteins,,Not specified,['Not specified'],['Not specified']
KE 1427,Opening of G protein gated inward rectifying K channels,,Not specified,['Not specified'],['Not specified']
KE 1428,Analgesia,,Not specified,['Not specified'],['Not specified']
KE 1429,Inhibition of N-type Ca ion channels,,Not specified,['Not specified'],['Not specified']
KE 1430,Inhibition of neurotransmitter vesicle release,,Not specified,['Not specified'],['Not specified']
KE 1431,Serotonin 1A Receptor Agonism,,Not specified,['Not specified'],['Not specified']
KE 1432,Anti-depressant Activity,,Not specified,['Not specified'],['Not specified']
KE 1438,"Transcription of genes encoding acute phase proteins, Increased",lung,10090,"['Male', 'Female']",['All life stages']
KE 1438,"Transcription of genes encoding acute phase proteins, Increased",lung,9606,"['Male', 'Female']",['All life stages']
KE 1439,Systemic acute phase response,blood,10090,"['Male', 'Female']",['All life stages']
KE 1439,Systemic acute phase response,blood,9606,"['Male', 'Female']",['All life stages']
KE 1443,Atherosclerosis,,9606,"['Male', 'Female']",['All life stages']
KE 1775,"Increase, Oocyte apoptosis",,Not specified,['Not specified'],['Not specified']
KE 1456,"Increase, Differentiation of fibroblasts",,Not specified,['Not specified'],['Not specified']
KE 1468,"Activation, Latent Transforming Growth Factor Beta 1",,Not specified,['Not specified'],['Not specified']
KE 1469,"Activation, Transforming Growth Factor beta pathway",,Not specified,['Not specified'],['Not specified']
KE 1462,Thiol group of chemicals interact with sulfuhydryl groups of proteins to form thiol adducts,,Not specified,['Not specified'],['Not specified']
KE 1463,Inhibition of lysyl oxidase,,Not specified,['Not specified'],['Not specified']
KE 1464,Reduction of collagen crosslinking,,Not specified,['Not specified'],['Not specified']
KE 1465,Weak collagen matrix,,Not specified,['Not specified'],['Not specified']
KE 1466,Notochord distortion or malformations,,Not specified,['Not specified'],['Not specified']
KE 1467,"Growth, reduction",,Not specified,['Not specified'],['Not specified']
KE 1471,"Increase, Uncoupling of photophosphorylation",,Not specified,['Not specified'],['Not specified']
KE 1472,"Decrease, ATP production",,Not specified,['Not specified'],['Not specified']
KE 1473,"Decrease, Chlorophyll synthesis",,Not specified,['Not specified'],['Not specified']
KE 1474,"Decrease, Light harvest capacity",,Not specified,['Not specified'],['Not specified']
KE 1475,"Decrease, Photosynthesis",,Not specified,['Not specified'],['Not specified']
KE 1476,"Decrease, Glycolysis",,Not specified,['Not specified'],['Not specified']
KE 1477,"Decrease, Oxidative phosphorylation",,Not specified,['Not specified'],['Not specified']
KE 1478,"Decrease, Leaf cell mitosis",,Not specified,['Not specified'],['Not specified']
KE 1479,"Decrease, Leaf development",,Not specified,['Not specified'],['Not specified']
KE 1521,"Decrease, Growth",,9606,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1521,"Decrease, Growth",,10116,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1521,"Decrease, Growth",,10090,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1521,"Decrease, Growth",,7955,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1521,"Decrease, Growth",,90988,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1521,"Decrease, Growth",,4472,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1521,"Decrease, Growth",,35525,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1481,Inhibition of mitochondrial DNA polymerase gamma (Pol gamma),,Not specified,['Not specified'],['Not specified']
KE 1482,"Depletion, mtDNA",,Not specified,['Not specified'],['Not specified']
KE 1486,"Binding of substrate, endocytic receptor",,Not specified,['Not specified'],['Not specified']
KE 1508,CYP2E1 Activation,prefrontal cortex,Not specified,['Not specified'],['Not specified']
KE 1509,Protein Adduct Formation,brain,Not specified,['Not specified'],['Not specified']
KE 1511,Lipid Peroxidation,,Not specified,['Not specified'],['Not specified']
KE 1512,Unfolded Protein Response,,Not specified,['Not specified'],['Not specified']
KE 1513,General Apoptosis,,9606,['Unspecific'],['All life stages']
KE 1513,General Apoptosis,,10116,['Unspecific'],['All life stages']
KE 1513,General Apoptosis,,10090,['Unspecific'],['All life stages']
KE 1514,Neurodegeneration,,Not specified,['Not specified'],['Not specified']
KE 1529,"Blockade, L-Type Calcium Channels",heart,Not specified,['Not specified'],['Not specified']
KE 1530,"Decrease, Calcium currents",,Not specified,['Not specified'],['Not specified']
KE 1531,"Decrease, Calcium binding to Troponin C",,Not specified,['Not specified'],['Not specified']
KE 1532,"Decrease, Cardiac contractility",,Not specified,['Not specified'],['Not specified']
KE 1533,"Decrease, Cardiac ejection fraction",,Not specified,['Not specified'],['Not specified']
KE 1535,Heart failure,,33208,['Unspecific'],['All life stages']
KE 1536,"Disruption, Intracellular calcium mobilization",,Not specified,['Not specified'],['Not specified']
KE 1537,"Disruption, Sarcomere assembly",,Not specified,['Not specified'],['Not specified']
KE 1446,"Decrease, Coupling of oxidative phosphorylation",,7955,['Unspecific'],"['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 1446,"Decrease, Coupling of oxidative phosphorylation",,9606,['Unspecific'],"['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 1446,"Decrease, Coupling of oxidative phosphorylation",,10090,['Unspecific'],"['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 1446,"Decrease, Coupling of oxidative phosphorylation",,10116,['Unspecific'],"['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 1446,"Decrease, Coupling of oxidative phosphorylation",,4472,['Unspecific'],"['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 1771,"Decrease, Adenosine triphosphate pool",,7955,['Unspecific'],"['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 1771,"Decrease, Adenosine triphosphate pool",,9606,['Unspecific'],"['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 1771,"Decrease, Adenosine triphosphate pool",,10116,['Unspecific'],"['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 1771,"Decrease, Adenosine triphosphate pool",,10090,['Unspecific'],"['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 1821,"Decrease, Cell proliferation",,7955,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1821,"Decrease, Cell proliferation",,9606,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1821,"Decrease, Cell proliferation",,10116,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1821,"Decrease, Cell proliferation",,10090,['Unspecific'],"['Embryo', 'Juvenile']"
KE 2064,"Increase, Cytosolic calcium",,Not specified,['Not specified'],['Not specified']
KE 1562,Decreased Na/K ATPase activity,,33208,['Unspecific'],['All life stages']
KE 1527,"Increase, Cell membrane depolarization",,Not specified,['Not specified'],['Not specified']
KE 2070,"Increase, Glycolysis",,Not specified,['Not specified'],['Not specified']
KE 2071,"Decrease, Glucose pool",,Not specified,['Not specified'],['Not specified']
KE 2072,"Increase, Mitochondrial swelling",,Not specified,['Not specified'],['Not specified']
KE 1636,"Increase, Chromosomal aberrations",,9606,['Unspecific'],['All life stages']
KE 1636,"Increase, Chromosomal aberrations",,10116,['Unspecific'],['All life stages']
KE 1636,"Increase, Chromosomal aberrations",,10090,['Unspecific'],['All life stages']
KE 1556,"Increase, lung cancer",,9606,['Unspecific'],['All life stages']
KE 1556,"Increase, lung cancer",,10116,['Unspecific'],['All life stages']
KE 1556,"Increase, lung cancer",,10090,['Unspecific'],['All life stages']
KE 1542,"Increase, Mitochondrial complex III antagonism",,Not specified,['Not specified'],['Not specified']
KE 1543,Mitochondrial Complex IV inhibition,,Not specified,['Not specified'],['Not specified']
KE 1544,Mitochondrial Complex V inhibition,,Not specified,['Not specified'],['Not specified']
KE 1545,Decrease in mitochondrial oxidative phosphorylation,,Not specified,['Not specified'],['Not specified']
KE 1547,Mitochondrial Injury,,Not specified,['Not specified'],['Not specified']
KE 1548,Necrotic Tissue,,Not specified,['Not specified'],['Not specified']
KE 1549,Liver Injury,,Not specified,['Not specified'],['Not specified']
KE 1653,Binding of inhibitor to mitochondrial complex III,,Not specified,['Not specified'],['Not specified']
KE 1654,Binding of inhibitor to mitochondrial complex IV,,Not specified,['Not specified'],['Not specified']
KE 1655,Binding of inhibitor to mitochondrial complex V,,Not specified,['Not specified'],['Not specified']
KE 1557,"Neural crest cell migration, reduced",,Not specified,['Not specified'],['Not specified']
KE 1558,"Collagen production, reduced",,Not specified,['Not specified'],['Not specified']
KE 1559,Facial cartilage structures are reduced in size and morphologically distorted,,Not specified,['Not specified'],['Not specified']
KE 1560,Altered differentiation,,10090,['Unspecific'],"['Birth to < 1 month', 'Pregnancy']"
KE 1561,Neural tube defects,,Not specified,['Not specified'],['Not specified']
KE 1563,Decreased proximal tubular vectorial transport,,Not specified,['Not specified'],['Not specified']
KE 1564,Chemical induced Fanconi syndrome,,Not specified,['Not specified'],['Not specified']
KE 1700,Impaired IL-1R1 signaling in T cell,immune system,9606,['Unspecific'],['All life stages']
KE 1700,Impaired IL-1R1 signaling in T cell,immune system,10090,['Unspecific'],['All life stages']
KE 1700,Impaired IL-1R1 signaling in T cell,immune system,10116,['Unspecific'],['All life stages']
KE 1702,Suppression of  T cell activation,immune system,9606,['Unspecific'],['All life stages']
KE 1702,Suppression of  T cell activation,immune system,10090,['Unspecific'],['All life stages']
KE 1702,Suppression of  T cell activation,immune system,10116,['Unspecific'],['All life stages']
KE 1574,"Inhibition, IKK complex",,Not specified,['Not specified'],['Not specified']
KE 1575,"Activation, Caspase 8 pathway",,Not specified,['Not specified'],['Not specified']
KE 1576,"Activation, Tissue resident cells (Kuppfer cells)",,Not specified,['Not specified'],['Not specified']
KE 1579,"Increase, proinflammatory mediators (TNFalpha)",,Not specified,['Not specified'],['Not specified']
KE 1580,Binding of microtubule stabilizing agents (MSA) to microtubules,,Not specified,['Not specified'],['Not specified']
KE 1581,Disturbance in microtubule dynamic instability,,Not specified,['Not specified'],['Not specified']
KE 1582,Impaired axonial transport,,Not specified,['Not specified'],['Not specified']
KE 1583,Sensory axonal peripheral neuropathy,,Not specified,['Not specified'],['Not specified']
KE 1584,Interaction of α-diketones with arginine residues,,Not specified,['Not specified'],['Not specified']
KE 1585,Proteasomal dysfunction,,Not specified,['Not specified'],['Not specified']
KE 1586,Airway epithelial injury,,Not specified,['Not specified'],['Not specified']
KE 1587,Fibroproliferative airway lesions,,Not specified,['Not specified'],['Not specified']
KE 1588,Bronchiolitis obliterans,,Not specified,['Not specified'],['Not specified']
KE 1602,Increased Muscarinic Acetylcholine Receptors,,7955,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1602,Increased Muscarinic Acetylcholine Receptors,,10095,['Unspecific'],"['Embryo', 'Juvenile']"
KE 1623,"Occurrence, Focal Seizure",brain,10116,['Unspecific'],['Adult']
KE 1623,"Occurrence, Focal Seizure",brain,10141,['Unspecific'],['Adult']
KE 1788,Status epilepticus,,10116,['Unspecific'],['Adult']
KE 1788,Status epilepticus,,10141,['Unspecific'],['Adult']
KE 1592,ROS generation from photoactivated chemicals,,9606,['Mixed'],['All life stages']
KE 1594,Oxidation of membrane lipids,,9606,['Mixed'],['All life stages']
KE 1595,Oxidation/denatuation of membrane proteins,,9606,['Mixed'],['All life stages']
KE 1599,Inflamatory events in light-exposed tissues,,9606,['Mixed'],['All life stages']
KE 926,"Oxidation, Glutathione (To be considered with MIE)",,9606,['Unspecific'],['All life stages']
KE 926,"Oxidation, Glutathione (To be considered with MIE)",,9913,['Unspecific'],['All life stages']
KE 926,"Oxidation, Glutathione (To be considered with MIE)",,10090,['Unspecific'],['All life stages']
KE 926,"Oxidation, Glutathione (To be considered with MIE)",,10116,['Unspecific'],['All life stages']
KE 1603,Chronic kidney disease,,Not specified,['Not specified'],['Not specified']
KE 1604,Inhibition of N-linked glycosylation,,Not specified,['Not specified'],['Not specified']
KE 1605,Accumulation of misfolded proteins,,Not specified,['Not specified'],['Not specified']
KE 1606,Activation of hepatic stellate cells,,Not specified,['Not specified'],['Not specified']
KE 1825,"Increase, Cell death",organ,7955,['Unspecific'],['All life stages']
KE 1825,"Increase, Cell death",organ,9606,['Unspecific'],['All life stages']
KE 1825,"Increase, Cell death",organ,10116,['Unspecific'],['All life stages']
KE 1825,"Increase, Cell death",organ,10090,['Unspecific'],['All life stages']
KE 1609,"Inhibition, Cytochrome P450 enzyme (CYP17A1) activity",,Not specified,['Not specified'],['Not specified']
KE 1610,"Reduction, 17-OH-pregnenolone conversion in DHEA",,Not specified,['Not specified'],['Not specified']
KE 1611,"Reduction, 17-OH-progesterone conversion in androstenedione",,Not specified,['Not specified'],['Not specified']
KE 1613,"Decrease, dihydrotestosterone (DHT) level",,40674,['Mixed'],['All life stages']
KE 1615,Impaired inguinoscrotal testicular descent phase,gonad,40674,['Male'],['During development and at adulthood']
KE 1616,"Malformation, cryptorchidism - maldescended testis",,7742,['Male'],['During development and at adulthood']
KE 1785,"Increase, Mitochondrial ATP synthase antagonism",,Not specified,['Not specified'],['Not specified']
KE 1627,Inhibition of tyrosinase,,Not specified,['Not specified'],['Not specified']
KE 1628,Reduction of L-Dopaquinone,,Not specified,['Not specified'],['Not specified']
KE 1629,Reduction in melanin level,,Not specified,['Not specified'],['Not specified']
KE 1630,Reduction of melanosome level,,Not specified,['Not specified'],['Not specified']
KE 1631,Reduction fo Pigmentation pattern,,Not specified,['Not specified'],['Not specified']
KE 1632,Increase in reactive oxygen and nitrogen species (RONS),,Not specified,['Not specified'],['Not specified']
KE 1634,"Increase, Oxidative DNA damage",organ,9606,['Unspecific'],['All life stages']
KE 1634,"Increase, Oxidative DNA damage",organ,4932,['Unspecific'],['All life stages']
KE 1634,"Increase, Oxidative DNA damage",organ,10090,['Unspecific'],['All life stages']
KE 1634,"Increase, Oxidative DNA damage",organ,10116,['Unspecific'],['All life stages']
KE 1634,"Increase, Oxidative DNA damage",organ,9913,['Unspecific'],['All life stages']
KE 1634,"Increase, Oxidative DNA damage",organ,9606,['Unspecific'],['All life stages']
KE 1634,"Increase, Oxidative DNA damage",organ,9986,['Unspecific'],['All life stages']
KE 1637,Retinaldehyde dehydrogenase inhibition,,Not specified,['Not specified'],['Not specified']
KE 1640,"Altered, Photoreceptor patterning",retina,7955,"['Male', 'Female']","['Embryo', 'Juvenile', 'Larvae', 'All life stages']"
KE 1640,"Altered, Photoreceptor patterning",retina,8022,"['Male', 'Female']","['Embryo', 'Juvenile', 'Larvae', 'All life stages']"
KE 1640,"Altered, Photoreceptor patterning",retina,10095,"['Male', 'Female']","['Embryo', 'Juvenile', 'Larvae', 'All life stages']"
KE 1640,"Altered, Photoreceptor patterning",retina,10116,"['Male', 'Female']","['Embryo', 'Juvenile', 'Larvae', 'All life stages']"
KE 1640,"Altered, Photoreceptor patterning",retina,7742,"['Male', 'Female']","['Embryo', 'Juvenile', 'Larvae', 'All life stages']"
KE 1641,Decreased retinoic acid (RA) synthesis,,Not specified,['Not specified'],['Not specified']
KE 1642,Decreased plasma RA level,,Not specified,['Not specified'],['Not specified']
KE 1643,"Altered, Visual function",eye,7955,['Unspecific'],"['Embryo', 'Juvenile', 'Larvae']"
KE 1651,Treatment-resistant gastric cancer,organ,9606,['Unspecific'],['All life stages']
KE 1753,Chronic reactive oxygen species,organ,9606,['Unspecific'],['All life stages']
KE 1754,Porcupine-induced Wnt secretion and Wnt signaling activation,organ,9606,['Unspecific'],['All life stages']
KE 1754,Porcupine-induced Wnt secretion and Wnt signaling activation,organ,10090,['Unspecific'],['All life stages']
KE 1755,beta-catenin activation,organ,9606,['Unspecific'],['All life stages']
KE 1656,"Antagonism, Thyroid Receptor",,9606,['Mixed'],['During development and at adulthood']
KE 1656,"Antagonism, Thyroid Receptor",,10090,['Mixed'],['During development and at adulthood']
KE 1657,Inhibition of cystathionine beta-synthase,,Not specified,['Not specified'],['Not specified']
KE 1661,Increased Homocysteine level,,Not specified,['Not specified'],['Not specified']
KE 1665,"Increased, Plasma HCY level",,Not specified,['Not specified'],['Not specified']
KE 1666,"Induced, dysfunction of microcirculation",,Not specified,['Not specified'],['Not specified']
KE 1667,"Impaired,anterior-posterior axis development",,Not specified,['Not specified'],['Not specified']
KE 1677,Reduced tidal volume,,Not specified,['Not specified'],['Not specified']
KE 1672,Inhibition of lung surfactant function,,9606,['Mixed'],['All life stages']
KE 1672,Inhibition of lung surfactant function,,10090,['Mixed'],['All life stages']
KE 1673,Alveolar collapse,,9606,['Mixed'],['All life stages']
KE 1673,Alveolar collapse,,10090,['Mixed'],['All life stages']
KE 1673,Alveolar collapse,,10116,['Mixed'],['All life stages']
KE 1668,Frustrated phagocytosis,,40674,['Unspecific'],['Adult']
KE 1669,"Increased, DNA damage and mutation",,40674,['Unspecific'],['Adult']
KE 1670,Lung cancer,,40674,['Unspecific'],['Adult']
KE 1680,"Inhibition, TBX1",,Not specified,['Not specified'],['Not specified']
KE 1681,"Disruption, Neural crest cell migration",,Not specified,['Not specified'],['Not specified']
KE 1682,"Disruption, Progenitor cells of second heart field",,Not specified,['Not specified'],['Not specified']
KE 1683,"Impairment, Fourth pharyngeal arch development",,Not specified,['Not specified'],['Not specified']
KE 1684,"Abnormalities, Cardiac outflow tract formation",,Not specified,['Not specified'],['Not specified']
KE 1685,"Anomalies, Congenital cardiac conotruncal",,Not specified,['Not specified'],['Not specified']
KE 1688,"anogenital distance (AGD), decreased",perineum,9606,['Male'],['Foetal']
KE 1688,"anogenital distance (AGD), decreased",perineum,10116,['Male'],['Foetal']
KE 1688,"anogenital distance (AGD), decreased",perineum,10090,['Male'],['Foetal']
KE 2298,"Decrease, intratesticular testosterone levels",testis,7742,['Male'],['During development and at adulthood']
KE 2298,"Decrease, intratesticular testosterone levels",testis,40674,['Male'],['During development and at adulthood']
KE 1691,"Antagonism,LH receptor",,Not specified,['Not specified'],['Not specified']
KE 1692,"Reduction, Progesterone synthesis",,Not specified,['Not specified'],['Not specified']
KE 1693,"Reduction, Plasma progesterone concentration",,7742,['Mixed'],['All life stages']
KE 1694,"Reduction, progesterone uptake, decresed maturation",,Not specified,['Not specified'],['Not specified']
KE 1695,Impaired ovulation,female gonad,40674,['Female'],['Adults']
KE 1696,Decrease of egg production and cummulative fecundity,,Not specified,['Not specified'],['Not specified']
KE 679,"Decline, Population trajectory",,Not specified,['Not specified'],['Not specified']
KE 1697,"Increase, DNA methyltransferase expression",,Not specified,['Not specified'],['Not specified']
KE 1698,"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor",,Not specified,['Not specified'],['Not specified']
KE 1699,"Decrease, expression of gonadotropin releasing hormone receptor",,Not specified,['Not specified'],['Not specified']
KE 1705,Impaired coordination and movement,,Not specified,['Not specified'],['Not specified']
KE 1706,"Stimulation, TLR7/8",,Not specified,['Not specified'],['Not specified']
KE 1707,"Increase, IL-23 from matured dendritic cells",immune system,Not specified,['Not specified'],['Not specified']
KE 1708,Th17 cell migration and inflammation induction,immune system,Not specified,['Not specified'],['Not specified']
KE 1709,Psoriatic skin disease,,Not specified,['Not specified'],['Not specified']
KE 1822,Maturation of TNF/iNOS-Producing Dendritic Cells,,Not specified,['Not specified'],['Not specified']
KE 1710,Binding to estrogen receptor (ER)-α in immune cells,immune system,9606,['Mixed'],['All life stages']
KE 1710,Binding to estrogen receptor (ER)-α in immune cells,immune system,10090,['Mixed'],['All life stages']
KE 1711,Induction of GATA3 expression,immune system,Not specified,['Mixed'],['All life stages']
KE 1712,Increase of Th2 cells producing IL-4,immune system,Not specified,['Mixed'],['All life stages']
KE 1713,Increase of anti-DNA antibody from autoreactive B cell,immune system,Not specified,['Mixed'],['All life stages']
KE 1714,Exacerbation of systemic lupus erythematosus (SLE),,Not specified,['Mixed'],['All life stages']
KE 1715,Inhibition of JAK3,immune system,9606,['Unspecific'],['All life stages']
KE 1715,Inhibition of JAK3,immune system,10090,['Unspecific'],['All life stages']
KE 1715,Inhibition of JAK3,immune system,10117,['Unspecific'],['All life stages']
KE 1716,Blockade of STAT5 phosphorylation,immune system,9606,['Unspecific'],['All life stages']
KE 1716,Blockade of STAT5 phosphorylation,immune system,10090,['Unspecific'],['All life stages']
KE 1717,Suppression of STAT5 binding to cytokine gene promoters,immune system,9606,['Unspecific'],['All life stages']
KE 1717,Suppression of STAT5 binding to cytokine gene promoters,immune system,60742,['Unspecific'],['All life stages']
KE 1718,Suppression of IL-4 production,immune system,9606,['Unspecific'],['All life stages']
KE 1718,Suppression of IL-4 production,immune system,10090,['Unspecific'],['All life stages']
KE 1719,Impairment of T-cell dependent antibody response,,9606,['Unspecific'],['All life stages']
KE 1719,Impairment of T-cell dependent antibody response,,10090,['Unspecific'],['All life stages']
KE 1720,Trypsin inhibition,,9606,['Mixed'],['All life stages']
KE 1720,Trypsin inhibition,,10090,['Mixed'],['All life stages']
KE 1720,Trypsin inhibition,,10116,['Mixed'],['All life stages']
KE 1720,Trypsin inhibition,,9541,['Mixed'],['All life stages']
KE 1721,Increased intestinal monitor peptide level,,9606,['Mixed'],['All life stages']
KE 1721,Increased intestinal monitor peptide level,,9541,['Mixed'],['All life stages']
KE 1721,Increased intestinal monitor peptide level,,10116,['Mixed'],['All life stages']
KE 1721,Increased intestinal monitor peptide level,,10090,['Mixed'],['All life stages']
KE 1722,Increased blood CCK level,,9606,['Mixed'],['All life stages']
KE 1722,Increased blood CCK level,,9541,['Mixed'],['All life stages']
KE 1722,Increased blood CCK level,,10116,['Mixed'],['All life stages']
KE 1722,Increased blood CCK level,,10090,['Mixed'],['All life stages']
KE 1723,Increased exocrine secretion from pancreatic acinar cells,,9606,['Mixed'],['All life stages']
KE 1723,Increased exocrine secretion from pancreatic acinar cells,,9541,['Mixed'],['All life stages']
KE 1723,Increased exocrine secretion from pancreatic acinar cells,,10116,['Mixed'],['All life stages']
KE 1723,Increased exocrine secretion from pancreatic acinar cells,,10090,['Mixed'],['All life stages']
KE 1724,Acinar cell proliferation,,9606,['Not specified'],['All life stages']
KE 1724,Acinar cell proliferation,,9541,['Not specified'],['All life stages']
KE 1724,Acinar cell proliferation,,10116,['Not specified'],['All life stages']
KE 1724,Acinar cell proliferation,,10090,['Not specified'],['All life stages']
KE 1725,Pancreatic acinar cell tumors,,9606,['Mixed'],['All life stages']
KE 1725,Pancreatic acinar cell tumors,,9541,['Mixed'],['All life stages']
KE 1725,Pancreatic acinar cell tumors,,10116,['Mixed'],['All life stages']
KE 1725,Pancreatic acinar cell tumors,,10090,['Mixed'],['All life stages']
KE 860,"Decreased, Mitochondrial Fatty Acid Beta Oxidation",,9606,"['Male', 'Female']",['Not Otherwise Specified']
KE 860,"Decreased, Mitochondrial Fatty Acid Beta Oxidation",,10090,"['Male', 'Female']",['Not Otherwise Specified']
KE 1834,"Decrease, Acyl-CoA dehydrogenases",,Not specified,['Not specified'],['Not specified']
KE 1752,Increased Angiotensin II,,Not specified,['Not specified'],['Not specified']
KE 1740,Induced dysregulation of ACE2,,Not specified,['Not specified'],['Not specified']
KE 1851,"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)",,Not specified,['Not specified'],['Not specified']
KE 1172,"Increased activation, Nuclear factor kappa B (NF-kB)",tissue,9606,['Mixed'],['Not Otherwise Specified']
KE 1854,"Dysregulation, ACE2 expression and activity",,Not specified,['Not specified'],['Not specified']
KE 1738,SARS-CoV-2 cell entry,organ,9606,['Unspecific'],['All life stages']
KE 1738,SARS-CoV-2 cell entry,organ,9974,['Unspecific'],['All life stages']
KE 1738,SARS-CoV-2 cell entry,organ,9615,['Unspecific'],['All life stages']
KE 1738,SARS-CoV-2 cell entry,organ,9541,['Unspecific'],['All life stages']
KE 1738,SARS-CoV-2 cell entry,organ,10036,['Unspecific'],['All life stages']
KE 1738,SARS-CoV-2 cell entry,organ,9669,['Unspecific'],['All life stages']
KE 1738,SARS-CoV-2 cell entry,organ,9685,['Unspecific'],['All life stages']
KE 1738,SARS-CoV-2 cell entry,organ,9666,['Unspecific'],['All life stages']
KE 1738,SARS-CoV-2 cell entry,organ,452646,['Unspecific'],['All life stages']
KE 1738,SARS-CoV-2 cell entry,organ,9694,['Unspecific'],['All life stages']
KE 1739,Binding to ACE2,organ,9606,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 1739,Binding to ACE2,organ,10090,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 1739,Binding to ACE2,organ,9666,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 1739,Binding to ACE2,organ,9685,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 1739,Binding to ACE2,organ,9694,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 1739,Binding to ACE2,organ,9615,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 1748,"Increase, the risk of acute respiratory failure",,Not specified,['Not specified'],['Not specified']
KE 1750,Increased inflammatory immune responses,,Not specified,['Not specified'],['Not specified']
KE 1848,Toll Like Receptor (TLR) Dysregulation,,9606,"['Mixed', 'Male']","['Birth to < 1 month', 'Old Age', 'All life stages']"
KE 1848,Toll Like Receptor (TLR) Dysregulation,,10095,"['Mixed', 'Male']","['Birth to < 1 month', 'Old Age', 'All life stages']"
KE 1848,Toll Like Receptor (TLR) Dysregulation,,131567,"['Mixed', 'Male']","['Birth to < 1 month', 'Old Age', 'All life stages']"
KE 1847,Increased SARS-CoV-2 production,organ,9606,['Unspecific'],['All life stages']
KE 1847,Increased SARS-CoV-2 production,organ,10090,['Unspecific'],['All life stages']
KE 1847,Increased SARS-CoV-2 production,organ,9669,['Unspecific'],['All life stages']
KE 1901,"Interferon-I antiviral response, antagonized by SARS-CoV-2",organ,9606,['Unspecific'],['All life stages']
KE 1901,"Interferon-I antiviral response, antagonized by SARS-CoV-2",organ,9666,['Unspecific'],['All life stages']
KE 1901,"Interferon-I antiviral response, antagonized by SARS-CoV-2",organ,9685,['Unspecific'],['All life stages']
KE 1901,"Interferon-I antiviral response, antagonized by SARS-CoV-2",organ,9544,['Unspecific'],['All life stages']
KE 1901,"Interferon-I antiviral response, antagonized by SARS-CoV-2",organ,9615,['Unspecific'],['All life stages']
KE 1901,"Interferon-I antiviral response, antagonized by SARS-CoV-2",organ,40674,['Unspecific'],['All life stages']
KE 1365,"Increase, Apoptosis",,Not specified,['Not specified'],['Not specified']
KE 1757,"Reduce, Sperm count",,Not specified,['Not specified'],['Not specified']
KE 1756,"Decreased,  plasma 11-ketotestosterone level",blood plasma,70862,"['Male', 'Female']","['Juvenile', 'Adult, reproductively mature', 'Larvae']"
KE 1756,"Decreased,  plasma 11-ketotestosterone level",blood plasma,30483,"['Male', 'Female']","['Juvenile', 'Adult, reproductively mature', 'Larvae']"
KE 1756,"Decreased,  plasma 11-ketotestosterone level",blood plasma,40674,"['Male', 'Female']","['Juvenile', 'Adult, reproductively mature', 'Larvae']"
KE 1758,"Impaired, Spermatogenesis",testis,7742,['Male'],"['Adult, reproductively mature']"
KE 2147,"Decreased, Viable Offspring",,39108,['Unspecific'],"['Adult, reproductively mature', 'Adult']"
KE 1445,"Increase, Lipid peroxidation",,7955,['Unspecific'],['All life stages']
KE 1445,"Increase, Lipid peroxidation",,40674,['Unspecific'],['All life stages']
KE 1767,"Increase, Protein oxidation",,Not specified,['Not specified'],['Not specified']
KE 1768,"Increase, Abnormal osmoregulation",,33208,['Unspecific'],['All life stages']
KE 1769,"Increase, Body fluid overload",,Not specified,['Not specified'],['Not specified']
KE 1770,"Decrease, Mitochondrial membrane potential",,Not specified,['Not specified'],['Not specified']
KE 1772,"Decrease, Triglyceride",,Not specified,['Not specified'],['Not specified']
KE 1759,"Increase, Cripto-1 expression",,7955,['Mixed'],['Larvae']
KE 1760,"Inhibition, Activin signaling",,Not specified,['Mixed'],['All life stages']
KE 1761,"Inhibition, Fin regeneration",fin,70862,['Mixed'],['All life stages']
KE 1762,Urothelial cell injury/death,,Not specified,['Not specified'],['Not specified']
KE 1763,Urothelial Tumor,,Not specified,['Not specified'],['Not specified']
KE 1619,"Increase, DNA methyltransferase inhibition",,Not specified,['Not specified'],['Not specified']
KE 1773,"Decrease, Global DNA methylation",,Not specified,['Not specified'],['Not specified']
KE 1774,"Increase, Caspase transcription",,Not specified,['Not specified'],['Not specified']
KE 328,"Decrease, Fecundity",,Not specified,['Not specified'],['Not specified']
KE 1776,"Increase, Ovarian somatic cell apoptosis",,Not specified,['Not specified'],['Not specified']
KE 1777,"Increase, Ovarian follicle breakdown",,Not specified,['Not specified'],['Not specified']
KE 1778,"Decrease, Heritable DNA methylation (F3)",,Not specified,['Not specified'],['Not specified']
KE 1779,"Increase, Caspase transcription (F3)",,Not specified,['Not specified'],['Not specified']
KE 1780,"Increase, Oocyte apoptosis (F3)",,Not specified,['Not specified'],['Not specified']
KE 1781,"Decrease, Fecundity (F3)",,Not specified,['Not specified'],['Not specified']
KE 1782,"Decrease, Oogenesis (F3)",,Not specified,['Not specified'],['Not specified']
KE 1783,"Increase, Ovarian somatic cell apoptosis (F3)",,Not specified,['Not specified'],['Not specified']
KE 1784,"Increase, Ovarian follicle breakdown (F3)",,Not specified,['Not specified'],['Not specified']
KE 1522,"Inhibition, Chitin synthase 1",epithelium,7165,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,7070,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,7111,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,7123,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,35572,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,55057,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,168631,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,7004,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,108931,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,307491,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,72036,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,50023,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,192188,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,248899,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1522,"Inhibition, Chitin synthase 1",epithelium,158387,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1523,"Decrease, Cuticular chitin content",cuticle,7116,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1523,"Decrease, Cuticular chitin content",cuticle,7375,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1523,"Decrease, Cuticular chitin content",cuticle,7091,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1523,"Decrease, Cuticular chitin content",cuticle,85549,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1523,"Decrease, Cuticular chitin content",cuticle,29057,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1524,"Increase, Premature molting",,7116,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1524,"Increase, Premature molting",,7375,['Unspecific'],"['Larvae', 'Juvenile', 'Adult']"
KE 1525,"Increase, Sulfonylurea receptor binding",,Not specified,['Not specified'],['Not specified']
KE 1526,"Increase, Opening of voltage-dependent calcium channel",,Not specified,['Not specified'],['Not specified']
KE 1786,"Nipple retention (NR), increased",,10116,['Male'],['Birth to < 1 month']
KE 1786,"Nipple retention (NR), increased",,10090,['Male'],['Birth to < 1 month']
KE 1800,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",ovarian follicle,9606,['Female'],['During development and at adulthood']
KE 1800,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",ovarian follicle,10090,['Female'],['During development and at adulthood']
KE 1800,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",ovarian follicle,10116,['Female'],['During development and at adulthood']
KE 1800,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",ovarian follicle,9544,['Female'],['During development and at adulthood']
KE 1800,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",ovarian follicle,9823,['Female'],['During development and at adulthood']
KE 1800,"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced",ovarian follicle,9913,['Female'],['During development and at adulthood']
KE 1789,"Reduction, 17beta-estradiol synthesis by the undifferentiated gonad",gonad,7742,['Unspecific'],['Development']
KE 1790,"Increased, Differentiation to Testis",testis,7742,['Male'],['Development']
KE 1791,"Increased, Male Biased Sex Ratio",,Not specified,['Male'],['Adults']
KE 1792,Toll-like receptor 4 activation,,Not specified,['Not specified'],['Not specified']
KE 1793,Activator protein 1 activation,,Not specified,['Not specified'],['Not specified']
KE 1794,Pin-1 activation,,Not specified,['Not specified'],['Not specified']
KE 1795,Latent Transforming growth Factor beta expression,,Not specified,['Not specified'],['Not specified']
KE 1799,Inhibition of 11β-HSD,,Not specified,['Not specified'],['Not specified']
KE 1796,11β-hydroxylase inhibition,,Not specified,['Not specified'],['Not specified']
KE 1798,Decreased spermatogenesis,,Not specified,['Not specified'],['Not specified']
KE 1835,Cortisol and 11β-(OH) testosterone decreased,,Not specified,['Not specified'],['Not specified']
KE 1836,Decreased plasma Cortisol level,,Not specified,['Not specified'],['Not specified']
KE 1837,decreased oocyte maturation,,Not specified,['Not specified'],['Not specified']
KE 1806,"Inhibition, Chitinase",,Not specified,['Not specified'],['Not specified']
KE 996,"Decrease, Digestion of old cuticle",,Not specified,['Not specified'],['Not specified']
KE 1807,"Inhibition, Chitobiase",,Not specified,['Not specified'],['Not specified']
KE 1814,benzoquinone imine and acylglucuronide metabolites,,Not specified,['Not specified'],['Not specified']
KE 1817,Apoptotic cell death,,Not specified,['Not specified'],['Not specified']
KE 1818,Immune cell activation,,Not specified,['Not specified'],['Not specified']
KE 1819,IFNγ signaling,,Not specified,['Not specified'],['Not specified']
KE 1633,Increase in inflammation,,Not specified,['Not specified'],['Not specified']
KE 1820,Immune mediated hepatitis,,Not specified,['Not specified'],['Not specified']
KE 1815,Activation of ER stress,,Not specified,['Not specified'],['Not specified']
KE 1877,"Altered, retinal layer structure",eye,7955,['Unspecific'],"['Embryo', 'Larvae']"
KE 1878,"Decreased, Eye size",eye,7955,['Not specified'],['Larval development']
KE 1830,"Displacement, Serum thyroxine (T4) from carrier protein",,8355,['Not specified'],['Not specified']
KE 1831,"Binding, Thyroid binding globulin in serum",,8355,['Not specified'],['Not specified']
KE 1840,"Inhibition, cytochrome oxidase",,10116,['Unspecific'],['All life stages']
KE 1840,"Inhibition, cytochrome oxidase",,9606,['Unspecific'],['All life stages']
KE 2312,"Increased, nasal lesions",nose,10116,['Unspecific'],['All life stages']
KE 2312,"Increased, nasal lesions",nose,9606,['Unspecific'],['All life stages']
KE 1839,Testicular Cancer,,Not specified,['Not specified'],['Not specified']
KE 1841,Encephalitis,brain,9606,['Mixed'],['Adults']
KE 1842,Prolonged TLR9 activation,,Not specified,['Not specified'],['Not specified']
KE 1843,Multi Organ Failure involving Acute Respiratory Distress Syndrome,,Not specified,['Not specified'],['Not specified']
KE 1844,systemic inflammatory response syndrome,,Not specified,['Not specified'],['Not specified']
KE 1897,increased MyD88 activation,,Not specified,['Not specified'],['Not specified']
KE 1895,"NLRP3 inflammasome activity, increased",,Not specified,['Not specified'],['Not specified']
KE 1869,Diminished protective oxidative stress response,organ,9606,['Unspecific'],['All life stages']
KE 1898,increased release of danger/damage associated molecular patterns,,Not specified,['Not specified'],['Not specified']
KE 1857,"Platelet-neutrophil interactions, Increased",,9606,['Not specified'],['Not specified']
KE 1899,formation of neutrophil extracellular traps (NETs),,Not specified,['Not specified'],['Not specified']
KE 1868,Hyperinflammation,,9606,['Mixed'],['Not specified']
KE 1868,Hyperinflammation,,10090,['Mixed'],['Not specified']
KE 1809,"Increase, Tissue/organ damage",,Not specified,['Not specified'],['Not specified']
KE 902,"Inflammation, Liver",liver,10090,['Not specified'],['Not specified']
KE 902,"Inflammation, Liver",liver,9606,['Not specified'],['Not specified']
KE 902,"Inflammation, Liver",liver,10116,['Not specified'],['Not specified']
KE 1900,increased platelet surface TLR9 expression,,Not specified,['Not specified'],['Not specified']
KE 1846,Thrombosis and Disseminated Intravascular Coagulation,blood,9606,['Unspecific'],['All life stages']
KE 1845,Coagulation,blood plasma,9606,['Unspecific'],['All life stages']
KE 1849,Impaired gustatory nerve,,Not specified,['Not specified'],['Not specified']
KE 1850,dysgeusia,,Not specified,['Not specified'],['Not specified']
KE 1787,"Downregulation, ACE2",,Not specified,['Not specified'],['Not specified']
KE 1856,Imbalanced salty and sweet taste responses,,Not specified,['Not specified'],['Not specified']
KE 1852,Increased Ang II type 1 receptor (AT1R),,Not specified,['Not specified'],['Not specified']
KE 1501,"Increased, extracellular matrix deposition",,Not specified,['Not specified'],['Not specified']
KE 1743,Increase plasma Ang II,,Not specified,['Not specified'],['Not specified']
KE 1853,Hyperactivation of ACE/Ang-II/AT1R axis,,Not specified,['Not specified'],['Not specified']
KE 1855,Increased Sodium-sensitive hypertension,,Not specified,['Not specified'],['Not specified']
KE 2096,"Occurrence, (Micro)vascular dysfunction",vascular system,Not specified,['Not specified'],['Not specified']
KE 1861,"Increase, D1 protein deactivation",,Not specified,['Not specified'],['Not specified']
KE 1862,"Decrease, Photosystem II efficiency",,Not specified,['Not specified'],['Not specified']
KE 1863,"Decrease, Reproduction",,Not specified,['Not specified'],['Not specified']
KE 1864,"Increase, Programmed cell death",,Not specified,['Not specified'],['Not specified']
KE 1865,"Increase, Oxygen-evolving complex damage",,Not specified,['Not specified'],['Not specified']
KE 1866,"Fibrinolysis, decreased",,9606,['Not specified'],['Not specified']
KE 1867,"Bradykinin system, hyperactivated",,9606,"['Male', 'Female']",['Not specified']
KE 1555,Increase cell proliferation,,Not specified,['Not specified'],['Not specified']
KE 1870,"Sustentacular cells, decrease",nose epithelium,Not specified,['Not specified'],['Not specified']
KE 1871,"olfactory sensory neurons, decrease",nose epithelium,Not specified,['Not specified'],['Not specified']
KE 1872,Olfactory epithelium degeneration,olfactory epithelium,Not specified,['Not specified'],['Not specified']
KE 1873,impaired olfactory function (anosmia),nose epithelium,Not specified,['Not specified'],['Not specified']
KE 1874,blood brain barrier disruption,,Not specified,['Not specified'],['Not specified']
KE 1875,Cerebrovascular disease (stroke),,9606,"['Male', 'Female']","['Adult', 'Old Age']"
KE 1550,Deposition of Ionizing Energy,,Not specified,['Not specified'],['Not specified']
KE 997,"Decreased, Population size",,Not specified,['Not specified'],['Not specified']
KE 1879,"Bulky DNA adducts, increase",,9606,['Unspecific'],['All life stages']
KE 1879,"Bulky DNA adducts, increase",,9606,['Unspecific'],['All life stages']
KE 1879,"Bulky DNA adducts, increase",,10090,['Unspecific'],['All life stages']
KE 1879,"Bulky DNA adducts, increase",,10116,['Unspecific'],['All life stages']
KE 1880,"Decreased, ALDH1A (RALDH) enzyme activity",,9606,"['Male', 'Female']",['All life stages']
KE 1880,"Decreased, ALDH1A (RALDH) enzyme activity",,10090,"['Male', 'Female']",['All life stages']
KE 1880,"Decreased, ALDH1A (RALDH) enzyme activity",,10116,"['Male', 'Female']",['All life stages']
KE 1881,"Decreased, all-trans retinoic acid (atRA) concentration",,10090,"['Male', 'Female']",['All life stages']
KE 1881,"Decreased, all-trans retinoic acid (atRA) concentration",,10116,"['Male', 'Female']",['All life stages']
KE 1881,"Decreased, all-trans retinoic acid (atRA) concentration",,9606,"['Male', 'Female']",['All life stages']
KE 1881,"Decreased, all-trans retinoic acid (atRA) concentration",,7742,"['Male', 'Female']",['All life stages']
KE 1882,"Disrupted, initiation of meiosis of oogonia in the ovary",ovary sex cord,10090,['Female'],"['Foetal', 'Development']"
KE 1882,"Disrupted, initiation of meiosis of oogonia in the ovary",ovary sex cord,9606,['Female'],"['Foetal', 'Development']"
KE 1882,"Disrupted, initiation of meiosis of oogonia in the ovary",ovary sex cord,10116,['Female'],"['Foetal', 'Development']"
KE 1883,"Decreased, size of the ovarian reserve",ovary sex cord,10090,['Female'],['All life stages']
KE 1883,"Decreased, size of the ovarian reserve",ovary sex cord,9606,['Female'],['All life stages']
KE 1883,"Decreased, size of the ovarian reserve",ovary sex cord,10116,['Female'],['All life stages']
KE 1884,Inhibition of Fyna,brain,7955,['Unspecific'],['Larvae']
KE 1885,Inhibition of Plxna2,optic vesicle,7955,['Unspecific'],['Larvae']
KE 1886,Overexpression of rasl11b,,7955,['Unspecific'],['Larvae']
KE 1888,Increased (ectopic) all-trans retinoic acid concentration,,7742,"['Male', 'Female']",['Fetal']
KE 1888,Increased (ectopic) all-trans retinoic acid concentration,,40674,"['Male', 'Female']",['Fetal']
KE 1889,Premature initiation of meiosis in fetal male germ cells,,7742,['Male'],['Foetal']
KE 1889,Premature initiation of meiosis in fetal male germ cells,,10116,['Male'],['Foetal']
KE 1889,Premature initiation of meiosis in fetal male germ cells,,10090,['Male'],['Foetal']
KE 1889,Premature initiation of meiosis in fetal male germ cells,,9606,['Male'],['Foetal']
KE 1890,Decrease (loss of) fetal male germ cells,,10116,['Male'],['Fetal']
KE 1890,Decrease (loss of) fetal male germ cells,,10090,['Male'],['Fetal']
KE 1890,Decrease (loss of) fetal male germ cells,,9606,['Male'],['Fetal']
KE 2029,protein-coupled estrogen receptor 1 (GPER) activation,,Not specified,['Not specified'],['Not specified']
KE 1310,"Activation, PI3K",,Not specified,['Not specified'],['Not specified']
KE 1299,"Activation, AKT",,Not specified,['Not specified'],['Not specified']
KE 1300,"Activation, mTORC1",,Not specified,['Not specified'],['Not specified']
KE 1995,Abnormal lipid metabolism,,Not specified,['Not specified'],['Not specified']
KE 771,"Decrease, Serum thyroid hormone (T4/T3)",serum,10116,['Not specified'],['Not specified']
KE 771,"Decrease, Serum thyroid hormone (T4/T3)",serum,10090,['Not specified'],['Not specified']
KE 2093,Brain thyroid hormone (T4/T3) decreased,,Not specified,['Not specified'],['Not specified']
KE 2094,"Abnormal, neuroblast migration",,Not specified,['Not specified'],['Not specified']
KE 2095,Periventricular heterotopia formation,,Not specified,['Not specified'],['Not specified']
KE 1967,Pyroptosis,,Not specified,['Not specified'],['Not specified']
KE 1896,Genomic instability,,Not specified,['Female'],['All life stages']
KE 1903,"foxi1 expression, increased",,7955,['Unspecific'],['Not specified']
KE 1904,"six1b expression, increased",,Not specified,['Not specified'],['Not specified']
KE 1905,"eya1 expression, inhibited",,7955,['Not specified'],['During brain development']
KE 1930,"altered, inner ear development",ear,7955,['Unspecific'],['Embryo']
KE 1008,"Reduced, Hearing",ear,7742,['Not specified'],['Not specified']
KE 1008,"Reduced, Hearing",ear,50557,['Not specified'],['Not specified']
KE 1647,GSK3beta inactivation,organ,9606,['Unspecific'],['All life stages']
KE 1647,GSK3beta inactivation,organ,7955,['Unspecific'],['All life stages']
KE 1902,Repression of Gbx2 expression,,7955,['Unspecific'],['Embryo']
KE 1908,"Cilia Beat Frequency, Decreased",lung epithelium,9606,['Mixed'],['All life stages']
KE 1908,"Cilia Beat Frequency, Decreased",lung epithelium,10090,['Mixed'],['All life stages']
KE 1908,"Cilia Beat Frequency, Decreased",lung epithelium,10116,['Mixed'],['All life stages']
KE 1908,"Cilia Beat Frequency, Decreased",lung epithelium,9986,['Mixed'],['All life stages']
KE 1908,"Cilia Beat Frequency, Decreased",lung epithelium,9913,['Mixed'],['All life stages']
KE 1908,"Cilia Beat Frequency, Decreased",lung epithelium,10141,['Mixed'],['All life stages']
KE 1908,"Cilia Beat Frequency, Decreased",lung epithelium,8400,['Mixed'],['All life stages']
KE 1909,"Mucociliary Clearance, Decreased",,9606,['Mixed'],['All life stages']
KE 1909,"Mucociliary Clearance, Decreased",,9825,['Mixed'],['All life stages']
KE 1909,"Mucociliary Clearance, Decreased",,9940,['Mixed'],['All life stages']
KE 1909,"Mucociliary Clearance, Decreased",,10141,['Mixed'],['All life stages']
KE 1909,"Mucociliary Clearance, Decreased",,9612,['Mixed'],['All life stages']
KE 1909,"Mucociliary Clearance, Decreased",,8400,['Mixed'],['All life stages']
KE 1909,"Mucociliary Clearance, Decreased",,9986,['Mixed'],['All life stages']
KE 1913,Endothelial cell dysfunction,,Not specified,['Not specified'],['Not specified']
KE 1914,"Platelet activation, Increased",,Not specified,['Not specified'],['Not specified']
KE 1915,"Neutrophil activation, Increased",,Not specified,['Not specified'],['Not specified']
KE 1916,"Thromboinflammation, Increased",,Not specified,['Not specified'],['Not specified']
KE 1607,"Increase, Necrosis",,Not specified,['Not specified'],['Not specified']
KE 1920,"Altered gene expression, TGF-β dependent fibrosis pathway",,Not specified,['Not specified'],['Not specified']
KE 1921,"Altered gene expression, NF-kB dependent Interleukin-6 pathway",,Not specified,['Not specified'],['Not specified']
KE 1933,"Increased, Interleukin-6 production",,Not specified,['Not specified'],['Not specified']
KE 1922,"Increased, Reactive metabolites production",,Not specified,['Not specified'],['Not specified']
KE 17,"Altered gene expression, AHR nuclear translocator (ARNT)-dependent pathway",,Not specified,['Not specified'],['Not specified']
KE 1923,"Altered gene expression, P53 dependent apoptosis pathway",,Not specified,['Not specified'],['Not specified']
KE 1917,"Altered gene expression, NRF2 dependent antioxidant pathway",,Not specified,['Not specified'],['Not specified']
KE 1931,"Intestinal barrier, disruption",intestine,Not specified,"['Male', 'Female']",['Not specified']
KE 2030,"Activation, PARP1",,Not specified,['Not specified'],['Not specified']
KE 2031,"Releasing, Apoptosis-Inducing Factor (AIF)",,Not specified,['Not specified'],['Not specified']
KE 1906,"Cystic Fibrosis Transmembrane Regulator Function, Decreased",lung,9606,['Mixed'],['All life stages']
KE 1906,"Cystic Fibrosis Transmembrane Regulator Function, Decreased",lung,10090,['Mixed'],['All life stages']
KE 1907,"Airway Surface Liquid Height, Decreased",lung,9606,['Mixed'],['All life stages']
KE 1907,"Airway Surface Liquid Height, Decreased",lung,10090,['Mixed'],['All life stages']
KE 1907,"Airway Surface Liquid Height, Decreased",lung,9823,['Mixed'],['All life stages']
KE 1907,"Airway Surface Liquid Height, Decreased",lung,9940,['Mixed'],['All life stages']
KE 1907,"Airway Surface Liquid Height, Decreased",lung,10141,['Mixed'],['All life stages']
KE 1907,"Airway Surface Liquid Height, Decreased",lung,9913,['Mixed'],['All life stages']
KE 1911,"FOXJ1 Protein, Decreased",lung epithelium,7955,['Mixed'],['All life stages']
KE 1911,"FOXJ1 Protein, Decreased",lung epithelium,8355,['Mixed'],['All life stages']
KE 1911,"FOXJ1 Protein, Decreased",lung epithelium,10090,['Mixed'],['All life stages']
KE 1911,"FOXJ1 Protein, Decreased",lung epithelium,9606,['Mixed'],['All life stages']
KE 1912,"Motile Cilia Number/Length, Decreased",lung epithelium,7955,['Mixed'],['During development and at adulthood']
KE 1912,"Motile Cilia Number/Length, Decreased",lung epithelium,9606,['Mixed'],['During development and at adulthood']
KE 1912,"Motile Cilia Number/Length, Decreased",lung epithelium,8355,['Mixed'],['During development and at adulthood']
KE 1912,"Motile Cilia Number/Length, Decreased",lung epithelium,10090,['Mixed'],['During development and at adulthood']
KE 1934,Myocardial Infarction,,Not specified,['Not specified'],['Not specified']
KE 1946,Impaired mechanotransduction of pericytes,,Not specified,['Not specified'],['Not specified']
KE 1947,Pericyte dysfunction,,Not specified,['Not specified'],['Not specified']
KE 1948,Increased ACE2 expression,,Not specified,['Not specified'],['Not specified']
KE 1935,Angiotensin (1-7) levels diminished,,Not specified,['Not specified'],['Not specified']
KE 1741,"Induced, Angiotensin (Ang) II accumulation",,Not specified,['Not specified'],['Not specified']
KE 1936,Angiotensin II degradation reduced,,Not specified,['Not specified'],['Not specified']
KE 1937,ADAM17 expression induction,,Not specified,['Not specified'],['Not specified']
KE 1938,ACE2 increased shedding,,Not specified,['Not specified'],['Not specified']
KE 1954,"Gut microbiota, alteration",,9606,"['Male', 'Female']",['All life stages']
KE 1954,"Gut microbiota, alteration",,9544,"['Male', 'Female']",['All life stages']
KE 1954,"Gut microbiota, alteration",,9541,"['Male', 'Female']",['All life stages']
KE 1954,"Gut microbiota, alteration",,10090,"['Male', 'Female']",['All life stages']
KE 1816,Mitochondrial dysfunction EMPTY,,Not specified,['Not specified'],['Not specified']
KE 1941,Memory Loss,,Not specified,['Not specified'],['Not specified']
KE 1942,"Accumulation, Cytosolic toxic Tau oligomers",,Not specified,['Not specified'],['Not specified']
KE 1943,Hyperphosphorylation of Tau,,Not specified,['Not specified'],['Not specified']
KE 1945,Dysfunctional Autophagy,,Not specified,['Not specified'],['Not specified']
KE 1944,Synaptic dysfunction,principal neuronal circuit,10116,['Unspecific'],['All life stages']
KE 1944,Synaptic dysfunction,principal neuronal circuit,10090,['Unspecific'],['All life stages']
KE 1944,Synaptic dysfunction,principal neuronal circuit,9606,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,9606,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,9685,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,9544,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,34880,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,9880,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,9666,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,9627,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,10036,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,9669,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,246437,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,230844,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,30548,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,105147,['Unspecific'],['All life stages']
KE 1939,"Viral infection and host-to-host transmission, proliferated",,9986,['Unspecific'],['All life stages']
KE 1950,"Increase, TNF",,Not specified,['Not specified'],['Not specified']
KE 1949,"Decrease, GLUT4",,Not specified,['Not specified'],['Not specified']
KE 1951,"Decrease, Glucose uptake",,Not specified,['Not specified'],['Not specified']
KE 1952,"Abnormal, Glucose homeostasis",,Not specified,['Not specified'],['Not specified']
KE 1953,Gestational diabetes mellitus,,Not specified,['Not specified'],['Not specified']
KE 1955,Acute Myeloid Leukemia,,Not specified,['Not specified'],['Not specified']
KE 2099,hERG channel blockade,,Not specified,['Not specified'],['Not specified']
KE 2100,Inhibition of rapid delayed rectifying potassium current,,Not specified,['Not specified'],['Not specified']
KE 1961,Prolongation of Action Potential Duration,,Not specified,['Not specified'],['Not specified']
KE 1962,Prolongation of QT interval,,Not specified,['Not specified'],['Not specified']
KE 1963,Torsades de Pointes,,Not specified,['Not specified'],['Not specified']
KE 1964,Sudden cardiac death,,Not specified,['Not specified'],['Not specified']
KE 1965,"Increase, Pollen abnormal",,Not specified,['Not specified'],['Not specified']
KE 442,"Decreased, Population trajectory",,Not specified,['Not specified'],['Not specified']
KE 1970,transposition of the great arteries,,Not specified,['Not specified'],['Not specified']
KE 105,"Inhibition, Mitochondrial Electron Transport Chain Complexes",,9606,['Not specified'],['Not specified']
KE 105,"Inhibition, Mitochondrial Electron Transport Chain Complexes",,10116,['Not specified'],['Not specified']
KE 105,"Inhibition, Mitochondrial Electron Transport Chain Complexes",,10090,['Not specified'],['Not specified']
KE 1971,"Increased, tumor growth",,9606,['Mixed'],['Adults']
KE 1982,metastatic breast cancer,,9606,['Mixed'],['Adult']
KE 1982,metastatic breast cancer,,9606,['Mixed'],['Adult']
KE 1972,"Increased, Steroidogenic acute regulatory protein (StAR)",reproductive organ,9606,"['Female', 'Male']","['Adult, reproductively mature']"
KE 1972,"Increased, Steroidogenic acute regulatory protein (StAR)",reproductive organ,10095,"['Female', 'Male']","['Adult, reproductively mature']"
KE 1972,"Increased, Steroidogenic acute regulatory protein (StAR)",reproductive organ,10116,"['Female', 'Male']","['Adult, reproductively mature']"
KE 1972,"Increased, Steroidogenic acute regulatory protein (StAR)",reproductive organ,9544,"['Female', 'Male']","['Adult, reproductively mature']"
KE 1973,"Increased, estrogens",reproductive organ,9606,"['Female', 'Male']","['Adult, reproductively mature']"
KE 1973,"Increased, estrogens",reproductive organ,10116,"['Female', 'Male']","['Adult, reproductively mature']"
KE 1973,"Increased, estrogens",reproductive organ,10095,"['Female', 'Male']","['Adult, reproductively mature']"
KE 2092,"Promotion, Ovarian Cancer",female reproductive organ,9606,['Female'],['Adult']
KE 2092,"Promotion, Ovarian Cancer",female reproductive organ,10116,['Female'],['Adult']
KE 2092,"Promotion, Ovarian Cancer",female reproductive organ,10095,['Female'],['Adult']
KE 1974,Activation of Tumor Protein 53,,10090,['Unspecific'],['Pregnancy']
KE 1974,Activation of Tumor Protein 53,,10116,['Unspecific'],['Pregnancy']
KE 1978,"Increase risk, microcephaly",,Not specified,['Not specified'],['Not specified']
KE 1979,Premature cell differentiation,,Not specified,['Not specified'],['Not specified']
KE 2200,"decline, neural progenitor cells",,Not specified,['Not specified'],['Not specified']
KE 1977,Disruption of sodium channel gating kinetics,nervous system,10090,"['Male', 'Female']",['All life stages']
KE 1977,Disruption of sodium channel gating kinetics,nervous system,10116,"['Male', 'Female']",['All life stages']
KE 1977,Disruption of sodium channel gating kinetics,nervous system,9606,"['Male', 'Female']",['All life stages']
KE 1983,"Disruption, action potential generation",,10090,"['Male', 'Female']",['All life stages']
KE 1983,"Disruption, action potential generation",,10116,"['Male', 'Female']",['All life stages']
KE 1983,"Disruption, action potential generation",,9606,"['Male', 'Female']",['All life stages']
KE 2005,Altered neurotransmission in development,brain,10090,"['Male', 'Female']",['During brain development']
KE 2005,Altered neurotransmission in development,brain,10116,"['Male', 'Female']",['During brain development']
KE 2005,Altered neurotransmission in development,brain,9606,"['Male', 'Female']",['During brain development']
KE 1980,Increased microRNA expression,,10095,['Female'],"['Adult, reproductively mature']"
KE 1980,Increased microRNA expression,,9606,['Female'],"['Adult, reproductively mature']"
KE 1981,Decreased SIRT1 expression,,9606,['Female'],"['Adult, reproductively mature']"
KE 1981,Decreased SIRT1 expression,,10095,['Female'],"['Adult, reproductively mature']"
KE 1554,Increase Chromosomal Aberrations,,9606,['Unspecific'],['All life stages']
KE 1554,Increase Chromosomal Aberrations,,10116,['Unspecific'],['All life stages']
KE 1554,Increase Chromosomal Aberrations,,10090,['Unspecific'],['All life stages']
KE 1985,"Increased, Kisspeptin signalling",,Not specified,['Not specified'],['Not specified']
KE 1986,"Decreased, Gonadotropins",,Not specified,['Not specified'],['Not specified']
KE 1987,"Decreased, Androgen and Progestin",,Not specified,['Not specified'],['Not specified']
KE 1988,"Decreased, Maturation Inducing Steroid Surge by Granulosa cells",,Not specified,['Not specified'],['Not specified']
KE 1989,"Impaired, Oocyte maturation and ovulation",,Not specified,['Not specified'],['Not specified']
KE 1990,"Increased, Oocyte Atresia",,Not specified,['Not specified'],['Not specified']
KE 1991,"Impaired, Reproduction",,Not specified,['Not specified'],['Not specified']
KE 2023,Inhibition of Ceramide Synthase,,Not specified,['Not specified'],['Not specified']
KE 2024,Reduced complex sphingolipids,,Not specified,['Not specified'],['Not specified']
KE 2025,Affected folate transporter,,Not specified,['Not specified'],['Not specified']
KE 2026,decreased folate uptake,,Not specified,['Not specified'],['Not specified']
KE 2033,Increased sphingolipid-1-phosphate,,Not specified,['Not specified'],['Not specified']
KE 2006,Secondary genotoxicity,,Not specified,['Not specified'],['Not specified']
KE 2007,Non-coding RNA expression profile alteration,,Not specified,['Not specified'],['Not specified']
KE 2008,Chronic obstructive pulmonary disease,,Not specified,['Not specified'],['Not specified']
KE 2009,Activation of inflammation pathway,,Not specified,['Not specified'],['Not specified']
KE 2010,Pulmonary inflammation,,Not specified,['Not specified'],['Not specified']
KE 2011,Emphysema,,Not specified,['Not specified'],['Not specified']
KE 2012,Fibroblast proliferation and differentiation,,Not specified,['Not specified'],['Not specified']
KE 2013,Airway remodeling,,Not specified,['Not specified'],['Not specified']
KE 2017,Endoplasmic reticulum stress,,Not specified,['Not specified'],['Not specified']
KE 2019,Non-alcoholic fatty liver disease,,Not specified,['Not specified'],['Not specified']
KE 2065,"Inhibition, Fatty acid oxidation",,Not specified,['Not specified'],['Not specified']
KE 2119,"Insulin resistance, increased",,9606,"['Male', 'Female']",['Adult']
KE 2119,"Insulin resistance, increased",,10116,"['Male', 'Female']",['Adult']
KE 2020,"Decrease, sox9 expression",,7955,['Unspecific'],"['Embryo', 'Development']"
KE 2020,"Decrease, sox9 expression",,9606,['Unspecific'],"['Embryo', 'Development']"
KE 2020,"Decrease, sox9 expression",,10090,['Unspecific'],"['Embryo', 'Development']"
KE 2020,"Decrease, sox9 expression",,10116,['Unspecific'],"['Embryo', 'Development']"
KE 2021,"Increase, slincR expression",,7955,['Unspecific'],"['Embryo', 'Development']"
KE 2021,"Increase, slincR expression",,10090,['Unspecific'],"['Embryo', 'Development']"
KE 2021,"Increase, slincR expression",,9606,['Unspecific'],"['Embryo', 'Development']"
KE 2118,"Succinate dehydrogenase, inhibited",liver parenchyma,10116,['Male'],['Adult']
KE 2120,"Superoxide generation, increased",,40674,['Mixed'],['Adult']
KE 2027,"Antagonism, Smoothened receptor",,7742,['Unspecific'],"['Embryo', 'All life stages']"
KE 2027,"Antagonism, Smoothened receptor",,50557,['Unspecific'],"['Embryo', 'All life stages']"
KE 2028,"Decrease, GLI1/2 translocation to nucleus",,Not specified,['Unspecific'],"['Embryo', 'All life stages']"
KE 2040,"Decrease, GLI1/2 target gene expression",,Not specified,['Unspecific'],['All life stages']
KE 2041,"Decrease, palatal shelf outgrowth",,7742,['Unspecific'],['Embryo']
KE 2042,Orofacial clefting,,7742,['Unspecific'],['Embryo']
KE 2043,"Decrease, Sonic Hedgehog second messenger production",,7742,['Unspecific'],['Embryo']
KE 2044,"Decrease, Smoothend relocation and activation",,7742,['Unspecific'],"['All life stages', 'Embryo']"
KE 2068,"Increase, Endothelial Dysfunction",endothelium,9606,['Unspecific'],['All life stages']
KE 2068,"Increase, Endothelial Dysfunction",endothelium,10116,['Unspecific'],['All life stages']
KE 2068,"Increase, Endothelial Dysfunction",endothelium,10090,['Unspecific'],['All life stages']
KE 901,"Infiltration, Inflammatory cells",liver,9606,['Not specified'],['Not specified']
KE 901,"Infiltration, Inflammatory cells",liver,10090,['Not specified'],['Not specified']
KE 1442,Foam cell formation,,Not specified,['Not specified'],['Not specified']
KE 2034,liver dysfunction,,Not specified,['Not specified'],['Not specified']
KE 2036,Activation of metabotropic glutamate receptor,,Not specified,['Not specified'],['Not specified']
KE 2037,Inositol triphosphate receptor activation,,Not specified,['Not specified'],['Not specified']
KE 2038,Activation of calpain signalling,,Not specified,['Not specified'],['Not specified']
KE 2039,Inhibition GABAA receptor,,Not specified,['Not specified'],['Not specified']
KE 2187,"Opening, voltage-gated calcium channels",,Not specified,['Not specified'],['Not specified']
KE 2188,"Activation, caspases",,Not specified,['Not specified'],['Not specified']
KE 1812,"Increase, Cytochrome c release",,Not specified,['Not specified'],['Not specified']
KE 2045,"Increase, Alcohol dehydrogenase",,Not specified,['Not specified'],['Not specified']
KE 2046,"Increase, Vitellogenin mRNA",,Not specified,['Not specified'],['Not specified']
KE 2047,"Delay, Ovarian maturation",,Not specified,['Not specified'],['Not specified']
KE 2048,"Increase, Body volume of female adults",,Not specified,['Not specified'],['Not specified']
KE 2049,"Increase, sex ratio (F/M)",,Not specified,['Not specified'],['Not specified']
KE 2050,"Increase, developmental abnormalities",,Not specified,['Not specified'],['Not specified']
KE 2051,"Decrease, Tyrosine",,Not specified,['Not specified'],['Not specified']
KE 2052,"Decrease, dopa decarboxylase",,Not specified,['Not specified'],['Not specified']
KE 2053,"Increase, Defects in tanning of new cuticle",,Not specified,['Not specified'],['Not specified']
KE 2054,"Increase,  impairment of cuticle sclerotization",,Not specified,['Not specified'],['Not specified']
KE 2055,"Increase,  pigmentation",,Not specified,['Not specified'],['Not specified']
KE 2056,"Increase,  delay in oviposition",,Not specified,['Not specified'],['Not specified']
KE 2057,"Decrease,  hatching of egg",,Not specified,['Not specified'],['Not specified']
KE 2058,"Decrease, 20-hydroxyecdysone",,Not specified,['Not specified'],['Not specified']
KE 2059,"Decrease, knickkopf gene",,Not specified,['Not specified'],['Not specified']
KE 2060,"Decrease, Chitin laminar organization",,Not specified,['Not specified'],['Not specified']
KE 2061,"Decrease, Prevent chitin degradation by chitinases",,Not specified,['Not specified'],['Not specified']
KE 2062,"Weak, Procuticle protection",,Not specified,['Not specified'],['Not specified']
KE 2063,"Decrease, New cuticle secretion",,Not specified,['Not specified'],['Not specified']
KE 2067,"Altered, Nitric Oxide Levels",,9606,"['Male', 'Female', 'Unspecific']","['Adult', 'Not Otherwise Specified']"
KE 2067,"Altered, Nitric Oxide Levels",,10116,"['Male', 'Female', 'Unspecific']","['Adult', 'Not Otherwise Specified']"
KE 2067,"Altered, Nitric Oxide Levels",,10090,"['Male', 'Female', 'Unspecific']","['Adult', 'Not Otherwise Specified']"
KE 2067,"Altered, Nitric Oxide Levels",,9986,"['Male', 'Female', 'Unspecific']","['Adult', 'Not Otherwise Specified']"
KE 2069,"Occurrence, Abnormal Vascular Remodeling",blood vessel,9606,"['Male', 'Female', 'Unspecific']","['Adult', 'Not Otherwise Specified']"
KE 2069,"Occurrence, Abnormal Vascular Remodeling",blood vessel,10116,"['Male', 'Female', 'Unspecific']","['Adult', 'Not Otherwise Specified']"
KE 2069,"Occurrence, Abnormal Vascular Remodeling",blood vessel,10090,"['Male', 'Female', 'Unspecific']","['Adult', 'Not Otherwise Specified']"
KE 2244,Altered Stress Response Signaling,,9606,['Unspecific'],['All life stages']
KE 2244,Altered Stress Response Signaling,,10116,['Unspecific'],['All life stages']
KE 2244,Altered Stress Response Signaling,,10090,['Unspecific'],['All life stages']
KE 2195,"Increase, CNS Neural cell death",,Not specified,['Not specified'],['Not specified']
KE 2196,"Decrease, elavl3",,Not specified,['Not specified'],['Not specified']
KE 2197,"Decrease, sox10",,Not specified,['Not specified'],['Not specified']
KE 2198,"Decrease, mbp",,Not specified,['Not specified'],['Not specified']
KE 2150,Neurological disorder,,Not specified,['Not specified'],['Not specified']
KE 191,Neuronal dysfunction,,Not specified,['Not specified'],['Not specified']
KE 637,"impaired, Learning and memory",,Not specified,['Not specified'],['Not specified']
KE 2078,Loss of drebrin,brain,10116,['Unspecific'],"['During brain development, adulthood and aging']"
KE 2078,Loss of drebrin,brain,10090,['Unspecific'],"['During brain development, adulthood and aging']"
KE 2078,Loss of drebrin,brain,9606,['Unspecific'],"['During brain development, adulthood and aging']"
KE 2151,"Disruption, neurotransmitter release",brain,10116,['Mixed'],"['Birth to < 1 month', 'Adult']"
KE 2151,"Disruption, neurotransmitter release",brain,9606,['Mixed'],"['Birth to < 1 month', 'Adult']"
KE 2151,"Disruption, neurotransmitter release",brain,10090,['Mixed'],"['Birth to < 1 month', 'Adult']"
KE 1177,"Decreased, Ionotropic GABA receptor chloride channel conductance",,Not specified,['Not specified'],['Not specified']
KE 2073,increase oxidation of the di-copper moiety of the hemocyanin active site,,Not specified,['Not specified'],['Not specified']
KE 2074,"Decreased, oxygen binding capacity by hemocyanin",,Not specified,['Not specified'],['Not specified']
KE 2075,"Cognitive, sensed as hypoxic/low oxygen environment",,Not specified,['Not specified'],['Not specified']
KE 2076,"Increase, hemocyanin mRNA",,Not specified,['Not specified'],['Not specified']
KE 2077,"Increase, pulmonate breathing",,Not specified,['Not specified'],['Not specified']
KE 2243,Succinate Accumulation,,Not specified,['Not specified'],['Not specified']
KE 2242,"Abnormality, dendritic spine morphology",brain,10116,['Unspecific'],"['During brain development, adulthood and aging']"
KE 2242,"Abnormality, dendritic spine morphology",brain,10090,['Unspecific'],"['During brain development, adulthood and aging']"
KE 2242,"Abnormality, dendritic spine morphology",brain,9606,['Unspecific'],"['During brain development, adulthood and aging']"
KE 2079,"Increased, glycolipid levels",,Not specified,['Not specified'],['Not specified']
KE 2080,"Impaired, blood testis barrier",,Not specified,['Not specified'],['Not specified']
KE 446,"Reduction, fetal/adult testosterone",blood,9606,['Not specified'],['Not specified']
KE 446,"Reduction, fetal/adult testosterone",blood,10116,['Not specified'],['Not specified']
KE 446,"Reduction, fetal/adult testosterone",blood,10090,['Not specified'],['Not specified']
KE 2141,"Disruption, Estrogen receptor",,Not specified,['Not specified'],['Not specified']
KE 2142,"Depletion, Ectoplasmic specialization (ES)",,Not specified,['Not specified'],['Not specified']
KE 2082,"Hypospadias, increased",penis,9606,['Male'],['Perinatal']
KE 2082,"Hypospadias, increased",penis,10090,['Male'],['Perinatal']
KE 2082,"Hypospadias, increased",penis,10116,['Male'],['Perinatal']
KE 2081,Increased Modified Proteins,,9606,"['Male', 'Female', 'Unspecific']","['Juvenile', 'Adult']"
KE 2081,Increased Modified Proteins,,10090,"['Male', 'Female', 'Unspecific']","['Juvenile', 'Adult']"
KE 2081,Increased Modified Proteins,,10116,"['Male', 'Female', 'Unspecific']","['Juvenile', 'Adult']"
KE 2081,Increased Modified Proteins,,9913,"['Male', 'Female', 'Unspecific']","['Juvenile', 'Adult']"
KE 2083,Occurrence of Cataracts,,9606,"['Female', 'Male']",['All life stages']
KE 2083,Occurrence of Cataracts,,10116,"['Female', 'Male']",['All life stages']
KE 2083,Occurrence of Cataracts,,10090,"['Female', 'Male']",['All life stages']
KE 2083,Occurrence of Cataracts,,9986,"['Female', 'Male']",['All life stages']
KE 2083,Occurrence of Cataracts,,9544,"['Female', 'Male']",['All life stages']
KE 2083,Occurrence of Cataracts,,9823,"['Female', 'Male']",['All life stages']
KE 2083,Occurrence of Cataracts,,10141,"['Female', 'Male']",['All life stages']
KE 2083,Occurrence of Cataracts,,8022,"['Female', 'Male']",['All life stages']
KE 2084,"Increase, Cardiac remodelling",,Not specified,['Not specified'],['Not specified']
KE 2215,Decrease Left Ventricular function,,Not specified,['Not specified'],['Not specified']
KE 1364,"Increase, Reactive oxygen species formation",,Not specified,['Not specified'],['Not specified']
KE 2085,Pulmonary epithelial injury,,Not specified,['Not specified'],['Not specified']
KE 2086,Airway inflammation,,Not specified,['Not specified'],['Not specified']
KE 2087,Increased incidence of respiratory disease,,Not specified,['Not specified'],['Not specified']
KE 2088,Dysfunction of respiratory system,,Not specified,['Not specified'],['Not specified']
KE 2089,Altered Bone Cell Homeostasis,,9606,['Unspecific'],['All life stages']
KE 2089,Altered Bone Cell Homeostasis,,10116,['Unspecific'],['All life stages']
KE 2089,Altered Bone Cell Homeostasis,,10090,['Unspecific'],['All life stages']
KE 2090,"Increase, Bone Remodeling",,9606,['Unspecific'],['All life stages']
KE 2090,"Increase, Bone Remodeling",,10116,['Unspecific'],['All life stages']
KE 2090,"Increase, Bone Remodeling",,10090,['Unspecific'],['All life stages']
KE 2091,"Occurrence, Bone Loss",,9606,['Unspecific'],['All life stages']
KE 2091,"Occurrence, Bone Loss",,10116,['Unspecific'],['All life stages']
KE 2091,"Occurrence, Bone Loss",,10090,['Unspecific'],['All life stages']
KE 2245,Altered Cell Differentiation Signaling,,9606,['Unspecific'],['All life stages']
KE 2245,Altered Cell Differentiation Signaling,,10116,['Unspecific'],['All life stages']
KE 2245,Altered Cell Differentiation Signaling,,10090,['Unspecific'],['All life stages']
KE 2097,"Increase, Pro-Inflammatory Mediators",,9606,['Mixed'],['Not Otherwise Specified']
KE 2097,"Increase, Pro-Inflammatory Mediators",,10116,['Mixed'],['Not Otherwise Specified']
KE 2097,"Increase, Pro-Inflammatory Mediators",,10090,['Mixed'],['Not Otherwise Specified']
KE 2098,"Increase, Abnormal Neural Remodeling",,9615,"['Male', 'Female', 'Unspecific']","['Juvenile', 'Adult']"
KE 2098,"Increase, Abnormal Neural Remodeling",,10116,"['Male', 'Female', 'Unspecific']","['Juvenile', 'Adult']"
KE 2098,"Increase, Abnormal Neural Remodeling",,10090,"['Male', 'Female', 'Unspecific']","['Juvenile', 'Adult']"
KE 2104,"Decreased, thyroid hormone binding to thyroid hormone receptor",,Not specified,['Not specified'],['Not specified']
KE 2105,"Decreased, myelin basic protein expression in oligodendrocytes",,Not specified,['Not specified'],['Not specified']
KE 2106,"Impaired, oligodendrocyte maturation",,Not specified,['Not specified'],['Not specified']
KE 2107,Hypomyelination,,Not specified,['Not specified'],['Not specified']
KE 2108,"Altered, white brain matter",,Not specified,['Not specified'],['Not specified']
KE 2109,"Binding, extracellular matrix protein laminin",,Not specified,['Not specified'],['Not specified']
KE 2110,"Disrupted binding, laminin-beta1-integrin receptors with laminin",,Not specified,['Not specified'],['Not specified']
KE 2111,"Decreased, neural progenitor cell adhesion to laminin",,Not specified,['Not specified'],['Not specified']
KE 2112,"Disturbed, radial glia cell alignment and migration",,Not specified,['Not specified'],['Not specified']
KE 2113,"Decreased, radial glia cell density",,Not specified,['Not specified'],['Not specified']
KE 2114,"Disturbed, cortical architecture",,Not specified,['Not specified'],['Not specified']
KE 2115,"Altered, cholesterol metabolism",,Not specified,['Not specified'],['Not specified']
KE 2116,"Decreased, oligodendrocyte differentiation",,Not specified,['Not specified'],['Not specified']
KE 1998,"Activation, Microglia",,Not specified,['Not specified'],['Not specified']
KE 2123,"decreased, Bcl-2 expression",,Not specified,['Not specified'],['Not specified']
KE 2124,"increased, Bax expression",organ,10090,['Female'],['All life stages']
KE 2124,"increased, Bax expression",organ,10116,['Female'],['All life stages']
KE 2124,"increased, Bax expression",organ,9606,['Female'],['All life stages']
KE 2124,"increased, Bax expression",organ,7227,['Female'],['All life stages']
KE 2121,"decreased, Intellectual Quotient",,Not specified,['Not specified'],['Not specified']
KE 2186,Ryanodine receptor activation,,Not specified,['Not specified'],['Not specified']
KE 130,"Depletion, GSH",liver,7742,['Unspecific'],['All life stages']
KE 2131,"Conjugation, GSH",liver,7742,['Unspecific'],['All life stages']
KE 2127,Increased adipocyte size,,Not specified,['Not specified'],['Not specified']
KE 2128,Increased adipocyte numbers,,Not specified,['Not specified'],['Not specified']
KE 2129,Metabolically unhealthy Obesity,,Not specified,['Not specified'],['Not specified']
KE 2125,Increased fat mass,,Not specified,['Not specified'],['Not specified']
KE 2126,Estrogen receptor alpha inactivation,,Not specified,['Not specified'],['Not specified']
KE 2130,increased lipid accumulation,,Not specified,['Not specified'],['Not specified']
KE 2132,Increased pro-inflammatory cytokine expression,,Not specified,['Not specified'],['Not specified']
KE 2134,"Increase, Androgen receptor protein expression/abundance",,Not specified,['Not specified'],['Not specified']
KE 2136,prostatic intraepithelial neoplasia,,Not specified,['Not specified'],['Not specified']
KE 2135,Prostate cancer,,Not specified,['Not specified'],['Not specified']
KE 2137,"Increase, Gonadotropins concentration in plasma",,Not specified,['Not specified'],['Not specified']
KE 2139,"Reduction, the ratio of 17beta-estradiol/11-Keto Testosterone in plasma",,Not specified,['Not specified'],['Not specified']
KE 2144,Impaired insulin signaling,,Not specified,['Not specified'],['Not specified']
KE 2145,Metabolic syndrome,,Not specified,['Not specified'],['Not specified']
KE 2148,Increased LCN2/iron complex  binds to SLC22A17 receptor in neuron,,Not specified,['Not specified'],['Not specified']
KE 2149,Increased intracelluar Iron accumulation,,Not specified,['Not specified'],['Not specified']
KE 2146,"Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2",brain,10116,['Mixed'],['Adult']
KE 2146,"Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2",brain,10090,['Mixed'],['Adult']
KE 2146,"Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2",brain,9606,['Mixed'],['Adult']
KE 2152,Epigenetic modification process,,40674,['Female'],['All life stages']
KE 2153,"Expression of factors ruling proliferation, modified",,131567,['Not specified'],['All life stages']
KE 2154,Uterine adenocarcinoma (endometrioid adenocarcinoma Type I),,40674,['Female'],['Not specified']
KE 2155,Inhibition of Sulfotransferase E1 (SULT1E1),organ,7742,['Unspecific'],['All life stages']
KE 2155,Inhibition of Sulfotransferase E1 (SULT1E1),organ,50557,['Unspecific'],['All life stages']
KE 2251,"Estradiol availability, increased",uterus,40674,"['Male', 'Female']","['Adult', 'Adult, reproductively mature', 'Old Age']"
KE 2158,Influenza A Virus (IAV) binds sialic acid glycan receptor,respiratory tract epithelium,9606,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 2158,Influenza A Virus (IAV) binds sialic acid glycan receptor,respiratory tract epithelium,9031,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 2158,Influenza A Virus (IAV) binds sialic acid glycan receptor,respiratory tract epithelium,9823,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 2158,Influenza A Virus (IAV) binds sialic acid glycan receptor,respiratory tract epithelium,10090,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 2158,Influenza A Virus (IAV) binds sialic acid glycan receptor,respiratory tract epithelium,9685,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 2158,Influenza A Virus (IAV) binds sialic acid glycan receptor,respiratory tract epithelium,9615,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 2158,Influenza A Virus (IAV) binds sialic acid glycan receptor,respiratory tract epithelium,9669,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 2158,Influenza A Virus (IAV) binds sialic acid glycan receptor,respiratory tract epithelium,10036,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 2158,Influenza A Virus (IAV) binds sialic acid glycan receptor,respiratory tract epithelium,10141,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 2158,Influenza A Virus (IAV) binds sialic acid glycan receptor,respiratory tract epithelium,9544,['Mixed'],"['Adult, reproductively mature', 'During development and at adulthood']"
KE 2159,Influenza A virus (IAV) cell entry,respiratory tract,9606,['Unspecific'],['All life stages']
KE 2159,Influenza A virus (IAV) cell entry,respiratory tract,9615,['Unspecific'],['All life stages']
KE 2180,Immune mechanisms antagonized by viral proteins,respiratory tract,9606,['Unspecific'],"['Adult, reproductively mature']"
KE 2180,Immune mechanisms antagonized by viral proteins,respiratory tract,9606,['Unspecific'],"['Adult, reproductively mature']"
KE 2192,Influenza A Virus production increased,respiratory tract,Not specified,['Not specified'],['Not specified']
KE 2193,Influenza A Virus (IAV) budding,respiratory tract,Not specified,['Not specified'],['Not specified']
KE 2194,Influenza A Virus (IAV) shedding and transmission,,Not specified,['Not specified'],['Not specified']
KE 1928,increased，Vascular endothelial dysfunction,,Not specified,['Not specified'],['Not specified']
KE 2161,"Increase, Vascular disrupting effects",,Not specified,['Not specified'],['Not specified']
KE 2181,Angiogenesis dysfunction,,Not specified,['Not specified'],['Not specified']
KE 2162,"Activation, HIF1α",,Not specified,['Not specified'],['Not specified']
KE 2163,Activation Sema6A,,Not specified,['Not specified'],['Not specified']
KE 2164,"Activation, Dll4-Notch pathway",,Not specified,['Not specified'],['Not specified']
KE 2165,Activation of PPAR,,Not specified,['Not specified'],['Not specified']
KE 2166,Abnormal expression of NO,,Not specified,['Not specified'],['Not specified']
KE 2167,Activation of MMP-2 MMP-9,,Not specified,['Not specified'],['Not specified']
KE 2168,Activation of angiopoietin like protein 4,,Not specified,['Not specified'],['Not specified']
KE 2169,Activation of Angiogenic cytokines,,Not specified,['Not specified'],['Not specified']
KE 257,"Increase, Excessive reactive Oxygen Species",,Not specified,['Not specified'],['Not specified']
KE 2170,Activated ANG/Tie2 pathway,,Not specified,['Not specified'],['Not specified']
KE 2171,Activated BMP/TGF-beta pathway,,Not specified,['Not specified'],['Not specified']
KE 2172,Activated Wnt/Frizzled pathway,,Not specified,['Not specified'],['Not specified']
KE 2173,Activated AKT/ERK/PI3K pathway,,Not specified,['Not specified'],['Not specified']
KE 2174,Inhibition VEGF/VEGFR pathway,,Not specified,['Not specified'],['Not specified']
KE 2178,Vascular barrier disruption,,Not specified,['Not specified'],['Not specified']
KE 2179,Impaired Platelet Aggregation,,Not specified,['Not specified'],['Not specified']
KE 2199,"Increased, Expression of LXR activated genes",,7742,['Unspecific'],"['Adult', 'Juvenile']"
KE 2282,Cardiac ion channels blockade,,Not specified,['Not specified'],['Not specified']
KE 2283,Increased the early premature depolarizations during repolarization,,Not specified,['Not specified'],['Not specified']
KE 1929,Increased incidence of cardiovascular morbidity and mortality in the general population,,Not specified,['Not specified'],['Not specified']
KE 2201,"Agonism, Retinoic acid receptor",,Not specified,['Not specified'],['During brain development']
KE 2202,Altered expression of cell cycle genes,,Not specified,['Not specified'],['Not specified']
KE 2203,Decreased proliferation of cortical neural progenitor cells,,9606,['Not specified'],['Not specified']
KE 2204,Altered brain morphology,,Not specified,['Not specified'],['Not specified']
KE 2205,"Increased, essential element imbalance",testis,39108,"['Male', 'Unspecific']","['Adult', 'All life stages']"
KE 2206,"Increased, histomorphological alteration of testis",testis,39108,['Male'],['Adult']
KE 2207,"inhibition, EKR1/2 signaling pathway",,Not specified,['Not specified'],['Not specified']
KE 2208,"Aberrant, synaptic formation and plasticity",,Not specified,['Not specified'],['Not specified']
KE 2209,autism-like behavior,,Not specified,['Not specified'],['Not specified']
KE 2210,Reduced cortical thickness,,Not specified,['Not specified'],['Not specified']
KE 2252,"Human leukocyte antigen DQ2/8-gluten complexes, formation",duodenum,9606,['Unspecific'],['All life stages']
KE 2253,"Gluten-reactive T cell receptors, generation",thymus,9606,['Unspecific'],['During development and at adulthood']
KE 2254,"Gluten-reactive and transglutaminase 2 reactive B cell receptors, generation",bone marrow,9606,['Unspecific'],['All life stages']
KE 2255,"Innate immune response, activation",small intestine,Not specified,['Not specified'],['Not specified']
KE 2256,"Gluten-reactive B cells and transglutaminase 2-reactive B cells, activation",duodenum,9606,['Unspecific'],['All life stages']
KE 2257,Celiac disease,,9606,['Unspecific'],['All life stages']
KE 2260,"Gluten-reactive CD4+ T cells, activation",duodenum,9606,['Unspecific'],['All life stages']
KE 2275,"Gluten reactive adaptive T-cells with antigen presenting cells, co-localization",duodenum lamina propria,9606,['Unspecific'],['All life stages']
KE 2216,Binding of antagonist to thyroid hormone receptor,,Not specified,['Not specified'],['Not specified']
KE 2217,Binding of antagonist to glucocorticoid hormone receptor,,Not specified,['Not specified'],['Not specified']
KE 2218,Binding of (ant)agonist to liver X receptor,,Not specified,['Not specified'],['Not specified']
KE 2219,Binding of (ant)agonist to peroxisome proliferator–activated receptor alpha,,Not specified,['Not specified'],['Not specified']
KE 2220,"Antagonism, Glucocorticoid hormone receptor",,Not specified,['Not specified'],['Not specified']
KE 2221,Altered Liver X receptor activity,,Not specified,['Not specified'],['Not specified']
KE 2222,Altered peroxisome proliferator–activated receptor alpha activity,,Not specified,['Not specified'],['Not specified']
KE 2223,Reduced number of oligodendrocytes,,Not specified,['Not specified'],['Not specified']
KE 2212,Epididymal agenesis,epididymis,7742,['Male'],['During development and at adulthood']
KE 2213,"Impaired, urethral tube closure",,7742,['Unspecific'],['During development and at adulthood']
KE 2214,"Decreased, Insulin-like peptide 3 (INSL3)",,40674,['Unspecific'],['Development']
KE 2224,Dysregulation of transcriptional expression within PPAR signaling network,liver,7742,"['Male', 'Female']","['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 2225,Disrupted Lipid Storage,liver,7742,"['Male', 'Female']","['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 2226,Stressor binding PPAR isoforms,liver,7742,"['Male', 'Female']","['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 2227,Disrupted PPAR isoform nuclear signaling,liver,7742,"['Male', 'Female']","['Embryo', 'Juvenile', 'Adult, reproductively mature']"
KE 2228,Cerebellar gene expression. Altered,,Not specified,['Not specified'],['Not specified']
KE 2229,Cerebellar neuronal differentiation. Decreased,,Not specified,['Not specified'],['Not specified']
KE 2230,Cerebellar hypoplasia,,Not specified,['Not specified'],['Not specified']
KE 2231,Locomotor function. Impaired,,Not specified,['Not specified'],['Not specified']
KE 2232,"Antagonism, Retinoic acid receptors",,Not specified,['Not specified'],['Not specified']
KE 1553,Increase mutations,,Not specified,['Not specified'],['Not specified']
KE 2233,"Decreased, ERαβ heterodimers",,Not specified,['Not specified'],['Not specified']
KE 2240,The NO synthase pathway activation,,Not specified,['Not specified'],['Not specified']
KE 2241,Ferroptosis related pathways activation,,Not specified,['Not specified'],['Not specified']
KE 2236,"Decreased, Sodium uptake in gills",,7955,['Unspecific'],"['Juvenile', 'Adult']"
KE 2237,"Decreased, Plasma sodium concentrations",,33208,['Unspecific'],['All life stages']
KE 2238,"Increased, Blood viscosity",,33208,['Unspecific'],['All life stages']
KE 2239,"Increased, Cardiac stress",,33208,['Unspecific'],['All life stages']
KE 2261,"Decreased, blood plasma volume",,33208,['Unspecific'],['All life stages']
KE 2262,"Neuropathy target esterase, inhibited",nervous system,Not specified,['Unspecific'],['Not specified']
KE 2263,"Lysolecithin, increased",,9606,['Unspecific'],['Not specified']
KE 2264,"Lysolecithin cell membrane integration, increased",,9606,['Unspecific'],['Not specified']
KE 2265,"Oligodendrocyte death, increased",nervous system,9606,['Unspecific'],['Not specified']
KE 2266,"Demyelination, increased",nervous system,9606,['Unspecific'],['Not specified']
KE 2267,"Delayed neuropathy, increased",,9606,['Unspecific'],['Not specified']
KE 2268,"Decreased, insulin-induced gene 1 (INSIG1) protein activity",,40674,['Unspecific'],['All life stages']
KE 2269,"Increased, Sterol Regulatory Element Binding Protein 2 (SREBP2) protein expression",,40674,['Unspecific'],['All life stages']
KE 2270,"Increased, cholesterol synthesis enzymes",,40674,['Unspecific'],['All life stages']
KE 2271,"Increased, plasma low-density lipoprotein (LDL) cholesterol",blood plasma,40674,['Unspecific'],['All life stages']
KE 2274,"Androgen receptor activation, increased",,40674,['Mixed'],['During development and at adulthood']
KE 2276,"Increased, protein expression of proprotein convertase subtilisin/kexin type 9 (PCSK9)",,40674,['Unspecific'],['All life stages']
KE 2277,"Inhibition, aromatase activity in plasma",,Not specified,['Not specified'],['Not specified']
KE 2278,Increased LMNA Mutation,,9606,['Mixed'],['Conception to < Fetal']
KE 2279,Structural changes in lamin A/C,,Not specified,['Not specified'],['Not specified']
KE 2066,Altered Signaling Pathways,,9606,['Unspecific'],['All life stages']
KE 2066,Altered Signaling Pathways,,10116,['Unspecific'],['All life stages']
KE 2066,Altered Signaling Pathways,,10090,['Unspecific'],['All life stages']
KE 1924,Increased，Cardiac fibrosis,,Not specified,['Not specified'],['Not specified']
KE 2280,Increased delay in heart electrical conduction,,Not specified,['Not specified'],['Not specified']
KE 2281,Increased uncoordinated cardiac contraction,,Not specified,['Not specified'],['Not specified']
KE 2284,Increased Intracellular cAMP Levels,,Not specified,['Not specified'],['Not specified']
KE 2285,Increased the delayed and early afterdepolarizations,,Not specified,['Not specified'],['Not specified']
KE 2287,Impaired Sodium-Calcium Exchange,,Not specified,['Not specified'],['Not specified']
KE 2157,Abnormal Cardiac Structure and Function,,Not specified,['Not specified'],['Not specified']
KE 2288,Phosphodiesterase inhibition,,Not specified,['Not specified'],['Not specified']
KE 2289,Hyperphosphorylation of ryanodine receptor (RyR2),,Not specified,['Not specified'],['Not specified']
KE 2290,Inhibition of Funny current (If),,Not specified,['Not specified'],['Not specified']
KE 2291,Slowed Heart Rate,,9606,['Mixed'],['Conception to < Fetal']
KE 2292,Altered Cardiac Electrical Conduction,,Not specified,['Not specified'],['Not specified']
KE 2293,"Aromatase, induction",gonad,40674,['Unspecific'],['All life stages']
KE 2293,"Aromatase, induction",gonad,7742,['Unspecific'],['All life stages']
KE 2293,"Aromatase, induction",gonad,50557,['Unspecific'],['All life stages']
KE 2294,"Plasma estradiol, increased",,Not specified,['Not specified'],['Not specified']
KE 2295,HCN Channel Inhibition,,Not specified,['Not specified'],['Not specified']
KE 2296,Reduced Pacemaker Activity in SA Node,,Not specified,['Not specified'],['Not specified']
KE 2305,Premature ovarian Insufficiency,ovarian cortex,10116,['Female'],['All life stages']
KE 2305,Premature ovarian Insufficiency,ovarian cortex,10090,['Female'],['All life stages']
KE 2305,Premature ovarian Insufficiency,ovarian cortex,9606,['Female'],['All life stages']
KE 1541,Mitochondrial Complex I inhibition,,Not specified,['Not specified'],['Not specified']
KE 2299,"Altered, Redox Homeostasis",,7955,['Unspecific'],"['Embryo', 'Larvae']"
KE 2300,"Disruption, Glucolipid metabolism",,7955,['Unspecific'],"['Embryo', 'Juvenile']"
KE 2301,"Abnormal, Behavior",,7955,['Unspecific'],['Larvae']
KE 2302,"Increase, Malformations",,7955,['Unspecific'],"['Embryo', 'Larvae']"
KE 2250,"17β-Hydroxysteroid dehydrogenase 2, inhibition",uterus,40674,"['Male', 'Female']",['All life stages']
KE 2250,"17β-Hydroxysteroid dehydrogenase 2, inhibition",uterus,50557,"['Male', 'Female']",['All life stages']
KE 2250,"17β-Hydroxysteroid dehydrogenase 2, inhibition",uterus,7955,"['Male', 'Female']",['All life stages']
KE 2250,"17β-Hydroxysteroid dehydrogenase 2, inhibition",uterus,8292,"['Male', 'Female']",['All life stages']
KE 2250,"17β-Hydroxysteroid dehydrogenase 2, inhibition",uterus,8782,"['Male', 'Female']",['All life stages']
KE 2303,Increased plasma estradiol to progesterone ratio (estrogen dominance/unopposed estrogen),blood plasma,Not specified,['Not specified'],['Not specified']
KE 2306,Persistent vaginal cornification,epithelium of vagina,40674,['Female'],"['Adult, reproductively mature']"
KE 2308,"Increased, stimulation of brain serotonin 5-HT1a, 5-HT2c receptors",brain,7955,['Unspecific'],['All life stages']
KE 2308,"Increased, stimulation of brain serotonin 5-HT1a, 5-HT2c receptors",brain,10116,['Unspecific'],['All life stages']
KE 2309,Decreased DNA methylation of FAM50B/PTCHD3,,Not specified,['Not specified'],['Not specified']
KE 2310,Elevated gene expression of FAM50B/PTCHD3,,Not specified,['Not specified'],['Not specified']
KE 2311,Inhibition of PI3K-Akt pathway,,Not specified,['Not specified'],['Not specified']
KE 1940,"Increased, Reactive oxygen species",organ,9606,['Unspecific'],['All life stages']
KE 1940,"Increased, Reactive oxygen species",organ,9606,['Unspecific'],['All life stages']
KE 1940,"Increased, Reactive oxygen species",organ,10090,['Unspecific'],['All life stages']
KE 1940,"Increased, Reactive oxygen species",organ,35525,['Unspecific'],['All life stages']
KE 1940,"Increased, Reactive oxygen species",organ,4472,['Unspecific'],['All life stages']
KE 1940,"Increased, Reactive oxygen species",organ,7955,['Unspecific'],['All life stages']
KE 2316,"Increased, pulmonary edema",lung,10116,['Unspecific'],['All life stages']
KE 2316,"Increased, pulmonary edema",lung,9606,['Unspecific'],['All life stages']
KE 2317,Loss of olfactory function,nose,10116,['Unspecific'],['All life stages']
KE 2317,Loss of olfactory function,nose,9606,['Unspecific'],['All life stages']
